
<html lang="en"     class="pb-page"  data-request-id="815011f2-1562-4c51-833a-1fa160422616"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-8;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm4002154"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species" /></meta><meta name="dc.Creator" content="Kevin W.  Hunt" /></meta><meta name="dc.Creator" content="Adam W.  Cook" /></meta><meta name="dc.Creator" content="Ryan J.  Watts" /></meta><meta name="dc.Creator" content="Christopher T.  Clark" /></meta><meta name="dc.Creator" content="Guy  Vigers" /></meta><meta name="dc.Creator" content="Darin  Smith" /></meta><meta name="dc.Creator" content="Andrew T.  Metcalf" /></meta><meta name="dc.Creator" content="Indrani W.  Gunawardana" /></meta><meta name="dc.Creator" content="Michael  Burkard" /></meta><meta name="dc.Creator" content="April A.  Cox" /></meta><meta name="dc.Creator" content="Mary K.  Geck Do" /></meta><meta name="dc.Creator" content="Darrin  Dutcher" /></meta><meta name="dc.Creator" content="Allen A.  Thomas" /></meta><meta name="dc.Creator" content="Sumeet  Rana" /></meta><meta name="dc.Creator" content="Nicholas C.  Kallan" /></meta><meta name="dc.Creator" content="Robert K.  DeLisle" /></meta><meta name="dc.Creator" content="James P.  Rizzi" /></meta><meta name="dc.Creator" content="Kelly  Regal" /></meta><meta name="dc.Creator" content="Douglas  Sammond" /></meta><meta name="dc.Creator" content="Robert  Groneberg" /></meta><meta name="dc.Creator" content="Michael  Siu" /></meta><meta name="dc.Creator" content="Hans  Purkey" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Creator" content="Allison  Marlow" /></meta><meta name="dc.Creator" content="Xingrong  Liu" /></meta><meta name="dc.Creator" content="Tony P.  Tang" /></meta><meta name="dc.Description" content="A hallmark of Alzheimer’s disease is the brain deposition of amyloid beta (Aβ), a peptide of 36–43 amino acids that is likely a primary driver of neurodegeneration. Aβ is produced by the sequential..." /></meta><meta name="Description" content="A hallmark of Alzheimer’s disease is the brain deposition of amyloid beta (Aβ), a peptide of 36–43 amino acids that is likely a primary driver of neurodegeneration. Aβ is produced by the sequential..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 16, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4002154" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4002154" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4002154" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4002154" /></link>
        
    
    

<title>Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4002154" /></meta><meta property="og:title" content="Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0015.jpeg" /></meta><meta property="og:description" content="A hallmark of Alzheimer’s disease is the brain deposition of amyloid beta (Aβ), a peptide of 36–43 amino acids that is likely a primary driver of neurodegeneration. Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer’s disease. Herein we describe BACE1 inhibitors with limited molecular flexibility and molecular weight that decrease CSF Aβ in vivo, despite efflux. Starting with spirocycle 1a, we explore structure–activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood–brain barrier (BBB) penetration. Using wild type guinea pig and rat, we demonstrate a PK/PD relationship between free drug concentrations in the brain and CSF Aβ lowering. Optimization of brain exposure led to the discovery of (R)-50 which reduced CSF Aβ in rodents and in monkey." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4002154"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4002154">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4002154&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4002154&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4002154&amp;href=/doi/10.1021/jm4002154" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3379-3403</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4002007" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4002346" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+W.++Hunt">Kevin W. Hunt</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam+W.++Cook">Adam W. Cook</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+J.++Watts">Ryan J. Watts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+T.++Clark">Christopher T. Clark</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Vigers">Guy Vigers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darin++Smith">Darin Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+T.++Metcalf">Andrew T. Metcalf</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Indrani+W.++Gunawardana">Indrani W. Gunawardana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Burkard">Michael Burkard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=April+A.++Cox">April A. Cox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+K.++Geck+Do">Mary K. Geck Do</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darrin++Dutcher">Darrin Dutcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allen+A.++Thomas">Allen A. Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sumeet++Rana">Sumeet Rana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+C.++Kallan">Nicholas C. Kallan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+K.++DeLisle">Robert K. DeLisle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+P.++Rizzi">James P. Rizzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Regal">Kelly Regal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Sammond">Douglas Sammond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Groneberg">Robert Groneberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Siu">Michael Siu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hans++Purkey">Hans Purkey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allison++Marlow">Allison Marlow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingrong++Liu">Xingrong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tony+P.++Tang">Tony P. Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 303-386-1153. Fax: 303-386-1130. E-mail: <a href="/cdn-cgi/l/email-protection#7b101e0d121555130e150f3b1a09091a021912140b131a09161a55181416"><span class="__cf_email__" data-cfemail="335856455a5d1d5b465d4773524141524a515a5c435b52415e521d505c5e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4002154&amp;href=/doi/10.1021%2Fjm4002154" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3379–3403</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 28, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 February 2013</li><li><span class="item_label"><b>Published</b> online</span>16 April 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 April 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4002154" title="DOI URL">https://doi.org/10.1021/jm4002154</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3379%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKevin%2BW.%2BHunt%252C%2BAdam%2BW.%2BCook%252C%2BRyan%2BJ.%2BWatts%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D8%26contentID%3Djm4002154%26title%3DSpirocyclic%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%253A%2BFrom%2BHit%2Bto%2BLowering%2Bof%2BCerebrospinal%2BFluid%2B%2528CSF%2529%2BAmyloid%2B%25CE%25B2%2Bin%2Ba%2BHigher%2BSpecies%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3403%26publicationDate%3DApril%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4002154"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2802</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4002154" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;W. Hunt&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;W. Cook&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;J. Watts&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;T. Clark&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Vigers&quot;},{&quot;first_name&quot;:&quot;Darin&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;T. Metcalf&quot;},{&quot;first_name&quot;:&quot;Indrani&quot;,&quot;last_name&quot;:&quot;W. Gunawardana&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Burkard&quot;},{&quot;first_name&quot;:&quot;April&quot;,&quot;last_name&quot;:&quot;A. Cox&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;K. Geck Do&quot;},{&quot;first_name&quot;:&quot;Darrin&quot;,&quot;last_name&quot;:&quot;Dutcher&quot;},{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;A. Thomas&quot;},{&quot;first_name&quot;:&quot;Sumeet&quot;,&quot;last_name&quot;:&quot;Rana&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;C. Kallan&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;K. DeLisle&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;P. Rizzi&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Regal&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Sammond&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Groneberg&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Siu&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;Purkey&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;Marlow&quot;},{&quot;first_name&quot;:&quot;Xingrong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Tony&quot;,&quot;last_name&quot;:&quot;P. Tang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;3379-3403&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4002154&quot;},&quot;abstract&quot;:&quot;A hallmark of Alzheimer’s disease is the brain deposition of amyloid beta (Aβ), a peptide of 36–43 amino acids that is likely a primary driver of neurodegeneration. Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer’s disease. Herein we describe BACE1 inhibitors with limited molecular flexibility and molecular weight that decrease CSF Aβ in vivo, despite efflux. Starting with spirocycle 1a, we explore structure–activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood–brain barrier (BBB) penetration. Using wild type guinea pig and rat, we demonstrate a PK/PD relationship between free drug concentrations in the brain and CSF Aβ lowering. Optimization of brain exposure led to the discovery of (R)-50 which reduced CSF Aβ in rodents and in monkey.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4002154&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002154" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4002154&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002154" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4002154&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002154" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4002154&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4002154&amp;href=/doi/10.1021/jm4002154" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4002154" /></input><a href="/doi/pdf/10.1021/jm4002154" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26pmid%3D23537249%26genre%3Darticle%26aulast%3DHunt%26date%3D2013%26atitle%3DSpirocyclic%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%253A%2BFrom%2BHit%2Bto%2BLowering%2Bof%2BCerebrospinal%2BFluid%2B%2528CSF%2529%2BAmyloid%2B%25CE%25B2%2Bin%2Ba%2BHigher%2BSpecies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D8%26spage%3D3379%26epage%3D3403%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jmcmar.2013.56.issue-8/production/jmcmar.2013.56.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A hallmark of Alzheimer’s disease is the brain deposition of amyloid beta (Aβ), a peptide of 36–43 amino acids that is likely a primary driver of neurodegeneration. Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer’s disease. Herein we describe BACE1 inhibitors with limited molecular flexibility and molecular weight that decrease CSF Aβ in vivo, despite efflux. Starting with spirocycle <b>1a</b>, we explore structure–activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood–brain barrier (BBB) penetration. Using wild type guinea pig and rat, we demonstrate a PK/PD relationship between free drug concentrations in the brain and CSF Aβ lowering. Optimization of brain exposure led to the discovery of <b>(</b><i><b>R</b></i><b>)-50</b> which reduced CSF Aβ in rodents and in monkey.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The PDB accession codes for the X-ray cocrystal structures of BACE1 + <b>1a</b>, BACE1 + <b>12</b>, BACE1 + <b>13</b>, and BACE1 + <b>(<i>R</i>)-50</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JOO">4JOO</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JP9">4JP9</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JPC">4JPC</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JPE">4JPE</a>, respectively.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is an irreversible neurodegenerative disease that affects more than 18 million patients worldwide. The cost of care for AD patients exceeds $172 billion in the U.S. alone, despite over 15 million family members providing unpaid care. By 2050, the U.S. cost of care is predicted to exceed $1 trillion.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The consequences of AD (principally the projected stresses upon health care systems) have spurred greater government funding for AD by France and the United States.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Further investment from government agencies is timely, as many pharmaceutical companies are divesting CNS research.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Modifying the course of AD may be possible by decreasing the production of amyloid β peptides (Aβ), the presumptive molecules central to the amyloid hypothesis resulting from metabolism of the amyloid precursor protein (APP).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This hypothesis is based upon the increased production of Aβ in patients with dominantly inherited forms of AD, the high Aβ<sub>1–40,42</sub> content in plaques from post-mortem brains of AD patients, and experiments demonstrating the neuronal toxicity of Aβ. Further, Down syndrome patients, who often develop AD pathology by age 50, have increased Aβ levels from birth and show plaque deposition as early as their preteen years.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The amyloid hypothesis has been modified slightly to focus on the greater in vivo neurotoxicity of Aβ oligomers vs monomers.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> A corollary to the amyloid hypothesis is that decreasing Aβ production will be disease modifying, at least in the early stages of the disease. This view was bolstered by the recent discovery of a coding mutation in the APP gene that protects against AD and cognitive decline in the elderly. The mutation is near the aspartyl protease β-site of APP and reduces in vitro Aβ production by approximately 40%.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">The enzyme that initiates the cascade of Aβ production is the β-site APP cleaving enzyme 1 (BACE1), also known as membrane-associated aspartic protease 2 (memapsin 2) and aspartyl protease 2 (ASP2).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> BACE1 is most highly expressed in the brain where it cleaves APP to release the amino-terminal fragment of APP (sAPPβ) and the membrane bound C-terminal fragment C99. Cleavage of the C99 fragment by γ-secretase releases Aβ.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The therapeutic potential for BACE1 inhibition coupled with the inferred safety from the viability of BACE1<sup>–/–</sup> mice<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> has resulted in numerous publications about the discovery and characterization of BACE1 inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Recently, Eli Lilly researchers published phase I clinical results for a BACE1 inhibitor yielding important proof of mechanism data for this pathway in humans. While the Lilly compound effectively lowered CSF Aβ levels, advancement of the molecule was halted because of retinal pathology identified in a 3-month rat toxicology study.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The observed retinal pathology of the Lilly compound is consistent with observations from animals deficient in the aspartyl protease cathepsin D (CatD).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These data suggest that selectivity for BACE1 over CatD inhibition is essential.</div><div class="NLM_p">The efficacy of a BACE1 inhibitor is equally dependent upon blood–brain barrier (BBB) permeability as it is upon potency. While protecting the brain from exposure to pollutants and toxins, the BBB also limits the entry of potentially beneficial xenobiotics such as pharmaceutical agents.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Fortunately, limiting total polar surface area (tPSA < 90),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> molecular weight (MW < 450), lipophilicity (cLogP < 4), hydrogen bond donors (<3), and rotatable bonds (molecular flexibility) generally enhances free drug exposure to the brain.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Adherence to these limits increases the probability of successfully discovering CNS penetrant molecules.</div><div class="NLM_p">A key advancement in BACE1 inhibitor design is the discovery of 2-amino heterocycles that engage both active site aspartyl moieties of BACE1.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These ligands enable a better balance of physical–chemical properties, improved brain penetrance, and in vivo efficacy. Although highly potent, the reported 2-amino heterocyclic inhibitors often utilize cores that are highly aromatic or contain multiple rotatable bonds. Seeking to identify novel, highly soluble, and permeable BACE1 inhibitors, we prepared a collection of small, rigid, and saturated or partially saturated cores utilizing 2-amino heterocycles, leading to the identification of spirocycle hydantoin <b>1a</b> (BACE1 IC<sub>50</sub> = 36.8 μM). Spirocycle <b>1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) presents an ideal core for optimization, as it combines (1) limited molecular flexibility with three-dimensionality, key factors for improved permeability and solubility,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> (2) accessible vectors to the S3 and S2′ sites of BACE1, (3) utilization of a 2-amino heterocycle to engage both Asp32 and Asp228 of the BACE1 active site, and (4) low MW (338.2). Note that only the density of the (<i>R</i>)-enantiomer of racemate <b>1a</b> was detectable in the BACE1 active site.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray cocrystal structure of BACE1 and <b>1a</b>. The surface of the protein is colored by electrostatic potential. Part of the flexible “flap” including Tyr14 is visible at the top of the image. The two key active site aspartic acids, Asp32 and Asp228, are also labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To limit the number of rotatable bonds while preserving three-dimensionality, our investigation utilized spiro-bicyclic cores that omit P2′ groups. The synthesis of aminohydantoin analogues commenced with Bucherer–Bergs reaction of ketones <b>2a</b>–<b>c</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Selective alkylation of the imide nitrogen of the intermediate hydantoins provided alkylated hydantoins <b>3a</b>–<b>c</b>. Reaction with Lawesson’s reagent followed by oxidative amination provided the desired spiro-bicyclic cores <b>1a</b>–<b>c</b>. A Suzuki reaction or amination–acylation sequence provided analogues <b>11</b>–<b>50</b> and <b>53</b>–<b>56</b>. Further diversity was introduced onto the spiro-hydantoin-tetrahydronaphthalene (THN) core by benzylic oxidation, benzylic fluorination, and subsequent Suzuki coupling (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><div class="NLM_p">The aminooxazoline and aminothiazoline heterocycles were readily introduced onto olefin <b>6</b>, obtained by Tebbe olefination of ketone <b>2c</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Treatment of <b>6</b> with iodine and either silver cyanate or silver thiocyanate provided intermediate iodoisocyanates or iodoisothiocyanates. Immediate reaction with ammonia provided the desired aminooxazoline<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and aminothiazoline, respectively. A Suzuki reaction provided the desired analogues <b>57</b>, <b>58</b>, and <b>61</b>–<b>63</b>.</div><div class="NLM_p">Synthesis of the six-membered amino heterocycles commenced from ketone <b>2c</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Vinyl Grignard addition, thionyl chloride treatment, and thiourea displacement of the allylic chloride provided carbamimidothioate <b>7</b>. Cyclization to the aminothiazine was accomplished at low temperature with a 1:1 mixture of methanesulfonic acid and TFA.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A Suzuki reaction provided thiazine <b>59</b>. Ellman–Tang methodology provided β-amino ester equivalent <b>8</b> from ketone <b>2c</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Deprotection followed by cyclization with protected thiourea <b>10</b> and EDCI provided bromide <b>9</b>. Standard Suzuki reaction conditions constructed the biaryl bond and removed the Boc protecting group to provide analogue <b>60</b>.</div><div class="NLM_p">All analogues were synthesized and assayed initially as racemates. Analogues with a range of BACE1 potency, selectivity vs CatD, permeability, efflux liability, and microsomal stability were assessed for BBB permeability in mice. Compounds achieving successful profiles including promising unbound concentrations in the brain (<i>C</i><sub>free,brain</sub>) were resolved and advanced to pharmacodynamic studies.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aminohydantoins<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) For X = O, S: (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, KCN, DMA, 80 °C. For X = CH<sub>2</sub>: (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, KCN, EtOH, 150 °C (steel pressure bomb). (b) K<sub>2</sub>CO<sub>3</sub>, RX, DMF, rt; (c) Lawesson’s reagent, toluene, reflux; (d) NH<sub>3</sub>, <sup><i>t</i></sup>BuOOH, MeOH, H<sub>2</sub>O, rt; (e) R′B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C; (f) BocNH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, THF, rt; (g) TFA, DCM, rt; (h) 5-methylfuran-2-carbonyl chloride, Et<sub>3</sub>N, DCM, rt.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Tetrahydronaphthalone and Difluoronaphthalene Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CrO<sub>3</sub>, <sup><i>t</i></sup>BuOOH, DCM, rt; (b) 5-pyrimidinylboronic acid, PdCl<sub>2</sub>(dppf)·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C; (c) bis(2-methoxyethyl)aminosulfur trifluoride, DCE, rt.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Aminooxazoline and Aminothiazoline Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe reagent, PhMe or DCM, rt. (b) For X═O: AgOCN, I<sub>2</sub>, THF, ether, 0 °C. (c) For X═S: AgSCN, I<sub>2</sub>, THF, ether, 0 °C. (d) NH<sub>3</sub>, MeOH, THF, rt; (e) RB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aminothiazine and Aminodihydropyrimidinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) vinylmagnesium bromide, THF, 0 °C; (b) Thionyl chloride, hexanes, 0 °C; (c) thiourea, CH<sub>3</sub>CN, 0–50 °C; (d) TFA, MsOH, 0 °C to rt; (e) 5-chloropyridine-3-boronic acid, PdCl<sub>2</sub>(dppf)·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C; (f) <i><sup>t</sup></i>BuSONH<sub>2</sub>, Ti(OEt)<sub>4</sub>, THF, reflux; (g) methyl acetate, LDA, THF, −78 °C; (h) HCl, dioxane, rt; (i) EDCI, 10, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DMF, rt.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Primary assays for our BACE program included BACE1 potency, CatD selectivity, and efflux liability. BACE1 and CatD potencies were based upon the cleavage of relevant peptide substrates, while efflux liability was assessed in LLC-PK1 cells transfected with human MDR1 gene. Prototype compounds and analogues meeting a potency threshold of <1000 nM progressed to a cell-based Aβ<sub>1–40</sub> inhibition assay. HEK-293 cells expressing wild type APP were treated with compound, and production of Aβ<sub>1–40</sub> was quantified with an HTRF assay (Cisbio). Compound toxicity was assessed using the CellTiter-Blue assay (Promega) as well by visual assessment of morphological change.</div><div class="NLM_p">The X-ray structure of <b>1a</b> reveals an opportunity to increase BACE1 potency by filling the S3 pocket, though the rigidity of the spiro-bicyclic core precludes direct trajectory into this pocket from the 5, 7, and 8 positions (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The 6 position, in contrast, is ideally positioned for extending into the S3 pocket. To test this hypothesis, a range of 6-position analogues were prepared, resulting in 4- to 3600-fold improvements in BACE1 potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">The potency of unsubstituted phenyl analogue <b>11</b> (BACE1 IC<sub>50</sub> = 455 nM) was further improved by meta substitution<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with lipophilic and hydrophilic groups (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). For example, the 3-chlorophenyl group improved BACE1 potency to 24 nM and the more polar 3-cyano- and 3-methoxyphenyl improved potency to 94 and 68 nM (compounds <b>12</b>, <b>13</b>, and <b>14</b>, respectively). In contrast, ortho and para substitutions (<b>15</b> and <b>16</b>) resulted in a significant loss of potency vs the unsubstituted phenyl of <b>11</b>. The preference for meta substitution is understood by examining the X-ray BACE1 cocrystal structures of <b>12</b> and <b>13</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) wherein the <i>m</i>-Cl and <i>m</i>-CN groups are readily accommodated in the BACE1 protein. In contrast, little room is available for ortho and para substitution of the phenyl ring. For similar reasons, additional phenyl substitution (compounds <b>17</b>–<b>21</b>) is not significantly beneficial.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structures of BACE1 and <b>12</b>, <b>13</b>, and <b>(</b><i><b>R</b></i><b>)-50</b>. Only density for the (<i>R</i>)-enantiomers of racemates <b>12</b> and <b>13</b> was detectable in the BACE1 protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Larger nonpolar meta substituents generally decreased BACE1 affinity and/or increased the enzyme to cell shift. For example, the 3-isopropoxy analogue <b>22</b> lost 40-fold BACE1 potency vs the 3-methoxy analogue <b>14</b>, while the 3-ethoxy analogue <b>23</b> lost significant cellular potency vs <b>14</b> (633 nM vs 164 nM, respectively). Similarly, the 3-CF<sub>3</sub> and 3-SMe analogues <b>24</b> and <b>25</b> were inferior to the 3-Cl analogue <b>12</b> (166 and 932 nM vs 107 nM, respectively). In contrast, difluorination of the 3-methoxy group of analogue <b>14</b> provided ∼2-fold potency improvement for analogue <b>26</b>. No benefit was seen with the smaller 3-F analogue <b>27</b> vs <b>12</b>; however, the 3-CN analogue <b>13</b> provided improved cellular potency vs <b>12</b> (36 vs 107 nM). The BACE1 cocrystal structures of <b>12</b> and <b>13</b> again provide insight into these trends as the pocket accepting the meta substituents is limited in width (decreased BACE1 potency for <b>22</b> and <b>25)</b> but extends deeply enough to accept the linear nitrile of <b>13</b>.</div><div class="NLM_p">Screening of nonaromatic P3 groups proved to be less productive than for the aryls. The best results were found with cyclohexyl <b>28</b> and ether <b>29</b>. Efforts to improve the potency of the cyclohexyl group by substitution (methylation of the 3 or the 3,5 position; data not shown) were not productive, as there is limited room in the S3 pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The intolerance for the piperidine moiety of analogue <b>30</b> (8661 nM) is likely due to the high lipophilicity of residues in the region near the piperidine nitrogen.</div><div class="NLM_p">For pyridine analogues, the 3-pyridyl isomer was substantially (20- to 55-fold) more potent than the 2- and 4-pyridyl isomers (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>31</b> vs <b>32</b> and <b>33</b>). Examination of BACE1 cocrystal structures (not shown) of nitrogen containing heterocycles revealed a water bridging the nitrogen of pyridin-3-yl and pyrimidin-5-yl analogues to Ser229. As previously described, this through-water interaction explains, at least in part, the preference for the 3-pyridyl isomer <b>31</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Combining the 3-pyridyl water bridge to Ser229 with the preference for meta substitution observed for analogue <b>12</b> led to the discovery of cell potent (30–47 nM) analogues <b>34</b>–<b>36</b>. The 5-chloropyridin-3-yl <b>34</b> was particularly attractive, as it maintained good enzyme potency (34 nM), low MW (370.8), limited molecular flexibility, and reasonable polarity (tPSA = 80). Additionally, <b>34</b> did not exhibit time dependent inhibition of cytochrome P450 enzymes, an advantage over alkyne <b>36</b>. Combining the 3-pyridyl water bridge with either a 2- or 5-fluoro was not as advantageous as introduction of the 5-Cl (<b>37</b> and <b>38</b> vs <b>34</b>).</div><div class="NLM_p">The low MW (337.4) and good CatD selectivity (97-fold) of the pyrimidine analogue <b>39</b> was appealing, despite the moderate potency. Introduction of a 2- or 4-methyl led to >5-fold loss in potency (data not shown) as predicted by the limited room available to these positions in the S3 pocket. However, the discovery that the pyrimidine moiety engages Gly11 through a bound water (exemplified with <b>(</b><i><b>R</b></i><b>)-50</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and provides good CatD selectivity maintained our interest in this P3 moiety as we explored other cores.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. S3 Exploration with Spiro-aminohydantoin-chroman<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Data for racemates.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Mean IC<sub>50</sub> of at least two independent experiments.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Mean EC<sub>50</sub> of at least two independent experiments for cellular Aβ production.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">(B to A)/(A to B)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a> value derived for compounds (1 μM) evaluated in LLC-PK1 cells transfected with human MDR1 (Pgp).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Apical (A) and basolateral (B).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">Seeking to capitalize on potential through-water interactions, we expanded the search to five-membered heterocycles. The most promising result from this effort was the isothiazole analogue <b>40</b> (501 nM). Other regioisomers and substitutions were not helpful, indicating that the nitrogen of the six-membered heterocycles is ideally directed for the through-water interaction.</div><div class="NLM_p">As potency and efflux were primary concerns for efficacy, selectivity vs CatD was necessary for tolerability.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In general, carbocyclic P3 groups provided compounds with poor selectivity vs CatD (<1 to 31-fold), while six-membered heterocycles showed greater promise (up to 97-fold). The greatest selectivity (784-fold) was achieved with furanylamide <b>41</b>. The observation that amide <b>41</b> possessed extremely weak CatD activity (180 420 nM) led to a parallel effort on a less electron rich core. Full details of that work will be reported in a subsequent publication.</div><div class="NLM_p">In an attempt to further reduce efflux and increase potency, our SAR exploration was extended from the chroman to the thiochroman and tetrahydronaphthalene (THN) cores. The SAR for the chroman, thiochroman, and THN cores (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was similar for BACE1 enzyme potency, CatD enzyme potency, and efflux. The cellular potency was found to be slightly divergent, with differences up to 6-fold favoring the THN core when compared to the chroman core (<b>46</b> vs <b>37</b>, <b>48</b> vs <b>34</b>, and <b>50</b> vs <b>39</b>). The improved cellular potency of the THN core brought compounds such as pyrimidine <b>50</b> into consideration for in vivo studies. Attempts to further increase the potency of the THN core by benzylic substitution (ketone <b>51</b> and difluoro analogue <b>52</b>) led to significant losses in potency and selectivity. Although we were pleased overall with the low MW, limited molecular flexibility, potency, and selectivity found in these cores, the efflux liability remained. We expected that analogues with tPSA of <70 would reach minimal efflux ratios of <2.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Unfortunately, this effort did not reach fruition, as even compounds with a tPSA value of <60 (analogues <b>42</b> and <b>43</b>) remained efflux substrates (efflux ratios of 4.8 and 5.7, respectively). We hypothesized that the compact polarity of the aminohydantoin (tPSA = 59) minimized the opportunity to identify efflux free analogues.</div><div class="NLM_p">As core manipulation was not successful for avoiding efflux, we turned our attention to decreasing the polarity of the Asp binding portion of the molecule to enable CNS exposure goals. Our first approach was an attempt to shield the compact polarity of the aminohydantoin with larger alkyl groups. As Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> shows, this effort did in fact result in improved efflux ratios of 2.8 and 1.8 for analogues <b>53</b> and <b>54</b>, respectively. Unfortunately, the improvement in efflux came with a significant loss of BACE1 potency and selectivity vs CatD. Further elaboration of the aminohydantoin to acylpiperidine <b>56</b> did rescue BACE1 potency; however, the compound equally inhibited CatD and the efflux liability returned.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Chroman, Thiochroman, and THN SAR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0009.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0010.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Data for racemates.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Mean IC<sub>50</sub> of at least two independent experiments.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Mean EC<sub>50</sub> of at least two independent experiments for cellular Aβ production.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">(B to A)/(A to B) value derived for compounds (1 μM) evaluated in LLC-PK1 cells transfected with human MDR1 (Pgp).</p></div></div><div></div></div><div class="NLM_p">In parallel, the polarity of the Asp binding moiety was directly modified by removing the amide carbonyl (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, analogues <b>57</b>–<b>59</b>, <b>61</b>–<b>63</b>). Of the analogues shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, only the thiazoline analogue <b>58</b> approached an efflux ratio of <2. It was disappointing that once again an improved efflux ratio came with greatly diminished BACE1 potency. Also, one carbon homologation of the aminohydantoin <b>48</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) to the aminopyrimidinone <b>60</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) resulted in a 1000-fold loss of potency and no improvement in efflux, a significant disconnect from the pioneering work of Astra Zeneca and Astex<a onclick="showRef(event, 'cit17a'); return false;" href="javascript:void(0);" class="ref cit17a">(17a)</a> as well as the optimization studies of Merck.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Expansion of the oxazoline SAR to other P3 groups (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, analogues <b>61</b>–<b>63</b>) did not result in improved BACE1 potency. Examination of cocrystal structures of BACE1 with these analogues did not reveal any loss of favorable interactions with the protein or the introduction of any unfavorable interactions. It is interesting to note that each of the oxazoline, thiazoline, and thiazine analogues demonstrated a significant and favorable potency shift (up to 26-fold) from the enzyme to cellular Aβ production.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Asp Binding Elements: Potency and Efflux SAR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0011.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Data for racemates.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Mean IC<sub>50</sub> of at least two independent experiments.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Mean EC<sub>50</sub> of at least two independent experiments for cellular Aβ production.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">(B to A)/(A to B) value derived for compounds (1 μM) evaluated in LLC-PK1 cells transfected with human MDR1 (Pgp).</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">Compounds of varying permeability, efflux liability, potency, selectivity, and liver microsomal stability were evaluated in the mouse to assess brain disposition (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Although close attention was paid to bioavailability, clearance, and plasma exposure, our primary focus was the free drug concentration in the brain. More specifically, we were concerned with the ratio of the free brain concentration to the cell IC<sub>50</sub>. This “coverage ratio” was a key assessment that incorporated PK, potency, and brain penetration. This ratio was calculated for the 1 and 4 h time points and is found in the bottom line of Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The team’s goal was to identify a compound with free brain exposure within range of its cellular potency when dosed orally (10 mg/kg), a significant hurdle for an efflux substrate.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Properties<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> and Brain and Plasma PK (3 mg/kg iv and 10 mg/kg po)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0012.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Compounds were racemic and >95% pure by <sup>1</sup>H NMR and HPLC.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">iv formulation: 40:10:50 PEG400/ethanol/H<sub>2</sub>O. po formulation: 1% carboxymethylcellulose (CMC), 0.5% polysorbate 80 (Tween 80), 5 mM citrate, pH 4, in water.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Mean EC<sub>50</sub> of at least two independent experiments for cellular Aβ production.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">A to B in parental LLC-PK1 cell line.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (Pgp).</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">Compounds (1 μM) incubated with mouse liver microsomes for 20 min at 37 °C in the presence of NADPH.</p></div><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">CL<sub>u</sub> = CL/<i>f</i><sub>u,plasma</sub>.</p></div><div class="footnote" id="t4fn8"><sup>Table h</sup><p class="last">po dose.</p></div><div class="footnote" id="t4fn9"><sup>Table i</sup><p class="last"><i>C</i><sub>free,brain</sub>/(cell IC<sub>50</sub>).</p></div><div class="footnote" id="t4fn10"><sup>Table j</sup><p class="last">Below level of quantification.</p></div></div><div></div></div><div class="NLM_p">The data in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> illustrate that despite efflux, conformationally constrained, permeable<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> compounds can effectively penetrate the BBB. Potency alone was not the most critical variable, as the most potent compound (<b>48</b>) had the poorest coverage ratio due to rapid CL, and the least potent compound evaluated (<b>63</b>) was one of the best at the 1 h time point (coverage ratio of 0.38). Pyrimidine <b>50</b> achieved the best overall coverage ratios (0.37 and 0.40) despite greater than liver blood flow CL.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Incorporating nonspecific binding improved the correlation, as the compounds with the best free brain concentration (<b>34</b>, <b>50</b>, and <b>63</b>) showed the lowest unbound CL (CL<sub>u</sub>) and compounds (<b>42</b>, <b>48</b>) with the highest CL<sub>u</sub> demonstrated low free brain concentrations. From the experimental results in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, molecules with the best balance of potency and in vivo stability (CL<sub>u</sub>) provided the best coverage ratios.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Single Enantiomer Profiles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0013.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Mean IC<sub>50</sub> of at least two independent experiments.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Mean EC<sub>50</sub> of at least two independent experiments for cellular Aβ production.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">A to B in parental LLC-PK1 cell line.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (Pgp).</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">Compounds (1 μM) incubated for 20 min at 37 °C in the presence of NADPH with mouse (M), rat (R), guinea pig (GP), cynomolgus monkey (C), or human (H) liver microsomes (LM).</p></div></div><div></div></div><div class="NLM_p">The compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> demonstrating the best brain PK were scaled, resolved, and profiled. We found that the BACE1 potency resided primarily within the (<i>R</i>)-enantiomers, as they were roughly twice as potent as the corresponding racemates (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Fortunately, the (<i>R</i>)-enantiomers did not consistently show increased affinity for CatD, effectively increasing the CatD/BACE1 window for most compounds. The increase in BACE1 affinity translated into improved cell potency for each (<i>R</i>)-enantiomer evaluated raising promise for in vivo CNS Aβ lowering. Liver microsomal assays predicted low to medium CL across species (mouse, rat, guinea pig, cynomolgus monkey, and human) for the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> with the exception of <b>(</b><i><b>R</b></i><b>)-46</b> in the rat. Though pleased with predicted stability of the single enantiomers, as well as the potency and selectivity increases, all compounds remained efflux substrates. Progression to pharmacodynamic assays would ascertain if permeable, low MW, limited molecular flexibility compounds could affect CNS Aβ<sub>1–40</sub> production despite the efflux liability.</div><div class="NLM_p">The single enantiomers were evaluated for their ability to achieve adequate <i>C</i><sub>free,brain</sub> to lower CNS Aβ<sub>1–40</sub> levels following oral dosing, the key proof of mechanism data for progressing lead compounds. For the majority of studies, the drug concentration was determined for the plasma, CSF, and brain compartments. The pharmacodynamic response (<i>n</i> = 6–8 animals per dose and time point) was measured as the percentage of CSF Aβ<sub>1–40</sub> vs the vehicle control (six to eight animals). For studies over 5 h, two vehicle control groups were utilized and assessed at the first and last time points.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Guinea Pig Pharmacodynamics (Aβ<sub>1–40</sub> Lowering)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">formulation</th><th class="colsep0 rowsep0" align="center">dose (po) (mg/kg)</th><th class="colsep0 rowsep0" align="center">time point (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>free,plasma</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>free,brain</sub> (nM)</th><th class="colsep0 rowsep0" align="center">free (b/p)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub> (nM)</th><th class="colsep0 rowsep0" align="center">coverage ratio<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CSF Aβ<sub>1–40</sub> reduction (%)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-34</b></td><td class="colsep0 rowsep0" align="left">1% CMC/0.5% Tween 80</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">224</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1209</td><td class="colsep0 rowsep0" align="left">105</td><td class="colsep0 rowsep0" align="left">0.087</td><td class="colsep0 rowsep0" align="left">456</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2891</td><td class="colsep0 rowsep0" align="left">224</td><td class="colsep0 rowsep0" align="left">0.077</td><td class="colsep0 rowsep0" align="left">1321</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">4962</td><td class="colsep0 rowsep0" align="left">456</td><td class="colsep0 rowsep0" align="left">0.091</td><td class="colsep0 rowsep0" align="left">2384</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-45</b></td><td class="colsep0 rowsep0" align="left">1% CMC/0.5% Tween 80</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">122</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">195</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-46</b></td><td class="colsep0 rowsep0" align="left">0.5% HPMC<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a>/0.5% Tween 80</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">304</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.037</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">562</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">247</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-50</b></td><td class="colsep0 rowsep0" align="left">1% CMC/0.5% Tween 80</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">913</td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">1620</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5380</td><td class="colsep0 rowsep0" align="left">146</td><td class="colsep0 rowsep0" align="left">0.027</td><td class="colsep0 rowsep0" align="left">2300</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1940</td><td class="colsep0 rowsep0" align="left">176</td><td class="colsep0 rowsep0" align="left">0.091</td><td class="colsep0 rowsep0" align="left">920</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">534</td><td class="colsep0 rowsep0" align="left">124</td><td class="colsep0 rowsep0" align="left">0.232</td><td class="colsep0 rowsep0" align="left">440</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">127</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">0.378</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">0.622</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-63</b></td><td class="colsep0 rowsep0" align="left">40/10/50 PEG400/ethanol/H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3019</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">888</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6673</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5609</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">70</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Purity of >95% by <sup>1</sup>H NMR and HPLC.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last"><i>C</i><sub>free,brain</sub>/(cell IC<sub>50</sub>).</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Reduction vs vehicle control.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Hydroxypropylmethylcellulose (HPMC).</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">The single enantiomers were progressed to single oral dose pharmacodynamic assessment in the guinea pig, a preferred rodent species due to the high homology with human APP.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Utilizing wild type animals precluded the cost of transgenic animals and the caveats associated with such strains.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We began with a dose response study of <b>(</b><i><b>R</b></i><b>)-34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Chloropyridine analogue <b>(</b><i><b>R</b></i><b>)-34</b> decreased CSF Aβ<sub>1–40</sub> levels at all doses from 25 to 400 mg/kg. Reduction of CSF Aβ<sub>1–40</sub> by 50% correlated with <i>C</i><sub>free,brain</sub> that exceeded 2-fold the compound’s cellular IC<sub>50</sub> (coverage ratio of >2). Increasing the dose to 200 mg/kg resulted in a coverage ratio of 16 and CSF Aβ<sub>1–40</sub> reduction of 71%. Interestingly, increasing the dose to 400 mg/kg did not result in further CSF Aβ<sub>1–40</sub> reduction despite doubling the coverage ratio to 33. It is possible that other secretases<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> are responsible for the remaining Aβ<sub>1–40</sub> production in the guinea pig.</div><div class="NLM_p">The next compound evaluated, the benzonitrile <b>(</b><i><b>R</b></i><b>)-45</b>, reduced CSF Aβ<sub>1–40</sub> by only 29% with a dose of 150 mg/kg. The F-pyridine analogue <b>(</b><i><b>R</b></i><b>)-46</b> demonstrated 50% CSF Aβ<sub>1–40</sub> reduction at 150 mg/kg but no effect at 75 mg/kg where the coverage ratio was only 1.2. The inferior results with these two compounds precluded further studies, including full evaluation of brain disposition for <b>(</b><i><b>R</b></i><b>)-45</b>.</div><div class="NLM_p">Early results with the pyrimidine analogue <b>(</b><i><b>R</b></i><b>)-50</b> were encouraging, resulting in both time course and dose response studies. In the dose response study, an oral dose of 100 mg/kg resulted in 55% CSF Aβ<sub>1–40</sub> reduction at 3 h, a decreased effect (23%) with 30 mg/kg, and no effect with the 10 mg/kg dose. With these promising data, an intermediate dose of 60 mg/kg <b>(</b><i><b>R</b></i><b>)-50</b> was evaluated in a time course study. We were pleased to find that 60 mg/kg <b>(</b><i><b>R</b></i><b>)-50</b> was sufficient to reduce CSF Aβ<sub>1–40</sub> by 50% at the 5 h time point with a coverage ratio of 4.4. Significant reduction (20–43%) was also observed at the other time points, including 12 h after dose (23% reduction with a coverage ratio of 1.5).</div><div class="NLM_p">Moving from the aminohydantoin to the aminooxazoline heterocycles, <b>(</b><i><b>R</b></i><b>)-63</b> was evaluated in the guinea pig at 3 h with doses of 50 and 150 mg/kg. Significant CSF Aβ<sub>1–40</sub> reduction was observed with both doses, although the 50 mg/kg dose provided only a modest CSF Aβ<sub>1–40</sub> reduction of 30%. Also, <b>(</b><i><b>R</b></i><b>)-63</b> was poorly soluble and required a less preferred formulation (PEG400/ethanol/water), decreasing enthusiasm for additional work with this analogue, including determining brain concentrations and coverage ratios.</div><div class="NLM_p">The free brain-to-free plasma ratios for all compounds evaluated from this series failed to reach unity in the guinea pig. While the poor free brain-to-free plasma ratios were predicted by the efflux data and the mouse PK results, we were surprised at the difference between the <i>C</i><sub>CSF</sub> and <i>C</i><sub>free,brain</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Although the CSF is often utilized as a surrogate for free brain levels,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> our observations suggest a clear difference in the guinea pig blood–CSF barrier vs the BBB. A similar disconnect has been reported in the mouse for efflux substrates.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">In parallel, we evaluated <b>(</b><i><b>R</b></i><b>)-34</b> and <b>(</b><i><b>R</b></i><b>)-50</b> in a rat pharmacodynamic model.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Both compounds were assayed in a time course study to correlate <i>C</i><sub>free,brain</sub> to CSF Aβ<sub>1–40</sub> response (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> At 150 mg/kg, <b>(</b><i><b>R</b></i><b>)-34</b> reduced CSF Aβ<sub>1–40</sub> levels at a maximum of 29% at 3 h. The <i>C</i><sub>free,brain</sub> at this point was >50 nM (coverage ratio of 3.8), which was greater than the concentration (32 nM) that provided 51% CSF Aβ<sub>1–40</sub> reduction in the guinea pig, an intriguing disconnect. Pyrimidine <b>(</b><i><b>R</b></i><b>)-50</b> provided similar reduction to <b>(</b><i><b>R</b></i><b>)-34</b> but with a smaller dose (60 mg/kg). The maximal effect of 24% CSF Aβ<sub>1–40</sub> reduction was achieved at 5 h with <i>C</i><sub>free,brain</sub> of 50 nM <b>(</b><i><b>R</b></i><b>)-50</b>. This compared well with the guinea pig result of 23% CSF Aβ<sub>1–40</sub> reduction for the 30 mg/kg dose (<i>C</i><sub>free,brain</sub> = 53 nM).</div><div class="NLM_p">As with the guinea pig, the variance in drug exposure in the CSF vs the brain suggests a difference in the rat blood–CSF barrier and BBB with these analogues. This disconnect greatly limits the ability to predict doses in higher species, particularly in humans. Eliminating efflux would address this liability, increase brain exposure, and decrease the likelihood of peripheral adverse events.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Rat Pharmacodynamics (Aβ<sub>1-40</sub> Lowering)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">formulation</th><th class="colsep0 rowsep0" align="center">dose (po) (mg/kg)</th><th class="colsep0 rowsep0" align="center">time point (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>free,plasma</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>free,brain</sub> (nM)</th><th class="colsep0 rowsep0" align="center">free (b/p)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>CSF</sub> (nM)</th><th class="colsep0 rowsep0" align="center">coverage ratio<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CSF Aβ<sub>1–40</sub> reduction (%)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-34</b></td><td class="colsep0 rowsep0" align="left">1% CMC/0.5% Tween 80</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1166</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">8330</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1023</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">0.052</td><td class="colsep0 rowsep0" align="left">15600</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1254</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">0.044</td><td class="colsep0 rowsep0" align="left">24200</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1353</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">0.050</td><td class="colsep0 rowsep0" align="left">2270</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-50</b></td><td class="colsep0 rowsep0" align="left">1% CMC/0.5% Tween 80</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2442</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">269</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1733</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">0.052</td><td class="colsep0 rowsep0" align="left">236</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">561</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">0.089</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Purity of >95% by <sup>1</sup>H NMR and HPLC.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last"><i>C</i><sub>free,brain</sub>/(cell IC<sub>50</sub>).</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Reduction vs vehicle control.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">Despite the efflux and moderate CSF Aβ<sub>1–40</sub> reduction in the rat, we were pleased to demonstrate proof of mechanism in two separate rodent species. These data, coupled with a >100-fold BACE1 vs CatD selectivity, led us to study <b>(</b><i><b>R</b></i><b>)-50</b> in a higher species. As a previous report utilized the monkey to measure Aβ lowering with a BACE1 inhibitor (co-dosed with a CYP inhibitor),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> we utilized this species for further pharmacological assessment.</div><div class="NLM_p">The pharmacodynamic response (CSF Aβ<sub>1–40</sub> lowering) in the cynomolgus monkey was measured as a percentage change from baseline, and the drug <i>C</i><sub>CSF</sub> was plotted from 0 to 48 h (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). A 100 mg/kg oral dose of <b>(</b><i><b>R</b></i><b>)-50</b> achieved >65% CSF Aβ<sub>1–40</sub> reduction at 8 h, approximately 4 h after <i>C</i><sub>max</sub>. The duration of response was quite robust, as the CSF Aβ<sub>1–40</sub> levels in the dose group had not returned to predose levels by 48 h. The results were encouraging, though the variability in the measurement of CSF Aβ<sub>1–40</sub> was a significant challenge. Full experimental details of this study will be discussed elsewhere.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0014.jpeg" id="GRAPHIC-d639e2650-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Monkey pharmacodynamics of <b>(</b><i><b>R</b></i><b>)-50</b> (Aβ<sub>1–40</sub> lowering). CSF concentration of Aβ<sub>1–40</sub> (baseline normalized, left <i>Y</i>-axis, broken line) and <b>(</b><i><b>R</b></i><b>)-50</b> (right <i>Y</i>-axis, solid line) following single 100 mg/kg oral dose of <b>(</b><i><b>R</b></i><b>)-50</b> in cynomolgus monkeys. Data points represent mean and SD from 12 animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We describe the utilization of structure-based design, conformation constraint, and wild type animal models to identify potent, selective, and brain penetrable inhibitors of the BACE1 enzyme. Though unable to identify potent alternative Asp binding moieties to eliminate efflux, we discovered analogues that decreased CSF Aβ<sub>1–40</sub> in nontransgenic rodent species. The CSF Aβ<sub>1–40</sub> response was directly related to free drug concentrations in the brain in the rat and guinea pig. Further proof of mechanism was demonstrated in the cynomolgus monkey with analogue <b>(</b><i><b>R</b></i><b>)-50</b>, providing >65% CSF Aβ<sub>1–40</sub> reduction at the 8 h time point. Efforts to optimize BACE1 potency by utilizing P2′ interactions, increase CatD selectivity with non-aniline amides, and eliminate efflux will be published in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> X-ray Crystal Structure</h3><div class="NLM_p">Human BACE1 (residues 57–453) was expressed in <i>E. coli</i> with a noncleavable 6-His tag at the C-terminus. The protein was refolded and purified in a manner similar to that from Tomasselli et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Briefly, cells were lysed using mechanical disruption and inclusion bodies recovered by differential centrifugation. Inclusion body proteins were solubilized in urea and refolded by dilution into water. Following a 3 week refold period, BACE protein was recovered by Q-Sepharose anion-exchange chromatography. Fractions containing active protein were pooled and further purified over Source-Q anion-exchange and Sephadex 200 size-exclusion columns. Purified BACE protein was concentrated to 10 mg/mL and frozen for crystallographic studies.</div><div class="NLM_p">Crystals were grown by hanging drop vapor diffusion with a precipitant of 20% PEG200, 0.1 M sodium acetate, pH 4.5–5.6, and 0–2 mM cobalt chloride. Crystals grew in space group <i>C</i>222<sub>1</sub> in approximately 1 week. Crystals were then transferred to a soaking solution (27–30% PEG200, 0.1 M NaOAc, pH 5.0–5.6, 0–2 mM CoCl<sub>2</sub>, and 10% DMSO) with compound at a final concentration of 1 mM. Crystals were soaked for 18–24 h and either flash-frozen in liquid nitrogen or mounted directly for data collection. The soaking solution also served as a cryprotectant for data collection at 100 K.</div><div class="NLM_p last">Diffraction data were collected on a Rigaku FR-E generator and R-axis IV++ detector (Rigaku Inc., 9009 New Trails Drive, The Woodlands, TX 77381-5209, U.S.). Data were processed in Moslfm,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and the initial structure was solved by molecular replacement from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FNK">1FNK</a>.pdb using Molrep. All crystal structures were refined in Refmac, all three of these programs being part of the CCP4 suite (Winn et al., 2011).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Model building was performed in Coot.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> BACE1 Enzymatic Assay</h3><div class="NLM_p last">The activity of purified recombinant human BACE1, expressed in CHO cells, was determined using a custom synthesized biotinylated peptide based upon sAPP. Uncleaved substrate was detected via HTRF whereby europium-labeled anti-Aβ (amino acids 1–17, clone 6E10) was combined with D2-labeled streptavidin. Specifically, 20 nM enzyme was incubated with 150 nM peptide (biotin-Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu, representing P10–P17′) for 6 h at 22 °C in an assay buffer consisting of 50 mM sodium acetate (pH 4.4) and 0.1% CHAPS. In IC<sub>50</sub> studies, compounds were serially diluted (1:2.5) in DMSO (11 points), compound and enzyme were preincubated for 15 min at room temperature, and the enzymatic reaction was initiated with peptide. The detection solution consisted of 43 nM streptavidin-D2 and 1.1 nM antibody in 200 mM Tris (pH 8.0), 20 mM EDTA (pH 8.0), 0.1% BSA, and 0.8 M KF. Following incubation for 2 h at 22 °C, the samples were excited at 320 nm and the emission ratio of 665 nm/615 nm was determined.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> CatD Enzymatic Assay</h3><div class="NLM_p last">The catalytic activity of cathepsin D, purified from human spleen (Calbiochem), was assessed in a FRET peptide substrate assay using 50 mM sodium acetate (pH 4.4) and 0.1% CHAPS. In IC<sub>50</sub> studies, compounds were serially diluted (1:2.5) in DMSO (11 points). The substrate (Anaspec catalog no. 72097) contains a 5-FAM/QXL 520 pair whereby cleavage results in an increase of 5-FAM fluorescence that is measured using an excitation of 485 nm and an emission of 535 nm. The fluorescence was monitored continuously for 1 h at room temperature, and initial rates were calculated from the fluorescence increase. The final concentrations were 10 nM enzyme and 2 μM substrate.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Cell-Based Assay</h3><div class="NLM_p last">Human embryonic kidney cells (HEK293) stably expressing APPwt were plated at a density of 35K cells/well in 96-well collagen coated plates (BD-Biosciences). The cells were cultivated overnight at 37 °C and 5% CO<sub>2</sub> in DMEM supplemented with 10% FBS. The following day the medium was changed and the cells were incubated for 48 h with test compounds at concentrations ranging from 0.0008 to 16 μM. Following incubation with the test compounds the conditioned medium was collected and the Aβ<sub>1–40</sub> levels were determined using an HTRF assay (CisBio). The IC<sub>50</sub> was calculated from the percent of control Aβ40 as a function of the concentration of the test compound. The HTRF to detect Aβ<sub>1–40</sub> was performed in 384-well microtiter plates (Corning). The antibody pair that was used to detect Aβ<sub>1–40</sub> from cell supernatants was a pair of monoclonal antibodies, one labeled with cryptate and one labeled with XL655 as supplied by the manufacturer (CisBio). Conditioned medium was incubated with antibody pair overnight at 4 °C. The plates were measured for time-resolved fluorescence on a Victor2 plate reader (Wallac).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Permeability and Efflux Assay</h3><div class="NLM_p last">The LLC-PK1 cell line, stably transfected with human MDR1 cDNA, was obtained from BD Biosciences (Franklin Lakes, NJ). Both parental LLC-PK1 and MDR1 transfected LLC-PK1 cells were cultured and plated according to the manufacturer’s recommendations with the exception that the passage medium contained only 2% fetal bovine serum to extend passage time out to 7 days. The cells were plated into Millicell-96 cell culture insert plates at a density of 50 000 and 40 000 cells/well for the MDR1 and parental LLC-PK1 cell lines, respectively. The plates were incubated at 37 °C and in an atmosphere of 5% CO<sub>2</sub> with saturating humidity. The medium was replaced on day 2 of culture. Permeability experiments were conducted on culture day 6. A trans-epithelial electrical resistance (TEER) value of at least 500 Ω as determined by the Millipore Millicell-ERS TEER device (Millipore, Billerica, MA) was required for monolayer acceptance. Transport buffer was prepared using Hanks balanced salt solution (HBSS), 1% DMSO, and 10 mM HEPES. The pH of the assay buffer was adjusted to 7.4, using 1.0 M KOH. Stock solutions for the test compounds were prepared in DMSO for final concentration of 1 μM. Final organic concentration in the assay was 1%. Bidirectional permeability was assessed by adding either 75 or 250 μL of buffer containing compound to the apical or basolateral compartments, respectively. Buffer only was added to the receiver compartment. All tests were performed in triplicate, and compounds were assayed for both apical to basolateral (A to B) and basolateral to apical (B to A) transport. After a 2 h incubation on an orbital plate shaker (VWR, West Chester, PA) at 50 rpm and 37 °C with 5% CO<sub>2</sub>, the culture plates were removed and an amount of 50 μL was sampled from the apical and basolateral portion of each well and added to a plate containing 150 μL of 1 μM labetalol (internal standard) in 2:1 acetonitrile (ACN)/H<sub>2</sub>O, v/v. The plates were read using a Molecular Devices (Sunnyvale, CA) Gemini fluorometer to evaluate the lucifer yellow concentrations at excitation/emission wavelengths of 425/535 nm. These values were accepted when found to be below 5% for apical to basolateral and basolateral to apical flux across the MDR1 transfected LLC-PK1 cell monolayers. The compound concentrations were determined from the ratio of the peak areas of the compound to labetalol in comparison to the dosing solution. The LC–MS/MS system comprised an HTS-PAL autosampler (Leap Technologies, Carrboro, NC), an HP1200 HPLC (Agilent, Palo Alto, CA), and a MDS Sciex 4000 Q trap system (Applied Biosystems, Foster City, CA). Mass spectrometric detection of the analytes was accomplished using the ion spray positive mode. Analyte responses were measured by multiple reaction monitoring (MRM) of transitions unique to each compound in comparison to labetalol. Permeability (<i>P</i><sub>app</sub>) was calculated in BioAssay, version 9.0 (Cambridge Soft, Cambridge, MA) using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/jm-2013-002154_m001.gif" alt="" /></img></span>where <i>C</i><sub>d</sub>, <i>V</i>, <i>t</i>, and <i>C</i><sub>0</sub> are the detected concentration (μM), the volume on the dosing side (mL), the incubation time (s), and the initial dosing concentration (μM), respectively. The calculations for <i>P</i><sub>app</sub> were made for each replicate and then averaged. The efflux ratio (ER) was calculated from the basolateral to apical transport divided by the apical to basolateral transport:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/jm-2013-002154_m002.gif" alt="" /></img></span></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Microsomal Stability Assay</h3><div class="NLM_p last">Compounds were prepared in a 100 mM potassium phosphate buffer solution (pH 7.4) for a final concentration of 1 μM and incubated in the presence of 1 mg/mL human, monkey, rat, guinea pig, or mouse liver microsomes. The final concentration of DMSO in the incubation was less than 0.1%. Metabolism was initiated with the addition of a 10 μL aliquot of NADPH-regenerating solution (20 mM MgCl<sub>2</sub> buffer containing NADP (17 mg/mL stock in 100 mM KH<sub>2</sub>PO<sub>4</sub>), glucose 6-phosphate (78 mg/mL stock in 100 mM KH<sub>2</sub>PO<sub>4</sub>), and glucose 6-phosphate dehydrogenase (150 U/mL stock in 100 mM KH<sub>2</sub>PO<sub>4</sub>)) for a total incubation volume of 50 μL. After 20 min of incubation at 37 °C and 100% relative humidity, metabolism was stopped with the addition of 150 μL of 60% acetonitrile containing internal standard (0.25 μM labetalol). The plate was immediately spun in a centrifuge at 2095<i>g</i> for 7 min at room temperature. A 200 μL aliquot of the supernatant was transferred from each well to a 96-well shallow plate, sealed, and analyzed by LC–MS/MS.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Pharmacodynamic Assays</h3><div class="NLM_p last">Male Sprague–Dawley rats and male Hartley guinea pigs (6–8 weeks old, 250–350 g) were purchased from Harlan (Indianapolis, IN) and Charles River Laboratories (Kingston, NY), respectively. The animals were housed in groups of 3 at controlled temperature and humidity in an alternating 12 h light and dark cycle with free access to food and water in accordance with Array BioPharma Institutional Animal Care and Use Committee Guidelines and in harmony with the Guide for Laboratory Animal Care and Use. Rats and guinea pigs (6–8 per group) received orally either vehicle or compound at appropriate dose at a volume of 4–5 mL/kg. The rats were euthanized by CO<sub>2</sub> inhalation, and guinea pigs were euthanized by euthasol (250 mg/kg) via intraperitoneal injection at predetermined time points after dosing. The whole blood samples were collected post-mortem via cardiac puncture in tubes containing 1.5% EDTA, centrifuged at 14 000 rpm for 10 min at 4 °C. The plasma was stored at −20 °C until drug concentration analysis. The CSF samples (40–100 μL) were drawn post-mortem via cisterna magna puncture with a 25 gauge needle (Becton Dickinson, Franklin Lakes, NJ) into tubes containing 50 μL of 10% BSA in water. The CSF samples were snap frozen in liquid nitrogen and stored at −80 °C until Aβ<sub>1–40</sub> analysis. Sample weights were recorded to determine the actual volume of CSF collected. The post-mortem animals were perfused with 20 mL of sterile saline. Brain hemispheres were dissected (brain stem and cerebellum were not collected), halved longitudinally, and weighed, and only the left half of the brain was placed in a 15 mL conical tube and snap frozen in liquid nitrogen. All tissues were stored at −80 °C until drug concentration determination. CSF Aβ<sub>1–40</sub> concentration in rat and guinea pig CSF samples was analyzed by MSD 96-well MULTI-ARRAY human/rodent (4G8) Aβ 40 ultrasensitive assay (rat) or human (6E10) Aβ 40 ultrasensitive kit (Meso Scale Discovery, Gaithersburg, MD). The 96-well MULTI-SPOT Aβ<sub>1–40</sub> peptide plate was incubated with 1% BSA solution at room temperature with shaking for 1 h and washed per manufacturer’s instructions with Tris wash buffer in deionized water. The detection antibody solution (25 μL/well, sulfo-tag 4G8 in 1% BSA) and CSF samples or standards (25 μL/well) were added to the plate for incubation at room temperature for 2 h. The plate was washed three times before addition of MSD read buffer and was read on Sector Imager 2400 (Meso Scale Discovery, Gaithersburg, MD) immediately afterward. The Aβ<sub>1–40</sub> levels obtained as pg/mL were analyzed by two-tailed Student’s <i>t</i> test to compare mean percentage Aβ<sub>1–40</sub> reduction in vehicle-treated control animals and compound-treated animals.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div class="NLM_p last">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from EM Science and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All final compounds were purified to ≥95% purity as determined by high-performance liquid chromatography (HPLC). Purity was measured using either system A (Varian ProStar with UV detection at 220 and 254 nm, a Waters YMC ODS-AQ C18 3.0 mm × 50 mm, 3.0 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% NH<sub>4</sub>OAc for 5 min at 1.0 mL/min) or system B (Varian ProStar with UV detection at 220 and 254 nm, a Waters YMC ODS-AQ C18 3.0 mm × 50 mm, 3.0 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% formic acid for 5 min at 1.0 mL/min). Silica gel columns were used with prepacked silica gel cartridges (Biotage or Teledyne Isco). <sup>1</sup>H NMR spectra were recorded on a Varian Mercury 400 (400 MHz) spectrometer or Varian Inova 400 (500 MHz) spectrometer at 25 °C. NMR spectra were processed using VNMRj, version 2.1b. All observed protons are reported as parts per million (ppm) downfield from tetramethylsilane (TMS) or other internal reference in the appropriate solvent indicated. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Low-resolution mass spectrometry (MS) data were determined on an Agilent 1100 series LCMS with UV detection at 220 and 254 nm, a Halo C18 2.1 mm × 30 mm, 2.7 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% NH<sub>4</sub>OAc for 3 min at 1.0 mL/min, and atmospheric-pressure chemical ionization (APCI).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2′-Amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>1a</b>)</h3><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Step A</h4><div class="NLM_p last">6-Bromo-2,2-dimethylchroman-4-one (18.2 g, 71.3 mmol), KCN (9.29 g, 143 mmol), and ammonium carbonate (48.0 g, 499 mmol) were diluted with formamide (200 mL). The mixture was bubbled with argon for 15 min, sealed, heated to 70 °C, and stirred for 24 h. The mixture was then heated to 110 °C and stirred for 48 h. The mixture was allowed to cool and poured into ice–water (1L). The pH was adjusted to 5 with concentrated HCl, and the mixture was stirred for 1 h. The precipitate was filtered and rinsed with water. The solid was air-dried for 5 h and placed under vacuum for 15 h to afford 6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (21 g, 64.6 mmol, 90.5% yield) as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.34 (dd, <i>J</i><sub>1</sub> = 9.4 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.21 (d, <i>J</i> = 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 9.4 Hz, 1H), 6.35 (br s, 1H), 2.6 (d, <i>J</i> = 14.9, 1H), 2.1 (d, <i>J</i> = 14.9 Hz, 1H), 1.51 (s, 3H), 1.31 (s, 3H); LCMS (APCI−) <i>m</i>/<i>z</i> 323, 325 (M – 1).</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step B</h4><div class="NLM_p last">To a suspension of NaH (246 mg, 6.15 mmol) in DMF (6 mL) was added dropwise a solution of 6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (1.0 g, 3.08 mmol) in DMF (8 mL). After the mixture was stirred for 1 h, CH<sub>3</sub>I (0.198 mL, 3.08 mmol) was added, and the mixture was stirred for 16 h. The mixture was diluted with DCM and washed with 1 N HCl, water, brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The isolated residue was purified on silica gel, eluting with 5–100% ethyl acetate/hexanes to yield 6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (1.03 g, 3.04 mmol, 98.7% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.34 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.04 (d, <i>J</i> = 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 8.6 Hz, 1H), 6.1 (br s, 1H), 3.1 (s, 3H), 2.6 (d, <i>J</i> = 14.8, 1H), 2.1 (d, <i>J</i> = 14.8 Hz, 1H), 1.51 (s, 3H), 1.31 (s, 3H).</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step C</h4><div class="NLM_p last">6-Bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (3.0 g, 8.8 mmol) and Lawesson’s reagent (2.1 g, 5.3 mmol) were diluted with toluene (50 mL) and heated under reflux with a condenser and drying tube for 12 h. The mixture was allowed to cool, diluted with ethyl acetate, and washed with 10% aqueous sodium carbonate, water, and brine. The organic layer was separated, dried (MgSO<sub>4</sub>), filtered, and concentrated. The residue obtained was purified on silica gel, eluting with 5–50% ethyl acetate/hexanes to yield 6-bromo-1′,2,2-trimethyl-2′-thioxospiro[chroman-4,4′-imidazolidin]-5′-one (2.0 g, 5.6 mmol, 64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.35 (dd, <i>J</i><sub>1</sub> = 9.0 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.34 (br s, 1H), 6.94 (d, <i>J</i> = 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 9.0 Hz, 1H), 3.34 (s, 3H), 2.56 (d, <i>J</i> = 14.8, 1H), 2.1 (d, <i>J</i> = 14.8 Hz, 1H), 1.51 (s, 3H), 1.35 (s, 3H).</div></div><div id="sec5_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step D</h4><div class="NLM_p last">A solution of 6-bromo-1′,2,2-trimethyl-2′-thioxospiro[chroman-4,4′-imidazolidin]-5′-one (2.0 g, 5.63 mmol) in methanol (40 mL) was treated with <i>tert</i>-butyl hydroperoxide (11.7 mL, 84.4 mmol) followed by concentrated NH<sub>4</sub>OH (19.7 mL, 563 mmol). The mixture was heated to 40 °C and stirred for 2 h. The mixture was removed from the heat and stirred for an additional 2 h. The mixture was diluted with water and extracted with DCM. The combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. The residue obtained was purified on silica gel, eluting with 1–10% methanol/DCM with 1% NH<sub>4</sub>OH to yield 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (1.5 g, 4.44 mmol, 78.8% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ 7.27 (d, <i>J</i> = 8.6 Hz, 1H), 6.88 (s, 1H), 6.74 (d, <i>J</i> = 8.6 Hz, 1H), 3.14 (s, 3H), 2.31 (d, <i>J</i> = 14.1 Hz, 1H), 1.93 (d, <i>J</i> = 14.1 Hz, 1H), 1.45 (s, 3H), 1.36 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 338.1 (M + 1).</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2′-Amino-6-(5-chloropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>11</b>)</h3><div class="NLM_p last">2′-Amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (50 mg, 0.15 mmol) (from step D of example <b>1a</b>), phenylboronic acid (28 mg, 0.18 mmol), and tetrakis(triphenylphosphine)palladium(0) (8.5 mg, 0.0074 mmol) were combined in a vial and diluted with dioxane (1 mL). Then 2 M aqueous Na<sub>2</sub>CO<sub>3</sub> (370 μL, 0.74 mmol) was added, and the vial was sealed and the mixture heated to 95 °C and stirred overnight. The mixture was allowed to cool and loaded onto silica gel, eluting with 1–10% MeOH/DCM with 1% NH<sub>4</sub>OH to yield 2′-amino-6-(5-chloropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (25 mg, 0.067 mmol, 46% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.40 (m, 5H), 7.30 (d, <i>J</i> = 8.6 Hz, 1H), 6.97 (s, 1H), 6.92 (d, <i>J</i> = 8.6 Hz, 1H), 3.18 (s, 3H), 2.55 (d, <i>J</i> = 14.1 Hz, 1H), 1.97 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.42 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 336.2 (M + 1).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2′-Amino-6-(3-chlorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>12</b>)</h3><div class="NLM_p last">was synthesized in the same fashion as compound <b>11</b>, substituting 3-chlorophenylboronic acid for phenylboronic acid to afford 2′-amino-6-(3-chlorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (8 mg, 0.022 mmol, 29% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.35 (m, 5H), 6.93 (m, 2H), 3.20 (s, 3H), 2.57 (d, <i>J</i> = 14.1 Hz, 1H), 1.99 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.40 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 370.2 (M + 1)</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(2′-Amino-1′,2,2-trimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-6-yl)benzonitrile (<b><i>rac</i>-</b><b>13</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>13</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with 3-cyanophenylboronic acid to afford 3-(2′-amino-1′,2,2-trimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-6-yl)benzonitrile (0.031 g, 0.0860 mmol, 58.2% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.71 (s, 1H), 7.66 (d, <i>J</i><sub>1</sub> = 7.83 Hz 1H), 7.56 (d, <i>J</i><sub>1</sub> = 7.83 Hz 1H), 7.48 (t, <i>J</i><sub>1</sub> = 7.63 Hz 1H), 7.38 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 1.97 Hz, 1H), 6.96 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 6.93 (s, 1H), 3.23 (s, 3H), 2.55 (d, <i>J</i><sub>1</sub> = 13.7 Hz, 1H), 1.99 (d, <i>J</i><sub>1</sub>= 14.1 Hz, 1H), 1.53 (s, 3H), 1.44 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 361.1 (M + 1)</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2′-Amino-6-(3-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>14</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>14</b> was synthesized in the same fashion as compound <b>11</b>, substituting 3-methoxyphenylboronic acid for phenylboronic acid to afford 2′-amino-6-(3-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (60 mg, 0.164 mmol, 25.9% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.40 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.30 (t, <i>J</i> = 7.8 Hz, 1H), 7.02 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (m, 2H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 6.84 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 2.7 Hz, 1H), 3.84 (s, 3H), 3.17 (s, 3H), 2.57 (d, <i>J</i> = 14.1 Hz, 1H), 1.99 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.40 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 366.2 (M + 1).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2′-Amino-6-(2-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>15</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>15</b> was synthesized in the same fashion as compound <b>11</b>, substituting 2-methoxyphenylboronic acid for phenylboronic acid to afford 2′-amino-6-(2-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (10 mg, 0.027 mmol, 19% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.38 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.27 (m, 1H), 7.22 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.03 (br d, <i>J</i> = 1.9 Hz, 1H), 6.98 (t, <i>J</i> = 7.4 Hz, 1H), 6.93 (d, <i>J</i> = 8.2 Hz, 1H), 3.76 (s, 3H), 3.17 (s, 3H), 2.6 (d, <i>J</i> = 14.1 Hz, 1H), 1.99 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.40 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 366.2 (M + 1).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2′-Amino-6-(4-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>16</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>16</b> was synthesized in the same fashion as compound <b>11</b>, substituting 4-methoxyphenylboronic acid for phenylboronic acid to afford 2′-amino-6-(4-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (18 mg, 0.049 mmol, 33% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.35 (m, 3H), 6.91 (m, 4H), 3.82 (s, 3H), 3.19 (s, 3H), 2.57 (d, <i>J</i> = 14.1 Hz, 1H), 1.99 (d, <i>J</i> = 14.1 Hz, 1H), 1.51 (s, 3H), 1.40 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 366.2 (M + 1).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2′-Amino-6-(3,5-dichlorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>17</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>17</b> was synthesized in the same fashion as compound <b>11</b>, substituting 3,5-dichlorophenylboronic acid for phenylboronic acid to afford 2′-amino-6-(3,5-dichlorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (20 mg, 0.05 mmol, 32% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.34 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.29 (d, <i>J</i> = 1.9 Hz, 2H), 7.27 (d, <i>J</i> = 1.9 Hz, 1H), 6.93 (d, <i>J</i> = 8.6 Hz, 1H), 6.91 (br s, 1H), 3.20 (s, 3H), 2.54 (d, <i>J</i> = 14.1 Hz, 1H), 1.99 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.42 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 404.1 (M + 1)</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2′-Amino-6-(3-fluoro-5-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>18</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>18</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-fluoro-5-methoxyphenyl)boronic acid to afford 2′-amino-6-(3-fluoro-5-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (19 mg, 0.050 mmol, 34% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.37 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 6.95 (s, 1H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 6.75 (m, 2H), 6.55 (m, 1H), 3.82 (s, 3H), 3.19 (s, 3H), 2.56 (d, <i>J</i> = 14.1 Hz, 1H), 1.97 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.41 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 384.2 (M + 1).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2′-Amino-6-(2-fluoro-5-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>19</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>19</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (2-fluoro-5-methoxyphenyl)boronic acid to afford 2′-amino-6-(2-fluoro-5-methoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (15 mg, 0.039 mmol, 26% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37 (m, 1H), 6.99 (m, 2H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 6.83 (m, 1H), 6.76 (m, 1H), 3.79 (s, 3H), 3.16 (s, 3H), 2.56 (d, <i>J</i> = 14.1 Hz, 1H), 1.97 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.41 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 384.2 (M + 1).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2′-Amino-6-(3-chloro-5-fluorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>20</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>20</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-chloro-5-fluorophenyl)boronic acid to afford 2′-amino-6-(3-chloro-5-fluorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (25 mg, 0.064 mmol, 44% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.35 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.21 (m, 1H), 7.01 (m, 2H), 6.92 (m, 2H), 3.20 (s, 3H), 2.54 (d, <i>J</i> = 14.1 Hz, 1H), 1.96 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.41 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 388.2 (M + 1).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2′-Amino-6-(5-chloro-2-fluorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>21</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>21</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-chloro-6-fluorophenyl)boronic acid to afford 2′-amino-6-(5-chloro-2-fluorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (25 mg, 0.064 mmol, 44% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.34 (dm, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.05 Hz, 1H) 7.29 (dd, <i>J</i><sub>1</sub> = 6.83 Hz, <i>J</i><sub>2</sub> = 2.73 Hz, 1H) 7.20 (m, 1H), 7.02 (dd, <i>J</i><sub>1</sub> = 9.96 Hz, <i>J</i><sub>2</sub> = 8.78 1H), 6.95 (s, 1H), 6.92 (d, <i>J</i><sub>1</sub> = 8.59 Hz, 1H), 3.18 (s, 3H), 2.56 (d, <i>J</i><sub>1</sub> = 14.3 Hz, 1H), 1.98 (d, <i>J</i><sub>1</sub> = 14.3 Hz, 1H), 1.52 (s, 3H), 1.42 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 388.2 (M + 1).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2′-Amino-6-(3-isopropoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>22</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>22</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-isopropoxyphenyl)boronic acid to afford 2′-amino-6-(3-isopropoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (27 mg, 0.069 mmol, 46% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.39 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 7.27 (t, <i>J</i> = 7.8 Hz, 1H), 6.99 (m, 3H), 6.90 (d, <i>J</i> = 8.6 Hz, 1H), 6.81 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 4.58 (qn, <i>J</i> = 5.9 Hz, 1H), 3.19 (s, 3H), 2.56 (d, <i>J</i> = 14.1 Hz, 1H), 1.97 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.41 (s, 3H), 1.35 (s, 3H), 1.34 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 394.2 (M + 1).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2′-Amino-6-(3-ethoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>23</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>23</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-ethoxyphenyl)boronic acid to afford 2′-amino-6-(3-ethoxyphenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (11 mg, 0.029 mmol, 20% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.34 (dd, <i>J</i><sub>1</sub> = 8.6 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 7.28 (d, <i>J</i> = 7.8 Hz, 1H), 6.99 (m, 3H), 6.90 (d, <i>J</i> = 8.6 Hz, 1H), 6.81 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 2.3 Hz, 1H), 4.06 (q, <i>J</i> = 7.0 Hz, 2H), 3.19 (s, 3H), 2.56 (d, <i>J</i> = 14.1 Hz, 1H), 1.97 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.42 (t, <i>J</i> = 7.0 Hz, 3H), 1.41 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 380.2 (M + 1).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2′-Amino-1′,2,2-trimethyl-6-(3-(trifluoromethyl)phenyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>24</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>24</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with 3-(triflouromethyl)phenylboronic acid to afford 2′-amino-1′,2,2-trimethyl-6-(3-(trifluoromethyl)phenyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (13 mg, 0.032 mmol, 22% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.66 (s, 1H), 7.60 (d, <i>J</i><sub>1</sub>= 7.61 Hz, 1H), 7.54 (d, <i>J</i><sub>1</sub> = 7.61 Hz, 1H), 7.49 (d, <i>J</i><sub>1</sub> = 7.61 Hz, 1H), 7.40 (dd, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.15 Hz, 1H), 6.97 (s, 1H), 6.95 (d, <i>J</i><sub>1</sub> = 8.59 Hz, 1H), 3.19 (s, 3H), 2.56 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.98 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.42 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 404.2 (M + 1).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2′-Amino-1′,2,2-trimethyl-6-(3-(methylthio)phenyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>25</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>25</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-(methylthio)phenylboronic acid to afford 2′-amino-1′,2,2-trimethyl-6-(3-(methylthio)phenyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (23 mg, 0.0619 mmol, 42% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.38 (dd, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.15 Hz, 1H), 7.31 (s, 1H), 7.28 (d, <i>J</i><sub>1</sub> = 7.61 Hz, 1H), 7.26 (s, 1H), 7.19 (s, 1H), 7.17 (s, 1H), 6.96 (d, <i>J</i><sub>1</sub> = 1.95 Hz, 1H), 6.91 (d, <i>J</i><sub>1</sub> = 8.59 Hz, 1H), 3.17 (s, 3H), 2.56 (d, <i>J</i><sub>1</sub> = 14.25 Hz, 1H), 2.49 (s, 3H), 1.97 (d, <i>J</i><sub>1</sub> = 14.25 Hz, 1H), 1.51 (s, 3H), 1.41 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 382.1 (M + 1).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2′-Amino-6-(3-(difluoromethoxy)phenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>26</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>26</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (3-(difluoromethoxy)phenyl)boronic acid to afford 2′-amino-6-(3-(difluoromethoxy)phenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (11 mg, 0.03 mmol, 19% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (m, 2H), 7.27 (m, 1H), 7.18 (m, 1H), 7.03 (m, 1H), 6.94 (m, 1H), 6.53 (t, <i>J</i> = 74 Hz, 1H), 3.19 (s, 3H), 2.54 (d, <i>J</i> = 14.1 Hz, 1H), 1.99 (d, <i>J</i> = 14.1 Hz, 1H), 1.52 (s, 3H), 1.42 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 402.1 (M + 1)</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2′-Amino-6-(3-fluorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>27</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>27</b> was synthesized in the same fashion as compound <b>11</b> substituting 3-fluorophenylboronic acid for phenylboronic acid to afford 2′-amino-6-(3-fluorophenyl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (8 mg, 0.023 mmol, 31% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.45 (m, 2H), 7.30 (m, 2H), 7.12 (m, 1H), 6.88 (m, 2H), 3.05 (s, 3H), 2.2 (d, <i>J</i> = 14.1 Hz, 1H), 1.80 (d, <i>J</i> = 14.1 Hz, 1H), 1.43 (s, 3H), 1.39 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 354.2 (M + 1).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2′-Amino-6-cyclohexyl-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>28</b>)</h3><div class="NLM_p last">A mixture of 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (0.050 g, 0.148 mmol), cyclohexylzinc(II) bromide (0.44 mmol), and bis(tri-<i>tert</i>-butylphosphine)palladium(0) (0.014 mmol) in THF (1 mL) was heated in a sealed vial overnight at 90 °C. MS showed that the reaction was completed. The sample was then purified on silica gel, eluting with 2–10% MeOH/DCM + 1% NH<sub>4</sub>OH to give 2′-amino-6-cyclohexyl-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (13.7 mg, 0.041 mmol, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.04 (dd, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.15 Hz, 1H), 6.76 (d, <i>J</i><sub>1</sub> = 8.40, 1H), 6.61 (d, <i>J</i><sub>1</sub> = 1.95 Hz, 1H), 3.20 (s, 3H), 2.53 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 2.34 (m, 1H), 1.94 (d, <i>J</i><sub>1</sub> = 14.3 Hz, 1H), 1.75 (m, 5H), 1.47 (s, 3H), 1.35 (s, 3H), 1.25 (m, 5H), LCMS (APCI+) <i>m</i>/<i>z</i> 342.2 (M + 1).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2′-Amino-6-isobutoxy-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>29</b>)</h3><div id="sec5_28_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step A</h4><div class="NLM_p last">A mixture of 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (2.0 g, 5.91 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (9.0 g, 35.5 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.683 g, 0.59 mmol), 3 M KHF<sub>2</sub> (5 mL, 15 mmol), and 2 M Na<sub>2</sub>CO<sub>3</sub> (5.91 mL, 11.8 mmol) in dioxane (9 mL, 5.91 mmol) was heated in a sealed vial at 90 °C overnight. The mixture was cooled to ambient temperature, filtered through a Celite plug, and the filtrate collected was concentrated in vacuo. The residue obtained was purified by flash chromatography on silica gel, eluting with 1–10% MeOH/EtOAc + 1% TEA to provide (<i>rac</i>)-2′-amino-1′,2,2-trimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (1.65 g, 72%) as a light yellow solid contaminated with a small amount of dioxaboralane. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.64 (dd, <i>J</i><sub>1</sub> = 8.589 Hz, <i>J</i><sub>2</sub> = 1.562 Hz, 1H), 7.29 (br s, 1H), 6.83 (d, <i>J</i> = 8.21 Hz, 1H), 3.21 (s, 3H), 2.55 (d, <i>J</i> = 14.445 Hz, 1H), 1.96 (d, <i>J</i> = 14.055 Hz, 1H), 1.49 (s, 3H), 1.36 (s, 3H), 1.29 (s, 12H); LCMS (APCI+) <i>m</i>/<i>z</i> 286.2 (M + 1), retention time 2.19 min.</div></div><div id="sec5_28_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step B</h4><div class="NLM_p last">To a solution of 2′-amino-1′,2,2-trimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (0.25 g, 0.649 mmol) in MeOH (5 mL) and CH<sub>2</sub>Cl<sub>2</sub> at 0 °C was added 50% hydrogen peroxide in H<sub>2</sub>O (1.1 mL, 16.2 mmol). The reaction mixture was stirred at 0 °C for 45 min and then diluted with EtOAc/H<sub>2</sub>O, and the layers were separated. The aqueous layer was extracted with EtOAc (2×). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to provide 2′-amino-6-hydroxy-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (0.113 g, 0.410 mmol, 63.3% yield) as a white foamy solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.20 (s, 1H), 8.789 (brs, 1H), 6.55 (m, 1H), 6.11 (s, 1H), 3.92 (s, 2H), 3.02 (s, 3H), 2.14 (d, <i>J</i> = 13.66 Hz, 1H), 1.77 (d, <i>J</i> = 12.664 Hz, 1H), 1.36 (s, 3H), 1.29 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 276.2 (M + 1), retention time 0.78 min.</div></div><div id="sec5_28_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Step C</h4><div class="NLM_p last">To a solution of 2′-amino-6-hydroxy-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (18 mg, 0.0654 mmol) in DMF (0.5 mL) were added Cs<sub>2</sub>CO<sub>3</sub> (21.3 mg, 0.0654 mmol) and 1-bromo-2-methylpropane (0.00782 mL, 0.0719 mmol). The reaction mixture was stirred at ambient temperature. After 18 h, an additional 3 equiv of Cs<sub>2</sub>CO<sub>3</sub> was added, stirred at room temperature for 2 h, and then heated at 60 °C overnight. The mixture was cooled to ambient temperature and partitioned between brine and EtOAc. The combined aqueous layers were back-extracted with EtOAc. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue obtained was purified by flash chromatography on silica gel (10 g Snap cartridge, on Biotage SP1) using a gradient of 2–15% MeOH/CH<sub>2</sub>Cl<sub>2</sub> + 2% NH<sub>4</sub>OH to provide 2′-amino-6-isobutoxy-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (6.2 mg, 28.6%) as a pale yellow foamy solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 6.78–6.77 (m, 2H), 6.37–6.36 (m, 1H), 3.59–3.58 (m, 2H), 3.19 (s, 3H), 2.52 (d, <i>J</i> = 14.09 Hz, 1H), 2.04–1.96 (m, 1H), 1.94 (d, <i>J</i> = 14.09 Hz, 1H), 1.47 (s, 3H), 1.34 (s, 3H), 0.99 (s, 3H), 0.97 (s, 3H).</div></div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2′-Amino-1′,2,2-trimethyl-6-(piperidin-1-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one formate (<b><i>rac</i>-</b><b>30</b>)</h3><div class="NLM_p last">A solution of 1 N lithium bis(trimethylsilyl)amide in THF (1.892 mL, 1.892 mmol) and piperidine (0.07018 mL, 0.7096 mmol) was injected into a vial containing Pd<sub>2</sub>dba<sub>3</sub> (10.83 mg, 0.011 83 mmol), 2′-(dicyclohexylphosphino)-<i>N</i>,<i>N</i>-dimethylbiphenyl-2-amine (5.585 mg, 0.014 19 mmol), and 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (200 mg, 0.5914 mmol). The mixture was stirred at 65 °C for 15 h. The mixture was cooled to room temperature and concentrated in vacuo. The residue obtained was purified first by silica gel chromatography, eluting with a gradient of 10–100% MeOH/DCM containing 1% NH<sub>4</sub>OH, then by C-18 reverse phase chromatography (10–100% CH<sub>3</sub>CN/H<sub>2</sub>O (both eluents with 0.5% TFA) to provide 2′-amino-1′,2,2-trimethyl-6-(piperidin-1-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one formate (0.8 mg, 0.002 059 mmol, 0.35% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ 6.98 (dd, <i>J</i><sub>1</sub> = 8.98 Hz, <i>J</i><sub>2</sub> = 2.73 Hz, 1H), 6.76 (d, <i>J</i><sub>1</sub> = 8.98 Hz, 1H), 6.49 (d, <i>J</i><sub>1</sub> = 2.73 1H), 3.23 (s, 3H), 2.92 (t, <i>J</i><sub>1</sub> = 4.57 Hz, 4H), 2.37 (d, <i>J</i><sub>1</sub> = 14.4 Hz, 1H), 2.14 (d, <i>J</i><sub>1</sub> = 14.4 Hz, 1H), 1.67 (m, 4H), 1.51 (m, 2H), 1.43 (s, 3H), 1.32 (s, 3H); MS (APCI+/ESI+ multimode) <i>m</i>/<i>z</i> 343.2 (M + 1).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2′-Amino-1′,2,2-trimethyl-6-(pyridin-3-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>31</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>31</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with pyridin-3-ylboronic acid to afford 2′-amino-1′,2,2-trimethyl-6-(pyridin-3-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (18 mg, 0.05351 mmol, 24.13% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (d, <i>J</i><sub>1</sub> = 1.96 Hz, 1H), 8.50 (dd, <i>J</i><sub>1</sub> = 4.70 Hz, <i>J</i><sub>2</sub> = 1.57 Hz, 1H), 7.87 (dt, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 1.96 Hz 1H), 7.49 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.42 (dd, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 4.70 Hz, 1H), 6.94 (d, <i>J</i><sub>1</sub> = 2.35 Hz 1H), 6.89 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 6.52 (s, 2H), 3.04 (s, 3H), 2.22 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.84 (d, <i>J</i><sub>1</sub> = 13.7 Hz, 1H), 1.46 (s, 3H), 1.39 (s, 3H); MS (APCI+) <i>m</i>/<i>z</i> 337.1 (M + 1).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2′-Amino-1′,2,2-trimethyl-6-(pyridin-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>32</b>)</h3><div id="sec5_31_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Step A</h4><div class="NLM_p last">A mixture of 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (2.0 g, 5.91 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (9.01 g, 35.5 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.683 g, 0.591 mmol), and Na<sub>2</sub>CO<sub>3</sub> (5.91 mL, 11.8 mmol) in dioxane (9 mL, 5.91 mmol) was heated in a sealed vial overnight at 90 °C. The mixture was filtered through Celite 545 and concentrated in vacuo. The residue obtained was purfied on silica gel, eluting with 1–10% MeOH/EtOAc (1% TEA) to provide 2′-amino-1′,2,2-trimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (1.65 g, 72.4%).</div></div><div id="sec5_31_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step B</h4><div class="NLM_p last">A solution of 4:1 dioxane/water (1 mL) was sparged with N<sub>2</sub> for 30 min. The sparged solution was added to a pressure vessel containing 2′-amino-1′,2,2-trimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (100 mg, 0.2596 mmol), 2-chloropyridine (0.036 54 mL, 0.3893 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (29.99 mg, 0.025 96 mmol), and 2 M Na<sub>2</sub>CO<sub>3</sub> (82.53 mg, 0.7787 mmol). The contents were sealed and heated to 80 °C for 15 h. The mixture was concentrated and purified by silica gel chromatography, eluting with a gradient of 0–30% MeOH/EtOAc containing 6% NH<sub>4</sub>OH to provide 2′-amino-1′,2,2-trimethyl-6-(pyridin-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (18 mg, 0.05351 mmol, 20.62% yield) as an off-white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (d, <i>J</i><sub>1</sub> = 4.70 Hz, 1H), 7.80 (m, 3H), 7.42 (s, 1H), 7.25 (m, 1H), 6.88 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 6.55 (s, 2H), 3.05 (s, 3H), 2.23 (d, <i>J</i><sub>1</sub> = 13.3 Hz, 1H), 1.83 (d, <i>J</i><sub>1</sub> = 14.5 Hz 1H), 1.47 (s, 3H), 1.39 (s, 3H); MS (APCI+) <i>m</i>/<i>z</i> 337.1 (M + 1).</div></div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2′-Amino-1′,2,2-trimethyl-6-(pyridin-4-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>33</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>33</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with (pyridin-4-ylboronic acid to afford 2′-amino-1′,2,2-trimethyl-6-(pyridin-4-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (18 mg, 0.05351 mmol, 18.1% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (d, <i>J</i><sub>1</sub> = 6.26 Hz 2H), 7.59 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz 1H), 7.52 (dd, <i>J</i><sub>1</sub> = 4.70 Hz, <i>J</i><sub>2</sub> = 1.57 Hz, 2H), 7.02 (d, <i>J</i><sub>1</sub> = 2.35 Hz 1H), 6.92 (d, <i>J</i><sub>1</sub> = 8.61 Hz 1H), 6.55 (s, 2H), 3.05 (s, 3H), 2.22 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.83 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.43 (s, 3H), 1.39 (s, 3H); MS (APCI/ESI, multimode) <i>m</i>/<i>z</i> 337.2. (M + 1).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2′-Amino-6-(5-chloropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>34</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>34</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with 5-chloropyridin-3-ylboronic acid to afford 2′-amino-6-(5-chloropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (25 mg, 0.067 mmol, 46% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.57 (d, <i>J</i><sub>1</sub> = 1.95 Hz, 1H), 8.48, (d, <i>J</i><sub>1</sub> = 2.34 Hz, 1H), 7.71 (t, <i>J</i><sub>1</sub> = 2.15 Hz, 1H), 7.37 (dd, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.34 Hz, 1H), 6.97 (d, <i>J</i><sub>1</sub> = 8.59 Hz, 1H), 6.94 (s, 1H), 3.21 (s, 3H), 2.55 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.97 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.53 (s, 3H), 1.43 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 371.2 (M + 1).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2′-Amino-1′,2,2-trimethyl-6-(5-(trifluoromethyl)pyridin-3-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>35</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>35</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with 5-(trifluoromethyl)pyridin-3-ylboronic acid to afford 2′-amino-1′,2,2-trimethyl-6-(5-(trifluoromethyl)pyridin-3-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (33 mg, 0.082 mmol, 55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.88 (s, 1H), 8.79 (s, 1H), 7.94 (s, 1H), 7.41 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.0 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 6.97 (d, <i>J</i><sub>1</sub> = 1.96 Hz, 1H), 3.20 (s, 3H), 2.55 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.98 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.54 (s, 3H), 1.44 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 405.2 (M + 1).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2′-Amino-1′,2,2-trimethyl-6-(5-(prop-1-ynyl)pyridin-3-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>36</b>)</h3><div class="NLM_p last">A resealable glass pressure tube was charged with 2′-amino-1′,2,2-trimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (30 mg, 0.078 mmol), 3-bromo-5-(prop-1-ynyl)pyridine (18 mg, 0.093 mmol), dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (3.2 mg, 0.0039 mmol), 20% aqueous Na<sub>2</sub>CO<sub>3</sub> (144 μL, 0.27 mmol), and 1,4-dioxane (779 μL, 0.078 mmol). The mixture was sparged with N<sub>2</sub> for 5 min, capped, and stirred at 90 °C for 1 h. The solvents were removed in vacuo, and the residue obtained was suspended in 1.5 mL of MeOH and filtered through a 45 μm filter. The filtrate collected was purified by C-18 reverse phase preparative HPLC on Gilson UniPoint instrument using a 5–95% CH<sub>3</sub>CN/water + 0.5% formic acid gradient. The fractions containing the product were pooled, concentrated in vacuo, evaporated from CH<sub>3</sub>CN (2 × 5 mL), and dried under high vacuum for 48 h to give 2′-amino-1′,2,2-trimethyl-6-(5-(prop-1-ynyl)pyridin-3-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (23 mg, 0.061 mmol, 79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.55 (d, <i>J</i><sub>1</sub> = 10.96 Hz, 2H), 7.72 (s, 1H), 7.42 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 6.99 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 6.95 (d, <i>J</i><sub>1</sub> = 2.35 Hz, 1H), 3.30 (s, 3H), 2.57 (d, <i>J</i><sub>1</sub> = 14.5 Hz, 1H), 2.12 (d, <i>J</i><sub>1</sub> = 14.5 Hz, 1H), 2.09 (s, 3H), 1.54 (s, 3H), 1.46 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 375.2 (M + 1).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2′-Amino-6-(2-fluoropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>37</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>37</b> was synthesized in the same fashion as compound <b>32</b>, substituting 2-chloropyridine for 2-fluoro-3-iodopyridine to afford 2′-amino-6-(2-fluoropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (15 mg, 0.04233 mmol, 32.61% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (d, <i>J</i><sub>1</sub> = 7.70 Hz, 1H), 7.90 (m, 1H), 7.40 (d, <i>J</i><sub>1</sub> = 8.61 Hz 1H), 7.35 (m, 1H), 7.05 (s, 1H), 6.91 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 2.79 (s, 3H), 2.36 (d, <i>J</i><sub>1</sub> = 11.74 Hz, 1H), 1.89 (m, 1H), 1.47 (s, 3H), 1.45 (s, 3H); MS (APCI+/ESI+ multimode) <i>m</i>/<i>z</i> 55.2 (M + 1).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2′-Amino-6-(5-fluoropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>38</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>38</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with 5-fluoropyridin-3-yl boronic acid (21 mg, 0.15 mmol) to afford 2′-amino-6-(5-fluoropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (10 mg, 0.028 mmol, 19% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.53 (s, 1H), 8.38 (d, <i>J</i><sub>1</sub> = 2.54 Hz, 1H), 7.44 (dt, <i>J</i><sub>1</sub> = 9.57 Hz, <i>J</i><sub>2</sub> = 2.25 Hz, 1H), 7.38 (dd, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.34 Hz, 1H), 6.97 (d, <i>J</i><sub>1</sub> = 8.59 Hz, 1H), 6.96 (s, 1H), 3.20 (s, 3H), 2.55 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.97 (d, <i>J</i><sub>1</sub> = 14.3 Hz, 1H), 1.53 (s, 3H), 1.43 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 355.2 (M + 1).</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2′-Amino-1′,2,2-trimethyl-6-(pyrimidin-5-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>39</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>39</b> was synthesized in the same fashion as compound <b>11</b>, replacing phenylboronic acid with pyrimidin-5-yl boronic acid to afford 2′-amino-1′,2,2-trimethyl-6-(pyrimidin-5-yl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (0.037 g, 0.110 mmol, 74.2% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.13 (s, 1H), 8.83 (s, 2H), 7.39 (d, <i>J</i><sub>1</sub> = 6.65 Hz, 1H), 7.00 (d, <i>J</i><sub>1</sub> = 8.61 Hz, 1H), 6.95 (s, 1H), 3.19 (s, 3H), 2.54 (d, <i>J</i><sub>1</sub> = 14.5 Hz, 1H), 1.97 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.53 (s, 3H), 1.44 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 338.3 (M + 1).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2′-Amino-6-(isothiazol-5-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>40</b>)</h3><div class="NLM_p last">A glass pressure tube was charged with a mixture of 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (50 mg, 0.15 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isothiazole (62 mg, 30 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (8.5 mg, 0.0074 mmol), 2 M Na<sub>2</sub>CO<sub>3</sub> (0.15 mL, 0.30 mmol), and dioxane (1.5 mL, 0.15 mmol). The tube was sealed and heated at 90 °C for 18 h. The crude reaction mixture was directly purified by flash chromatography on silica gel, eluting with a gradient of 2–10% MeOH/DCM containing 1% NH<sub>4</sub>OH to provide 2′-amino-6-(isothiazol-5-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (9 mg, 18%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl3-<i>d</i>) δ 8.395 (d, <i>J</i> = 1.56 Hz, 1H), 7.414 (dd, <i>J</i><sub>1</sub> = 8.589 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 7.26 (s, 1H), 7.22 (d, <i>J</i> = 1.952 Hz, 1H), 6.91 (d, <i>J</i> = 8.589 Hz, 1H), 3.21 (s, 3H), 2.54 (d, 14.06 Hz, 1H), 1.96 (d, <i>J</i> = 14.45 Hz, 1H), 1.52 (s, 3H), 1.42 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 343.1 (M + 1), retention time 1.996 min.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-(2′-Amino-1′,2,2-trimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-6-yl)-5-methylfuran-2-carboxamide (<b><i>rac</i>-</b><b>41</b>)</h3><div id="sec5_40_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Step A</h4><div class="NLM_p last">A mixture of 2′-amino-6-bromo-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (2.0 g, 5.91 mmol), <i>tert</i>-butyl carbamate (6.93 g, 59.1 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (3.85 g, 11.8 mmol) in THF (20 mL, 5.91 mmol) was purged with Ar for 5 min. Pd<sub>2</sub>dba<sub>3</sub> (542 mg, 0.591 mmol) and XPHOS (564 mg, 1.18 mmol) were added, and the mixture was heated to 90 °C overnight in a sealed vial. The mixture was then cooled to ambient temperature and filtered through Celite. The filtrate collected was concentrated in vacuo, and the residue obtained was purified by flash chromatography on silica gel, eluting with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH (90:9:1). The product isolated was taken up in DCM/TFA (1:3, 20 mL) and stirred at ambient temperature for 3 h. The mixture was concentrated in vacuo, and the resulting oil was evaporated from EtOAc and hexanes to provide 2′,6-diamino-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (1.15 g, 71% yield) as a light brown solid which was used for the next reaction directly. LCMS (APCI+) <i>m</i>/<i>z</i> 275.1 (M + 1).</div></div><div id="sec5_40_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Step B</h4><div class="NLM_p last">To a mixture of 2′,6-diamino-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (0.032 g, 0.0862 mmol) and 5-methylfuran-2-carbonyl chloride (0.0125 g, 0.0862 mmol) in DCM (0.007 32 g, 0.0862 mmol) was added TEA (d, 0.726) (0.0120 mL, 0.0862 mmol), and the mixture was stirred for 20 min at room temperature. The mixture was concentrated in vacuo, and the residue obtained was purified on reverse phase C-18 HPLC to give <i>N</i>-(2′-amino-1′,2,2-trimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-6-yl)-5-methylfuran-2-carboxamide (15 mg, 0.0384 mmol, 45% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 11.72 (br s, 1H), 11.09 (br s, 1H), 8.14 (s, 1H), 7.55 (s, 1H), 7.35 (d, <i>J</i> = 9.39 Hz, 1H), 7.06 (d, <i>J</i> = 3.13 Hz, 1H), 6.89 (d, <i>J</i> = 8.61 Hz, 1H), 6.15 (d, <i>J</i> = 3.13 Hz, 1H), 3.30 (s, 3H), 2.56 (d, <i>J</i> = 14.86 Hz, 1H), 2.37 (s, 3H), 2.17 (d, <i>J</i> = 14.08 Hz, 1H), 1.52 (s, 3H), 1.39 (s, 3H). LCMS (APCI+) <i>m</i>/<i>z</i> 483.2 (M + 1), retention time 1.956 min.</div></div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-Amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one (<b><i>rac</i>-</b><b>42</b>)</h3><div id="sec5_41_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Step A</h4><div class="NLM_p last">6-Bromo-2,2-dimethylthiochroman-4-one (7.456 mL, 7.456 mmol) in absolute ethanol (1M, 7.4 mL) was treated sequentially with (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> (7.165 g, 74.56 mmol), potassium cyanide (1.457 g, 22.37 mmol), and sodium acid sulfite (0.1552 g, 1.491 mmol) in a steal bomb containing a stir bar. The bomb was sealed and heated in an oil bath at 150 °C for 16 h. The mixture was cooled to ambient temperature and saw about >75% conversion by LC. Therefore an additional 4 equiv of (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> and 1 equiv of KCN were added to the mixture. The bomb was sealed and heated back to 150 °C for a further 24 h. The bomb mixture was cooled to ambient temperature, and the contents were poured into water. The rapidly stirred suspension was carefully acidified with 5 M hydrochloric acid (37.28 mL, 186.4 mmol). The mixture was diluted further with water (50 mL), and the resulting solids were filtered, washing with water. The solid collected was first air-dried and then vacuum-dried for 24 h to provide 6′-bromo-2′,2′-dimethylspiro[imidazolidine-4,4′-thiochroman]-2,5-dione (1.8 g, 7.75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub><i>-d</i>) δ 7.34–7.32 (m, 2H), 7.05 (<i>J</i> = 8.61 Hz, 1H), 2.68 (d, <i>J</i> = 14.08 Hz, 1H), 2.29 (d, <i>J</i> = 14.86 Hz, 1H), 1.47 (s, 3H), 1.45 (s, 3H). MS (neg) <i>m</i>/<i>z</i> 339.0, 341.0 (M – 1).</div></div><div id="sec5_41_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Step B</h4><div class="NLM_p last">6′-Bromo-2′,2′-dimethylspiro[imidazolidine-4,4′-thiochroman]-2,5-dione (1.75 g, 5.13 mmol) in DMF (0.4 M, 9.8 mL) was treated with K<sub>2</sub>CO<sub>3</sub> (709 mg, 5.13 mmol) followed by iodomethane (0.319 mL, 5.13 mmol) at ambient temperature. After 30 min, the reaction was diluted with water (50 mL), and the resulting solid was filtered, air-dried, and dried under high vacuum for 16 h to provide 6′-bromo-1,2′,2′-trimethylspiro[imidazolidine-4,4′-thiochroman]-2,5-dione (1.63 g, 4.59 mmol, 89.5% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.35–7.32 (m, 1H), 7.18–7.17 (m, 1H), 7.07 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 3.17 (s, 3H), 2.68 (d, <i>J</i> = 14.86 Hz, 1H), 2.12 (d, <i>J</i> = 14.86 Hz, 1H), 0.01 (s, 6H); MS (neg) <i>m</i>/<i>z</i> 352.1, 354.9 (M – 1)<sup>−</sup> .</div></div><div id="sec5_41_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Step C</h4><div class="NLM_p last">6′-Bromo-1,2′,2′-trimethylspiro[imidazolidine-4,4′-thiochroman]-2,5-dione (1.60 g, 4.50 mmol) in THF was concentrated to a paste. The paste was suspended in toluene (9 mL, 0.5 M) and heated to reflux under a reflux condenser fitted with a drying tube. When the mixture became a solution, Lawesson’s reagent (1.09 g, 2.70 mmol) was added and heating at reflux was continued for 16 h. The mixture was cooled to ambient temperature and partitioned between EtOAc and water. The aqueous layer was extracted a second time with ethyl acetate. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue isolated was purified by flash chromatography on silica gel, eluting with 5–50% ethyl acetate–hexanes to provide 6′-bromo-1,2′,2′-trimethyl-2-thioxospiro[imidazolidine-4,4′-thiochroman]-5-one (1.04 g, 2.80 mmol, 62.2% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.37–7.34 (m, 1H), 7.10–7.06 (m, 2H), 3.39 (s, 3H), 2.62 (d, <i>J</i> = 14.87 Hz, 1H), 2.26 (d, <i>J</i> = 14.87 Hz, 1H), 1.50 (s, 3H), 1.46 (s, 3H); MS (neg) <i>m</i>/<i>z</i> 368.9, 371.1 (M – 1).</div></div><div id="sec5_41_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Step D</h4><div class="NLM_p last">6′-Bromo-1,2′,2′-trimethyl-2-thioxospiro[imidazolidine-4,4′-thiochroman]-5-one (35 mg, 0.094 mmol) in DCM (0.5 mL) was treated with 7 N ammonia in methanol (673 μL, 4.7 mmol) at ambient temperature. Then 70% <i>tert</i>-butyl hydroperoxide in water (52 μL, 0.38 mmol) was added, and the mixture was stirred at ambient temperature. After 16 h, another 2 equiv of <sup><i>t</i></sup>Bu-OOH was added, and the mixture was stirred at room temperature for another 12 h. The reaction mixture was transferred to separatory funnel and partitioned between brine and ethyl acetate. The phases were separated, and the aqueous layer was extracted with ethyl acetate (1×). The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated, and purified by flash chromatography on silica gel, eluting with 4–20% methanol–dichloromethane to provide 2-amino-6′-bromo-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one (14 mg, 0.040 mmol, 42% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.26 (m, 1H), 7.04–7.01 (m, 1H), 3.18 (s, 3H), 2.61–2.56 (m, 1H), 2.09–2.05 (m, 1H), 1.50 (s, 3H), 1.46 (s, 3H); MS (APCI+) <i>m</i>/<i>z</i> 354.2, 356.0 (M + 1).</div></div><div id="sec5_41_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Step E</h4><div class="NLM_p last">2-Amino-6′-bromo-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one (42 mg, 0.119 mmol) in toluene (0.1 M) was treated with 3-chloro-5-fluorophenylboronic acid (26.9 mg, 0.154 mmol), 20% aqueous sodium carbonate (157 μL, 0.296 mmol), and tetrakis(triphenylphosphine)palladium(0) (6.85 mg, 0.005 93 mmol). The mixture was sparged with Ar for 2 min, capped, and heated to reflux for 16 h. The mixture was applied directly to silica gel, eluting with a gradient of 4–20% methanol–dichloromethane to provide 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one (30 mg, 0.0743 mmol, 62.7% yield) as a tan solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.33 (dd, <i>J</i><sub>1</sub> = 8.321 Hz, <i>J</i><sub>2</sub> = 1.664 Hz, 1H), 7.25 (m, 2H), 7.04 (m, 3H), 3.22 (s, 3H), 2.65 (d, <i>J</i> = 14.146 Hz, 1H), 2.14 (d, <i>J</i> = 14.146 Hz, 1H), 1.56 (s, 3H), 1.50 (s, 3H). <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) 155.8 (C), 143.6 (C), 136.0 (C), 135.3 (C), 132.1 (C), 131.9 (C), 131.9 (C), 128.9 (CH), 127.3 (CH), 125.9 (CH), 122.9 (CH), 113 (CH), 113 (CH), 112 (C), 67.4 (C), 49.5 (CH<sub>2</sub>), 41.4 (C), 31.5–29.2 (CH<sub>3</sub>), 26.1 (CH<sub>3</sub>). LCMS (APCI+) <i>m</i>/<i>z</i> 404.1 (M + 1), retention time = 1.10 min.</div></div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 2-Amino-7′-(3-chloro-5-fluorophenyl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (<b><i>rac</i>-</b><b>43</b>)</h3><div id="sec5_42_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Step A</h4><div class="NLM_p last">7-Bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one (3.00 g, 11.9 mmol) in EtOH (12 mL) was treated with sodium bisulfite (100 mg), KCN (2.32 g, 35.6 mmol), and (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> (7.97 g, 83.0 mmol) as described for the synthesis of 6′-bromo-2′,2′-dimethylspiro[imidazolidine-4,4′-thiochroman]-2,5-dione to provide 7′-bromo-3′,3′-dimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione (1.5 g, 4.64 mmol, 39% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.01 (br s, 1H), 8.58 (s, 1H), 7.46 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.14–7.12 (m, 2H), 2.59–2.52 (m, 2H), 2.10 (d, <i>J</i> = 14.09 Hz, 1H), 1.79 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 1.57 Hz, 1H), 1.07 (s, 3H), 0.86 (s, 3H).</div></div><div id="sec5_42_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Step B</h4><div class="NLM_p last">7′-Bromo-3′,3′-dimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione (15.0 g, 46.41 mmol) in DMF (60 mL) was treated with K<sub>2</sub>CO<sub>3</sub> (6.735 g, 48.73 mmol) and CH<sub>3</sub>I (3.04 mL, 48.73 mmol) according to the procedure described for the synthesis of 6′-bromo-1,2′,2′-trimethylspiro[imidazolidine-4,4′-thiochroman]-2,5-dione to provide 7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione (15.6 g, 46.26 mmol, 99.67% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>) δ 7.36 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.12 (d, <i>J</i> = 2.35 Hz, 1H), 6.99 (d, <i>J</i> = 8.61 Hz, 1H), 6.15 (br s, 1H), 3.13 (s, 3H), 2.72 (s, <i>J</i> = 16.43 Hz, 1H), 2.52 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.32 (d, <i>J</i> = 14.09 Hz, 1H), 1.82 (dd, <i>J</i><sub>1</sub> = 14.08 Hz, <i>J</i><sub>2</sub> = 3.13 Hz, 1H), 1.61 (s, 3H), 0.95 (s, 3H). Analytical HPLC purity 99%, retention time 3.780 min.</div></div><div id="sec5_42_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Step C</h4><div class="NLM_p last">7′-Bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione (874 mg, 2.59 mmol) was treated with Lawesson’s reagent (629 mg, 1.56 mmol), as described for the synthesis of 6′-bromo-1,2′,2′-trimethyl-2-thioxospiro[imidazolidine-4,4′-thiochroman]-5-one to provide 7′-bromo-1,3′,3′-trimethyl-2-thioxo-3′,4′-dihydro-2′<i>H</i>-spiro[imidazolidine-4,1′-naphthalen]-5-one (440 mg, 1.25 mmol, 48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.38 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.34 (brs, 1H), 7.02–6.99 (m, 2H), 3.37 (s, 3H), 2.72 (d, <i>J</i> = 16.43 Hz, 1H), 2.53 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 3.13 Hz, 1H), 2.27 (d, <i>J</i> = 14.08 Hz, 1H), 1.85 (dd, <i>J</i><sub>1</sub> = 14.08 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1,17 (s, 3H), 0.98 (s, 3H). LCMS (neg) <i>m</i>/<i>z</i> 351, 352 (M – 1); retention time 1.666 min.</div></div><div id="sec5_42_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Step D</h4><div class="NLM_p last">7′-Bromo-1,3′,3′-trimethyl-2-thioxo-3′,4′-dihydro-2′<i>H</i>-spiro[imidazolidine-4,1′-naphthalen]-5-one (2.44 g, 6.91 mmol) in THF (17 mL) was treated with 7 N NH<sub>3</sub> in MeOH (19.7 mL, 138 mmol) and 70% <i>tert</i>-butyl hydroperoxide in water (9.88 mL, 69.1 mmol) as described for the synthesis of 2-amino-6′-bromo-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one to provide 2-amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (1.71 g, 5.09 mmol, 73.6% yield) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.32 (dd, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 7.06 (d, <i>J</i> = 1.56 Hz, 1H), 6.97 (d, <i>J</i> = 8.61 Hz, 1H), 3.18 (s, 3H), 2.71 (d, <i>J</i> = 15.65 Hz, 1H), 2.50 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 3.13 Hz, 1H), 2.23 (d, <i>J</i> = 14.08 Hz, 1H), 1.75 (dd, <i>J</i><sub>1</sub> = 14.08 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.14 (s, 3H), 0.963 (s, 3H). LCMS (APCI+) <i>m</i>/<i>z</i> 336, 338 (M + 1), retention time 0.983 min.</div></div><div id="sec5_42_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Step E</h4><div class="NLM_p last">2-Amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (56 mg, 0.17 mmol) and 3-chloro-5-fluorophenylboronic acid (38 mg, 0.22 mmol) were processed as described for the synthesis of 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one to yield 2-amino-7′-(3-chloro-5-fluorophenyl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (37 mg, 0.096 mmol, 58% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.37 (dd, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 7.24 (s, 1H), 7.18 (d, <i>J</i> = 8.61 Hz, 1H), 7.07–7.03 (m, 3H), 3.22 (s, 3H), 2.82 (d, <i>J</i> = 16.42 Hz, 1H), 2.61 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.29 (d, <i>J</i> = 14.08 Hz, 1H), 1.82 (dd, <i>J</i><sub>1</sub> = 14.08 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.17 (s, 3H), 1.02 (s, 3H). MS (positive) <i>m</i>/<i>z</i> 387 (M + 1)+. Analytical HPLC purity = 93% (220 nm), retention time 3.546 min.</div></div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 3-(2-Amino-1,2′,2′-trimethyl-5-oxo-1,5-dihydrospiro[imidazole-4,4′-thiochroman]-6′-yl)benzonitrile (<b><i>rac</i>-</b><b>44</b>)</h3><div class="NLM_p last">2-Amino-6′-bromo-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one (51 mg, 0.144 mmol) and 3-cyanophenylboronic acid (31.7 mg, 0.216 mmol) were suspended in dioxane (0.75 mL), and 20% aqueous sodium carbonate (237 μL, 0.446 mmol) was added with rapid stirring. The suspension was sparged with argon for 2 min, at which point dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (6 mg, 0.0072 mmol) was added. The reaction vial was sealed and heated to 100 °C for 16 h. The reaction mixture was partitioned between EtOAc and water. The aqueous layer was extracted a second time with ethyl acetate. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated, and purified on silica gel, eluting with 1–15% MeOH/DCM (containing 2% ammonia) to provide 3-(2-amino-1,2′,2′-trimethyl-5-oxo-1,5-dihydrospiro[imidazole-4,4′-thiochroman]-6′-yl)benzonitrile (32 mg, 0.0850 mmol, 59% yield) as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.94 (m, 1H), 7.80 (d, <i>J</i> = 1.56 Hz, 1H), 7.79 (m, 1H), 7.65 (t, <i>J</i> = 7.83 Hz, 1H), 7.52–7.49 (m, 1H), 7.19 (d, <i>J</i> = 7.83 Hz, 1H), 6.98 (brs, 1H), 6.54 (brs, 2H), 3.05 (s, 3H), 2.35 (d, <i>J</i> = 14.09 Hz, 1H), 1.97–1.89 (m, 1H), 1.51 (s, 3H), 1.42 (m, 3H); MS (APCI+) <i>m</i>/<i>z</i> 377.2 (M + 1); analytical HPLC purity 95 area %, retention time 3.324 min.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 3-(2-Amino-1,3′,3′-trimethyl-5-oxo-1,3′,4′,5-tetrahydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-7′-yl)benzonitrile (<b><i>rac</i>-</b><b>45</b>)</h3><div class="NLM_p last">2-Amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2’H-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (50 mg, 0.15 mmol) and 3-cyanophenylboronic acid (28 mg, 0.19 mmol) were processed according to the method described for the synthesis of 3-(2-amino-1,2′,2′-trimethyl-5-oxo-1,5-dihydrospiro[imidazole-4,4′-thiochroman]-6′-yl)benzonitrile to provide 3-(2-amino-1,3′,3′-trimethyl-5-oxo-1,3′,4′,5-tetrahydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-7′-yl)benzonitrile (34 mg, 0.095 mmol, 64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.74 (d, <i>J</i> = 1.56 Hz, 1H), 7.69 (d, <i>J</i> = 7.83 Hz, 1H), 7.61–7.58 (m, 1H), 7.50 (t, <i>J</i> = 7.83 Hz, 1H), 7.39 (dd, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 2.25 Hz, 1H), 7.21 (d, <i>J</i> = 7.83 Hz, 1H), 7.06 (d, <i>J</i> = 1.56 Hz, 1H), 3.21 (s, 3H), 2.83 (d, <i>J</i> = 15.65 Hz, 1H), 2.61 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.29 (d, <i>J</i> = 14.09 Hz, 1H), 1.81 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.17 (s, 3H0, 1.02 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 359 (M + 1), retention time 2.263 min.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2-Amino-7′-(2-fluoropyridin-3-yl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (<b><i>rac</i>-</b><b>46</b>)</h3><div class="NLM_p last">2-Amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (50 mg, 0.15 mmol) and 2-fluoropyridin-3-ylboronic acid (27 mg, 0.19 mmol) were processed according to the method described for the synthesis of 2′-amino-6-(2-fluoropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one to yield 2-amino-7′-(2-fluoropyridin-3-yl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (37 mg, 0.10 mmol, 71% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.16 (dd, <i>J</i><sub>1</sub> = 7.04 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 7.80–7.75 (m, 1H), 7.42 (dt, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 1.56 Hz,1H), 7.26–7.23 (m, 1H), 7.27 (d, <i>J</i> = 7.82 Hz, 1H), 7.10 (s, 1H), 3.20 (s, 3H), 2.82 (d, <i>J</i> = 15.65 Hz, 1H), 2.62 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.31 (d, <i>J</i> = 14.09 Hz, 1H), 1.83 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 3.13 Hz, 1H), 1.17 (s, 3H), 1.03 (s, 3H); <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 178.4 (C), 160 (C), 156.0 (C), 146.4 (CH), 140.5 (CH), 137.4 (C), 134.2 (C), 132.6 (C), 130.5 (CH), 128.8 (CH), 127.8 (CH), 123.4 (C), 121.8 (CH), 65.6 (C), 46.8 (CH<sub>2</sub>), 43.4 (CH<sub>2</sub>), 31.3–25.8 (CH<sub>3</sub>), 29.6 (C), 25.8 (CH<sub>3</sub>); LCMS (APCI+) <i>m</i>/<i>z</i> 353.2 (M + 1), retention time 2.099 min.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 5-Amino-6′-(5-chloropyridin-3-yl)-1,2′,2′-trimethylspiro[pyrrole-3,4′-thiochroman]-2(1<i>H</i>)-one (<b><i>rac</i>-</b><b>47</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>47</b> was synthesized in the same fashion as 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one, substituting 5-chloropyridin-3-ylboronic acid (14.4 mg, 0.0915 mmol) for 3-chloro-5-fluorophenylboronic acid to afford 5-amino-6′-(5-chloropyridin-3-yl)-1,2′,2′-trimethylspiro[pyrrole-3,4′-thiochroman]-2(1<i>H</i>)-one (14 mg, 46% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.58 (m, 1H), 8.51 (m, 1H), 7.73 (m, 1H), 7.35–7.30 (m, 1H), 7.28 (m, 1H), 7.04 (m, 1H), 3.20 (s, 3H), 2.64 (d, <i>J</i> = 14.08 Hz, 1H), 2.13 (d, <i>J</i> = 14.08 Hz, 1H), 1.56 (s, 3H), 1.49 (s, 3H); MS (APCI+) <i>m</i>/<i>z</i> 387.2 (M + 1).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-Amino-7′-(5-chloropyridin-3-yl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (<b><i>rac</i>-</b><b>48</b>)</h3><div class="NLM_p last">2-Amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (112 mg, 0.333 mmol) and 5-chloropyridin-3-ylboronic acid (68 mg, 0.433 mmol) were processed according to the method described for the synthesis of 5-amino-6′-(5-chloropyridin-3-yl)-1,2′,2′-trimethylspiro[pyrrole-3,4′-thiochroman]-2(1<i>H</i>)-one to provide 2-amino-7′-(5-chloropyridin-3-yl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (50 mg, 0.136 mmol, 41% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.60 (d, <i>J</i> = 2.35 Hz, 1H), 8.51 (d, <i>J</i> = 2.35 Hz, 1H), 7.45 (m, 1H), 7.39 (dd, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 7.22 (d, <i>J</i> = 7.83 Hz, 1H), 7.06 (d, <i>J</i> = 1.56 Hz, 1H), 3.20 (s, 3H), 2.84 (d, <i>J</i> = 16.43 Hz, 1H), 2.62 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.31 (d, <i>J</i> = 14.09 Hz, 1H), 1.81 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.17 (s, 3H), 1.02 (s, 3H). MS (APCI+) <i>m</i>/<i>z</i> 369 (M + 1).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 5-Amino-1,2′,2′-trimethyl-6′-(pyrimidin-5-yl)spiro[pyrrole-3,4′-thiochroman]-2(1<i>H</i>)-one (<b><i>rac</i>-</b><b>49</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>49</b> was synthesized in the same fashion as 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one substituting pyrimidin-5-yl boronic acid (13.4 mg, 0.108 mmol) for 3-chloro-5-fluorophenylboronic acid to afford 5-amino-1,2′,2′-trimethyl-6′-(pyrimidin-5-yl)spiro[pyrrole-3,4′-thiochroman]-2(1<i>H</i>)-one (19 mg, 56.5% yield) as a tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.15 (s, 1H), 8.96 (s, 2H), 7.57 (m, 1H), 7.24 (m, 1H), 7.07 (m, 1H), 3.04 (s, 3H), 2.35 (m, 1H), 1.92 (m, 1H), 1.51 (s, 3H), 1.42 (s, 3H); MS (APCI+) <i>m</i>/<i>z</i> 354.2 (M + 1); analytical HPLC retention time 2.967 min.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-Amino-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (<b><i>rac</i>-</b><b>50</b>)</h3><div class="NLM_p last">2-Amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (50 mg, 0.15 mmol) and pyrimidin-5-yl boronic acid (24 mg, 0.19 mmol) were processed as described for the synthesis of 5-amino-1,2′,2′-trimethyl-6′-(pyrimidin-5-yl)spiro[pyrrole-3,4′-thiochroman]-2(1<i>H</i>)-one to yield 2-amino-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (38 mg, 0.11 mmol, 76% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.16 (s, 1H), 8.85 (s, 2H), 7.42 (dd, <i>J</i> = −7.83 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.09 (d, <i>J</i> = 1.56 Hz, 1H), 3.22 (s, 3H), 2.86 (d, <i>J</i> = 15.65 Hz, 1H), 2.63 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.29 (d, 14.08 Hz, 1H), 1.84 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.18 (s, 3H), 1.03 (s, 3H); <sup>13</sup>C NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 179.7 (C), 157.4 (CH), 155.3 (C), 154.8 (CH), 154.8 (CH), 138.1 (C), 135.4 (C), 133.9 (C), 133.0 (C), 131.1 (CH), 126.9 (CH), 125.3 (CH), 66.0 (C), 46.9 (CH<sub>2</sub>), 43.5 (CH<sub>2</sub>), 31.2–25.9 (CH<sub>3</sub>), 29.6 (C), 26.0 (CH<sub>3</sub>); LCMS (APCI+) <i>m</i>/<i>z</i> 336.2 (M + 1)<sup>+</sup>, retention time 1.905 min (5 min run).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-Amino-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-4′,5(1<i>H</i>,3′<i>H</i>)-dione (<b><i>rac</i>-</b><b>51</b>)</h3><div id="sec5_50_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Step A</h4><div class="NLM_p last">A solution of 2-amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (50 mg, 0.15 mmol) in acetic acid (124 μL, 0.15 mmol) was cooled to 0 °C and treated with a solution of CrO<sub>3</sub> (33 mg, 0.33 mmol) in acetic acid (124 μL, 0.15 mmol) and water (124 μL, 0.15 mmol). The resulting mixture was allowed to warm to ambient temperature overnight. The reaction mixture was diluted with water and extracted with DCM. The organic extracts were washed with NaHCO<sub>3</sub>, brine, dried, and concentrated in vacuo to provide crude 2-amino-7′-bromo-1,3′,3′-trimethyl-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-4′,5(1<i>H</i>,3′<i>H</i>)-dione 2,2,2-trifluoroacetate (26 mg, 38% yield), which was used for the next reaction directly. LCMS (APCI+) <i>m</i>/<i>z</i> 350, 352 (M + 1)<sup>+</sup>, retention time 1.005 min.</div></div><div id="sec5_50_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Step B</h4><div class="NLM_p last">2-Amino-7′-bromo-1,3′,3′-trimethyl-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-4′,5(1<i>H</i>,3′<i>H</i>)-dione 2,2,2-trifluoroacetate (26 mg, 0.056 mmol) and pyrimidin-5-yl-boronic acid (9.7 mg, 0.078 mmol) were processed according to the synthesis of 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one to provide 2-amino-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-4′,5(1<i>H</i>,3′<i>H</i>)-dione (22 mg, 0.0475 mmol, 85% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ 9.21 (s, 1H), 9.12 (s, 2H), 8.22 (d, <i>J</i> = 8.22 Hz, 1H), 7.97 (d, <i>J</i> = 8.22 Hz, 1H), 7.74 (s, 1H), 3.03 (s, 3H), 2.65 (d, <i>J</i> = 14.48 Hz, 1H), 2.42 (d, <i>J</i> = 14.86 Hz, 1H), 1.38 (s, 3H), 1.33 (s, 3H). LCMS (APCI+) <i>m</i>/<i>z</i> 350.1 (M + 1)<sup>+</sup>, retention time 0.911 min.</div></div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 2-Amino-4′,4′-difluoro-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (<b><i>rac</i>-</b><b>52</b>)</h3><div id="sec5_51_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Step A</h4><div class="NLM_p last">To a solution of 2-amino-7′-bromo-1,3′,3′-trimethyl-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-4′,5(1<i>H</i>,3′<i>H</i>)-dione 2,2,2-trifluoroacetate (17 mg, 0.0366 mmol) in dichloroethane (183 μL, 0.0366 mmol) at 0 °C in a plastic Falcon tube was added Deoxo-Fluor (20.3 μL, 0.110 mmol), and the resulting mixture was stirred at 0 °C for 15 min while warming to room temperature. The crude reaction mixture was purified by Gilson C18 HPLC to provide TFA salt of 2-amino-7′-bromo-4′,4′-difluoro-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (3 mg, 22%), which was used for the next reaction directly.</div></div><div id="sec5_51_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Step B</h4><div class="NLM_p last">2-Amino-7′-bromo-4′,4′-difluoro-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one 2,2,2-trifluoroacetate (3 mg, 0.00617 mmol) and pyrimidin-5-ylboronic acid (1.07 mg, 0.00864 mmol) were processed according to the method described for the synthesis of 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one and purified by reverse phase C-18 HPLC (5–95% gradient of CH<sub>3</sub>CN/water) to provide 2-amino-4′,4′-difluoro-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (2.6 mg, 0.005 36 mmol, 86.8% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD-<i>d</i><sub>4</sub>) δ 9.19 (s, 1H), 9.06 (s, 2H), 7.97–7.94 (m, 2H), 7.66 (m, 1H), 4.85 (s, 3H), 2.60 (d, <i>J</i> = 14.87 Hz, 1H), 2.31 (dd, <i>J</i><sub>1</sub> = 14.87 Hz, <i>J</i><sub>2</sub> = 4.34 Hz, 1H), 1.29 (s, 3H), 1.21 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 372.1 (M + 1)<sup>+</sup>, retention time 1.045 min.</div></div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 2′-Amino-6-(3-chlorophenyl)-1′-ethyl-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>53</b>)</h3><div id="sec5_52_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Step A</h4><div class="NLM_p last">To a mixture of 6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (200 mg, 0.6151 mmol) and K<sub>2</sub>CO<sub>3</sub> (850 mg, 0.6151 mmol) in DMF (4 mL) was added a solution of ethyl iodide (0.049 65 mL, 0.6151 mmol) in DMF (0.5 mL). The mixture was heated at 45 °C for 2 h and then at 60 °C for 18 h. Then an additional 0.3 equiv of ethyl iodide and K<sub>2</sub>CO<sub>3</sub> were added, and the mixture was heated at 60 °C for an additional 2 h. The mixture was concentrated in vacuo, and the residue obtained was partitioned between ethyl acetate and 2 M aqueous Na<sub>2</sub>CO<sub>3</sub>. The organic phases were combined and washed with 2 M aqueous Na<sub>2</sub>CO<sub>3</sub> (2×), water (1×), and brine (1×). The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue obtained was purified on silica gel, eluting with a gradient of 8–50% EtOAc/hexanes (10 CV) on Biotage SP1 unit to give 6-bromo-1′-ethyl-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (172 mg, 0.4870 mmol, 79% yield) as a pale yellow solid. Analytical HPLC, >92 area % pure, retention time 3.808 min. FIMS (APCI−) <i>m</i>/<i>z</i> 351/353 (M – 1) with Br isotope.</div></div><div id="sec5_52_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Step B</h4><div class="NLM_p last">6-Bromo-1′-ethyl-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (172 mg, 0.487 mmol) and Lawesson’s reagent (138 mg, 0.341 mmol) were processed according to the method described for the synthesis of 6′-bromo-1,2′,2′-trimethyl-2-thioxospiro[imidazolidine-4,4′-thiochroman]-5-one to provide 6-bromo-1′-ethyl-2,2-dimethyl-2′-thioxospiro[chroman-4,4′-imidazolidin]-5′-one (108 mg, 0.292 mmol, 60% yield) as a white solid. FIMS (APCI−) <i>m</i>/<i>z</i> 367, 369 (M – 1) with Br isotope; analytical HPLC purity 97 area %, retention time 4.35 min.</div></div><div id="sec5_52_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Step C</h4><div class="NLM_p last">To a solution of 6-bromo-1′-ethyl-2,2-dimethyl-2′-thioxospiro[chroman-4,4′-imidazolidin]-5′-one (108 mg, 0.292 mmol) in MeOH (2 mL) and THF (0.7 mL) were added sequentially <i>tert</i>-butyl hydroperoxide (70% aqueous) (607 μL, 4.39 mmol) and 30% NH<sub>4</sub>OH (1.14 mL, 8.77 mmol), and the reaction mixture was heated at 40 °C. After 2 h, the mixture was concentrated under a stream of N<sub>2</sub>, and the resulting residue was partitioned between saturated aqueous NH<sub>4</sub>Cl and DCM (2×). The organic layers were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue obtained was purified by silica gel flash chromatography to provide 2′-amino-6-bromo-1′-ethyl-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (41 mg, 0.116 mmol, 39.8% yield) as a white foam. FIMS (APCI−) <i>m</i>/<i>z</i> 352/354 (M – 1) with Br isotope, retention time 1.020 min.</div></div><div id="sec5_52_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Step D</h4><div class="NLM_p last">The compound was synthesized in the same fashion as 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one, substituting 3-chlorophenylboronic acid (22 mg, 0.140 mmol) for 3-chloro-5-fluorophenylboronic acid to provide 2′-amino-6-(3-chlorophenyl)-1′-ethyl-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (17 mg, 0.0443 mmol, 38% yield) as a white powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>) δ 7.44–7.35 (m, 2H), 7.33–7.27 (m, 3H), 6.70–6.91 (m, 2H), 3.75–3.67 (m, 2H), 2.56 (d, <i>J</i> = 14.09 Hz, 1H), 1.98 (d, <i>J</i> = 14.87 Hz, 1H), 1.51 (s, 3H), 1.41 (s, 3H), 1.33 (t, <i>J</i> = 7.04 Hz, 3H); FIMS (APCI+) <i>m</i>/<i>z</i> 384 (M + 1); analytical HPLC purity >99 area %, retention time 3.415 min.</div></div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 2′-Amino-6-(3-chlorophenyl)-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>54</b>)</h3><div id="sec5_53_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Step A</h4><div class="NLM_p last">To a mixture of 6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (200 mg, 0.615 mmol) and K<sub>2</sub>CO<sub>3</sub> (850 mg, 0.615 mmol) in DMF (1.5 mL) at ambient temperature was added a solution of 1,1,1-trifluoro-2-iodoethane (129 mg, 0.615 mmol) in DMF (1 mL). The reaction mixture was heated at 60 °C for 18 h and then at 85 °C and stirred for another 5 days. The mixture was cooled to ambient temperature and partitioned between saturated NH<sub>4</sub>Cl solution and DCM (2×). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The crude was purified on silica gel (Snap 50 cartridge), eluting with a gradient of 10–50% EtOAc/hexane (8 CV), followed by 50% EtOAc/hexanes (2 CV) to give 6-bromo-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazolidine]-2′,5′-dione (155 mg, 0.381 mmol, 62% yield) as a white foam. FIMS (APCI−) <i>m</i>/<i>z</i> 405/407 (M – 1) with Br isotope, retention time 4.054 min</div></div><div id="sec5_53_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Step B</h4><div class="NLM_p last">6-Bromo-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazolidine]-2′,5′-dione (155 mg, 0.381 mmol) and Lawesson’s reagent (108 mg, 0.266 mmol) were processed according to the procedure described for the synthesis of 6′-bromo-1,2′,2′-trimethyl-2-thioxospiro[imidazolidine-4,4′-thiochroman]-5-one to give 6-bromo-2,2-dimethyl-2′-thioxo-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazolidin]-5′-one (50 mg, 0.118 mmol, 31% yield) as a clear colorless residue. LC/MS (ESI−) <i>m</i>/<i>z</i> 421/423 (M – 1) with Br isotope; analytical HPLC purity 96 area %, retention time 4.379 min.</div></div><div id="sec5_53_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Step C</h4><div class="NLM_p last">To a mixture of 6-bromo-2,2-dimethyl-2′-thioxo-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazolidin]-5′-one (50 mg, 0.118 mmol) in MeOH (0.6 mL) and THF (0.15 mL) was added sequentially 70% aqueous <i>tert</i>-butyl hydroperoxide (0.245 mL, 1.77 mmol) and 30% NH<sub>4</sub>OH (0.460 mL, 3.54 mmol), and the reaction mixture was heated at 40 °C with stirring. After 2 h, the reaction mixture was diluted with water (2 mL), and the organics were removed in vacuo. The resulting mixture was partitioned between saturated aqueous NH<sub>4</sub>Cl and DCM (2×). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The crude was purified on silica gel (Snap 10g), eluting with a gradient of 1–8% MeOH/DCM (15 CV) followed by 8% MeOH/DCM (5 CV) on Biotage SP1 unit to provide 2′-amino-6-bromo-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (12 mg, 25% yield) as a white solid. LC/MS (APCI+) <i>m</i>/<i>z</i> 406/408 (M + 1) with Br isotope.</div></div><div id="sec5_53_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Step D</h4><div class="NLM_p last">2′-Amino-6-bromo-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (12 mg, 0.0295 mmol) and 3-chlorophenylboronic acid (7 mg, 0.0443 mmol) were processed according to the method described for the synthesis of 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one to provide 2′-amino-6-(3-chlorophenyl)-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (11 mg, 0.0251 mmol, 85% yield) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>) δ 7.68–7.63 (m, 1H), 7.48–7.46 (m, 1H), 7.43–7.40 (m, 2H), 7.31–7.29 (m, 2H), 6.94 (d, <i>J</i> = 8.61 Hz, 1H), 4.40–4.19 (m, 2H), 2.58 (d, <i>J</i> = 14.09 Hz, 1H), 2.02 (d, <i>J</i> = 14.86 Hz, 1H), 1.53 (s, 3H), 1.43 (s, 3H); FIMS (APCI+) <i>m</i>/<i>z</i> 438 (M + 1), retention time 3.630 min.</div></div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 2′-Amino-6-(3-chlorophenyl)-1′-(2-methoxyethyl)-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>55</b>)</h3><div id="sec5_54_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Step A</h4><div class="NLM_p last">To a mixture of 6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (200 mg, 0.6151 mmol) and K<sub>2</sub>CO3 (85 mg, 0.6151 mmol) in DMF (4 mL) was added a solution of 1-bromo-2-methoxyethane (86 mg, 0.615 mmol) in DMF (0.5 mL). The mixture was heated at 45 °C for 2 h and at 60 °C overnight. The mixture was cooled to ambient temperature and treated with an additional 0.3 equiv of 1-bromo-2-methoxyethane and K<sub>2</sub>CO<sub>3</sub> and heated at 60 °C. After 20 h (total time), DMF was removed in vacuo, and the residue obtained was partitioned between EtOAc and 2 M aqueous Na<sub>2</sub>CO<sub>3</sub>. The organic layers were combined, washed with water (1×), brine (1×), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue obtained was purified on silica gel, eluting with a gradient of 8–66% EtOAc/hexanes (10 CV) followed by 66% EtOAc/hexanes (2 CV) to give 6-bromo-1′-(2-methoxyethyl)-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (196 mg, 0.511 mmol, 83% yield) as a yellow solid. FIMS (APCI−) <i>m</i>/<i>z</i> 381/383 (M – 1) with Br isotope; HPLC purity >90 area%, retention time 3.702 min.</div></div><div id="sec5_54_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Step B</h4><div class="NLM_p last">6-Bromo-1′-(2-methoxyethyl)-2,2-dimethylspiro[chroman-4,4′-imidazolidine]-2′,5′-dione (196 mg, 0.511 mmol) and Lawesson’s reagent (145 mg, 0.358 mmol) were processed according to the method described for the synthesis of 6′-bromo-1,2′,2′-trimethyl-2-thioxospiro[imidazolidine-4,4′-thiochroman]-5-one to provide 6-bromo-1′-(2-methoxyethyl)-2,2-dimethyl-2′-thioxospiro[chroman-4,4′-imidazolidin]-5′-one (104 mg, 0.260 mmol, 51% yield) as a white solid. FIMS (APCI−) <i>m</i>/<i>z</i> 397/399 (M – 1) with Br isotope; HPLC purity 96 area %, retention time 4.211 min.</div></div><div id="sec5_54_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Step C</h4><div class="NLM_p last">6-Bromo-1′-(2-methoxyethyl)-2,2-dimethyl-2′-thioxospiro[chroman-4,4′-imidazolidin]-5′-one (104 mg, 0.260 mmol), <i>tert</i>-butyl hydroperoxide (70% aqueous) (0.541 mL, 3.91 mmol), and 30% NH<sub>4</sub>OH (1.01 mL, 7.81 mmol) were processed according to the method described for the synthesis of 2′-amino-6-bromo-2,2-dimethyl-1′-(2,2,2-trifluoroethyl)spiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one to provide 2′-amino-6-bromo-1′-(2-methoxyethyl)-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (90 mg, 0.235 mmol, 90% yield) as a white foam. FIMS (APCI−) <i>m</i>/<i>z</i> 382/384 (M – 1) with Br isotope.</div></div><div id="sec5_54_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Step D</h4><div class="NLM_p last">2′-Amino-6-bromo-1′-(2-methoxyethyl)-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (90 mg, 0.235 mmol) and 3-chlorophenylboronic acid (44 mg, 0.283 mmol) were processed according to the method described for the synthesis of 2-amino-6′-(3-chloro-5-fluorophenyl)-1,2′,2′-trimethylspiro[imidazole-4,4′-thiochroman]-5(1<i>H</i>)-one to provide 2′-amino-6-(3-chlorophenyl)-1′-(2-methoxyethyl)-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (23 mg, 0.0556 mmol, 24% yield) as a yellow powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>-<i>d</i>) δ 7.40 (s, 1H), 7.36 (dd, <i>J</i><sub>1</sub> = 8.61 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.30–7.25 (m, 2H), 7.24–7.21 (m, 1H), 6,92 (d, <i>J</i> = 8.61 Hz, 1H), 6.88 (s, 1H), 3.94–3.85 (m, 1H), 3.80–3.72 (m, 1H), 3.64–3.54 (m, 2H), 3.42 (s, 3H), 2.49 (d, <i>J</i> = 14.09 Hz, 1H), 1.94 (d, <i>J</i> = 14.09 Hz, 1H), 1.52 (s, 3H), 1.47 (s, 3H); FIMS (APCI+) <i>m</i>/<i>z</i> 414 (M + 1), retention time 3.480 min.</div></div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> 1′-((1-Acetylpiperidin-4-yl)methyl)-2′-amino-6-(3-chlorophenyl)-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b><i>rac</i>-</b><b>56</b>)</h3><div id="sec5_55_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Step A</h4><div class="NLM_p last">To a solution of 2′-amino-6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (100 mg, 0.308 mmol) in DMF (1.2 mL) was added DMF dimethylacetal (0.131 mL, 0.925 mmol). The reaction mixture was stirred at ambient temperature for 18 h and concentrated in vacuo. The resulting residue was dissolved in minimal DCM, and this solution was added dropwise to vigorously stirring hexanes, causing precipitation. The solids were isolated by vacuum filtration (0.2 μm nylon filter membrane), rinsed with hexanes, air-dried, and dried in vacuo to give (<i>E</i>)-<i>N</i>′-(6-bromo-2,2-dimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-2′-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (80 mg, 0.211 mmol, 68.4% yield) as a white powder. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.39 (s, 1H),8.78 (s, 1H), 7.31 (dd, <i>J</i><sub>1</sub> = 9.39 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 6.80 (d, <i>J</i> = 2.35 Hz, 1H), 6.75 (d, <i>J</i> = 8.61 Hz, 1H), 3.22 (s, 3H), 3.10 (s, 3H), 2.27 (d, <i>J</i> = 14.09 Hz, 1H), 1.94 (d, <i>J</i> = 14.09 Hz, 1H),1.41 (s, 3H), 1.27 (s, 3H); LC/MS (APCI+) <i>m</i>/<i>z</i> 379/381 (M + 1).</div></div><div id="sec5_55_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Step B</h4><div class="NLM_p last">To a mixture of (<i>E</i>)-<i>N</i>′-(6-bromo-2,2-dimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-2′-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (47 mg, 0.124 mmol) and K<sub>2</sub>CO<sub>3</sub> (26 g, 0.186 mmol) in DMF (0.6 mL) was added <i>tert</i>-butyl 4-(bromomethyl)piperidine-1-carboxylate (41.4 mg, 0.149 mmol). The mixture was heated to 60 °C and stirred overnight. After 16 h, additional K<sub>2</sub>CO<sub>3</sub> (26 mg, 0.186 mmol) and <i>tert-</i>butyl 4-(bromomethyl)piperidine-1-carboxylate (42 mg, 0.149 mmol) were added, and the reaction mixture was heated to 80 °C for 5 h and then at 90 °C for 2 more days. The reaction mixture was cooled to ambient temperature and concentrated under a nitrogen stream. The resulting residue was suspended in DCM, sonicated, and the resulting solids were removed by filtration. The filtrate collected was concentrated in vacuo, and the isolated crude was purified by preparative TLC, eluting with 9:1 DCM/MeOH to give (<i>E</i>)-<i>tert</i>-butyl 4-((6-bromo-2′-((dimethylamino)methyleneamino)-2,2-dimethyl-5′-oxospiro[chroman-4,4′-imidazole]-1′(5′<i>H</i>)-yl)methyl)piperidine-1-carboxylate (50 mg, 0.0867 mmol, 70% yield) as a clear colorless residue. LCMS (APCI+) <i>m</i>/<i>z</i> 576/578 (M + 1) with Br isotope; LC/MS purity 96 area %, retention time 1.347 min.</div></div><div id="sec5_55_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Step C</h4><div class="NLM_p last">To a solution of (<i>E</i>)-<i>tert</i>-butyl 4-((6-bromo-2′-((dimethylamino)methyleneamino)-2,2-dimethyl-5′-oxospiro[chroman-4,4′-imidazole]-1′(5′<i>H</i>)-yl)methyl)piperidine-1-carboxylate (43 mg, 0.0746 mmol) in DCM (0.7 mL) at ambient temperature was added neat TFA (0.115 mL, 1.49 mmol), and the mixture was stirred for 1 h. The mixture was then concentrated under a nitrogen stream to provide the crude (<i>E</i>)-<i>N′</i>-(6-bromo-2,2-dimethyl-5′-oxo-1′-(piperidin-4-ylmethyl)-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-2′-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (43 mg, 0.0750 mmol, 101% yield), which was used for the next reaction directly.</div></div><div id="sec5_55_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Step D</h4><div class="NLM_p last">To a solution of crude (<i>E</i>)-<i>N′</i>-(6-bromo-2,2-dimethyl-5′-oxo-1′-(piperidin-4-ylmethyl)-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-2′-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (53 mg, 0.0924 mmol) and TEA (0.0515 mL, 0.370 mmol) in DCM (0.8 mL) at ambient temperature was added acetyl chloride (0.00923 mL, 0.129 mmol), and the mixture was stirred for 2 h. The reaction mixture was concentrated under a nitrogen stream, and the crude was purified by preparative TLC (1 mm plate, 19:1 DCM/MeOH) to give (<i>E</i>)-<i>N′</i>-(1′-((1-acetylpiperidin-4-yl)methyl)-6-bromo-2,2-dimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-2′-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (23 mg, 0.0444 mmol, 48.0% yield) as a white residue. LCMS (APCI+) <i>m</i>/<i>z</i> 518/520 (M + 1) with Br isotope.</div></div><div id="sec5_55_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> Step E</h4><div class="NLM_p last">A sealable glass tube was charged with a mixture of (<i>E</i>)-<i>N′</i>-(1′-((1-acetylpiperidin-4-yl)methyl)-6-bromo-2,2-dimethyl-5′-oxo-1′,5′-dihydrospiro[chroman-4,4′-imidazole]-2′-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (18 mg, 0.034 72 mmol) and 7 N NH<sub>3</sub> in MeOH (0.4960 mL, 3.472 mmol). The tube was capped and heated at 50 °C. After 3 days, the mixture was cooled to ambient temperature and treated with additional 7 N NH<sub>3</sub> in MeOH (100 equiv) and heated at 60 °C with stirring. After 28 h, the mixture was cooled to ambient temperature, concentrated in vacuo, and the residue obtained was purified by preparative TLC (1 mm, 9:1 DCM/7 N NH<sub>3</sub>/MeOH) to give 1′-((1-acetylpiperidin-4-yl)methyl)-2′-amino-6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (14 mg, 0.03021 mmol, 87% yield) as a white residue. LCMS (APCI+) <i>m</i>/<i>z</i> 463/465 (M + 1) with Br isotope.</div></div><div id="sec5_55_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Step F</h4><div class="NLM_p last">A sealable glass vial was charged with a mixture of 1′-((1-acetylpiperidin-4-yl)methyl)-2′-amino-6-bromo-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (14 mg, 0.0302 mmol), 3-chlorophenylboronic acid (6.14 mg, 0.0393 mmol), PdCl<sub>2</sub>(dppf)·DCM (2.47 mg, 0.003 02 mmol), dioxane (0.3 mL), and 2 M aqueous Na<sub>2</sub>CO<sub>3</sub> (0.0604 mL, 0.121 mmol). The mixture was purged with nitrogen, vial capped, and the reaction mixture was heated at 90 °C and stirred for 90 min. The reaction mixture was diluted with DCM (0.2 mL) and purified by preparative TLC plate (1 mm plate, 9:1 DCM/7 N NH<sub>3</sub>/MeOH) to give 1′-((1-acetylpiperidin-4-yl)methyl)-2′-amino-6-(3-chlorophenyl)-2,2-dimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (11.6 mg, 0.0234 mmol, 77% yield) as a white residue. LC/MS (APCI+) <i>m</i>/<i>z</i> 495 (M + 1), retention time 1.024 min.</div></div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> 7-(5-Chloropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (<b><i>rac</i>-</b><b>57</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>57</b> was synthesized in the same fashion as compound <b>62</b> (below), replacing 2-fluoropyridin-3-ylboronic acid with (5-chloropyridin-3-yl)boronic acid to afford 7-(5-chloropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (8 mg, 0.023 mmol, 29% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.69 (d, <i>J</i> = 2 Hz, 1H), 8.51 (d, <i>J</i> = 2 Hz, 1H), 7.82 (m, 1H), 7.44 (d, <i>J</i> = 2 Hz, 1H), 7.35 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 2 Hz, 1H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 4.35 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 4.3 Hz, 2H), 2.7 (d, 16 Hz, 1H), 2.57 (dd, <i>J</i><sub>1</sub> = 16 Hz, <i>J</i><sub>2</sub> = 1.2 Hz, 1H), 2.06 (d, <i>J</i> = 14 Hz, 1H), 1.86 (dd, <i>J</i><sub>1</sub> = 14 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 1.1 (s, 3H), 0.98 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 342.1 (M + 1).</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> 7-(5-Chloropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-thiazol]-2′-amine (<b><i>rac</i>-</b><b>58</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>58</b> was synthesized in the same fashion as compound <b>57</b>, substituting silver cyanate with silver thiocyanate to afford 7-(5-chloropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-thiazol]-2′-amine (10 mg, 0.028 mmol, 45% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.69 (d, <i>J</i> = 2 Hz, 1H), 8.51 (d, <i>J</i> = 2 Hz, 1H), 7.84 (t, <i>J</i> = 2 Hz, 1H), 7.63 (d, <i>J</i> = 2 Hz, 1H), 7.35 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 2 Hz, 1H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 3.65 (dd, <i>J</i><sub>1</sub> = 11 Hz, <i>J</i><sub>2</sub> = 10 Hz, 2H), 2.7 (d, 16 Hz, 1H), 2.6 (dd, <i>J</i><sub>1</sub> = 16 Hz, <i>J</i><sub>2</sub> = 1.2 Hz, 1H), 2.07 (dd, <i>J</i><sub>1</sub> = 14 Hz, <i>J</i><sub>2</sub> = 1.6 1H), 1.9 (d, <i>J</i><sub>1</sub> = 14 Hz, 1H), 1.09 (s, 3H), 1.07 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 358.1 (M + 1).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> 7-(5-Chloropyridin-3-yl)-3,3-dimethyl-3,4,5′,6′-tetrahydro-2<i>H</i>-spiro[naphthalene-1,4′-[1,3]thiazin]-2′-amine (<b><i>rac</i>-</b><b>59</b>)</h3><div id="sec5_58_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Step A</h4><div class="NLM_p last">A solution of vinyl magnesium bromide 1 M in THF (39.5 mL, 39.5 mmol) was added dropwise to a solution of 7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one (5 g, 19.8 mmol) in THF at 0 °C under N<sub>2</sub>. After 2 h, the reaction mixture was poured into ice cold saturated NH<sub>4</sub>Cl solution (150 mL) and extracted into EtOAc (2 × 100 mL). The combined organic layers were washed with brine, then dried (MgSO<sub>4</sub>) and concentrated in vacuo to provide the crude 7-bromo-3,3-dimethyl-1-vinyl-1,2,3,4-tetrahydronaphthalen-1-ol as a liquid (5.7 g, 83% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.40 (d, <i>J</i> = 1.96 Hz, 1H), 7.33 (dd, <i>J</i><sub>1</sub> = 8.22 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.04 (d, <i>J</i> = 8.22 Hz, 1H), 5.91 (dd, <i>J</i><sub>1</sub> = 16.82 Hz, <i>J</i><sub>2</sub> = 10.17 Hz, 1H), 5.27 (dd, <i>J</i><sub>1</sub> = 16.84 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 5.06 (dd, <i>J</i><sub>1</sub> = 10.17 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 5.03 (s, 1H, exchanged with D<sub>2</sub>O), 2.45 (m, 2H), 1.74 (d, <i>J</i> = 14.06 Hz, 1H), 1.68 (d, <i>J</i> = 14.06 Hz, 1H), 0.98 (s, 3H), 0.96 (s, 3H).</div></div><div id="sec5_58_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Step B</h4><div class="NLM_p last">To a solution of crude 7-bromo-3,3-dimethyl-1-vinyl-1,2,3,4-tetrahydronaphthalen-1-ol (5.55g, 19.7 mmol) in CH<sub>3</sub>CN (50 mL) at 0 °C was added thionyl chloride (2.88 mL, 39.5 mmol). The reaction mixture was stirred at 0 °C for 10 min and treated with thiourea (3.0 g, 39.5 mmol) in one portion. The mixture was then allowed to stir at ambient temperature for 10 min and then at 50 °C for 1 h. The resulting mixture was allowed to stir at ambient temperature over the weekend. The solid formed was filtered and washed with additional CH<sub>3</sub>CN (3 × 5 mL) and dried to provide (<i>E</i>)-2-(7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-ylidene)ethyl carbamimidothioate hydrochloride (7.9 g, 90.5% yield) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80 (d, <i>J</i> = 2.35 Hz, 1H), 7.37 (dd, <i>J</i><sub>1</sub> = 8.22 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.09 (d, <i>J</i> = 8.22 Hz, 1H), 6.31 (t, <i>J</i> = 8.22 Hz, 1H), 4.10 (d, <i>J</i> = 7.83 Hz, 2H), 2.58 (s, 2H), 2.3 (s, 2H), 0.93 (s, 6H); LCMS (APCI+) <i>m</i>/<i>z</i> 400 (M + 1)<sup>+</sup>; analytical HPLC purity 91 area % (254 nM), retention time 3.276 min.</div></div><div id="sec5_58_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Step C</h4><div class="NLM_p last">A solution of (<i>E</i>)-2-(7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-ylidene)ethyl carbamimidothioate hydrochloride (7.8 g, 21 mmol) in 2,2,2-trifluoroacetic acid (21 mL, 21 mmol) at 0 °C was treated dropwise with methanesulfonic acid (10 mL, 21 mmol). The resulting mixture was stirred at 0 °C for 30 min and then at ambient temperature overnight. The mixture was then cooled to 0 °C and slowly poured into ice cold saturated Na<sub>2</sub>CO<sub>3</sub> solution (200 mL). The resulting slurry was stirred at ambient temperature for 30 min. The solid formed was filtered, washed with copious amount of water, then triturated with hot MeOH and filtered. The filtrate collected was concentrated in vacuo and dried to provide 7-bromo-3,3-dimethyl-3,4,5′,6′-tetrahydro-2<i>H</i>-spiro[naphthalene-1,4′-[1,3]thiazin]-2′-amine (5.2 g, 74% yield) as a solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.99 (br s, 1H), 7.70 (s, 1H), 7.50 (dd, <i>J</i><sub>1</sub> = 8.22 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.16 (d, <i>J</i> = 7.83 Hz, 1H), 3.39 (td, <i>J</i><sub>1</sub> = 12.91 Hz, <i>J</i><sub>2</sub> = 3.91 Hz, 1H), 3.25 (d,t, <i>J</i><sub>1</sub> = 12.91 Hz, <i>J</i><sub>2</sub> = 3.91 Hz, 1H), 2.55 (d, <i>J</i> = 5.87 Hz, 2H), 2.29–2.30 (m, 1H), 2.29–2.14 (m, 1H), 1.85 (s, 2H), 1.05 (s, 3H), 0.87 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 340 (M + 1); analytical HPLC purity 96 area %, retention time 3.032 min.</div></div><div id="sec5_58_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Step D</h4><div class="NLM_p last">A resealable glass pressure tube was charged with 7-bromo-3,3-dimethyl-3,4,5′,6′-tetrahydro-2<i>H</i>-spiro[naphthalene-1,4′-[1,3]thiazin]-2′-amine (40 mg, 0.12 mmol), 5-chloropyridin-3-ylboronic acid (22 mg, 0.14 mmol), Pd(dppf)·DCM complex (4.7 mg, 0.0059 mmol), 20% aqueous Na<sub>2</sub>CO<sub>3</sub> (219 μL, 0.41 mmol), and 1,4-dioxane (1179 μL, 0.12 mmol). The mixture was sparged with N<sub>2</sub> for 5 min, capped, and stirred at 90 °C for 15 h, and allowed to cool temperature. The mixture was diluted with EtOAc (10 mL) and washed with brine (2 × 5 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue obtained was passed through a silica plug (2 g), eluting with 10% MeOH/DCM + 1% NH<sub>3</sub>. The semipure material obtained was purified by C-18 reverse phase HPLC (Gilson Unipoint), eluting with a gradient of 5–95% CH<sub>3</sub>CN/water containing 0.1% TFA to provide the TFA salt of 7-(5-chloropyridin-3-yl)-3,3-dimethyl-3,4,5′,6′-tetrahydro-2<i>H</i>-spiro[naphthalene-1,4′-[1,3]thiazin]-2′-amine (8 mg, 0.022 mmol, 18% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 11.66 (s, 1H), 6.30 (m, 2H), 7.92 (s, 1H), 7.44 (m, 2H), 7.28 (m, 1H), 3.37–3.30 (m, 1H), 3.13–3.01 (m, 1H), 2.37–2.30 (m, 1H), 2.23–2.14 (m, 3H), 2.12 (d, <i>J</i> = 13.69 Hz, 1H), 1.85 (d, <i>J</i> = 14.09 Hz, 1H), 1.17 (s, 3H), 1.01 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 372 (M + 1), retention time 2.334 min.</div></div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> 2′-Amino-7-(5-chloropyridin-3-yl)-1′,3,3-trimethyl-3,4-dihydro-1′<i>H</i>,2<i>H</i>-spiro[naphthalene-1,4′-pyrimidin]-6′(5′<i>H</i>)-one (<b><i>rac</i>-</b><b>60</b>)</h3><div id="sec5_59_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Step A</h4><div class="NLM_p last">To a solution of 7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one (5 g, 19.8 mmol) and 2-methylpropane-2-sulfinamide (3.11 g, 25.7 mmol) in THF (65.8 mL, 19.8 mmol) was added freshly distilled Ti(OEt)<sub>4</sub> (9.01 g, 39.5 mmol) in one portion. The resulting mixture was refluxed for 18 h. The mixture was cooled to ambient temperature and poured into saturated NaHCO<sub>3</sub> (500 mL) solution. The resulting suspension was shaken with EtOAc (300 mL) and filtered through a pad of Celite 545. The solid particles in the filter funnel were crushed with a spatula and washed well with EtOAc (∼200 mL) until all the yellow color disappeared from the solids. The filtrate was transferred to a separatery funnel, and the layers were separated. The aqueous layer was extracted once with EtOAc (100 mL). The combined organic layers were washed with brine (1 × 100 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. The residue obtained was purified by flash chromatography on silica gel (Ready Sep 120 g), eluting with 15% EtOAc (2 L) followed by 20% EtOAc/hexane (500 mL) to provide (<i>E</i>)-<i>N</i>-(7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-ylidene)-2-methylpropane-2-sulfinamide (4.2 g, 11.8 mmol, 59.7% yield) as a yellow solid. The unreacted SM 7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one was also recovered from this reaction. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.22 (d, <i>J</i> = 1.96 Hz, 1H), 7.50 (dd, <i>J</i><sub>1</sub> = 8.88 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.04 (d, <i>J</i> = 8.22 Hz, 1H), 3.14 (d, <i>J</i> = 16.82 Hz, 1H), 2.87 (dd, <i>J</i><sub>1</sub> = 16.82 Hz, <i>J</i><sub>2</sub> = 0.783 Hz, 1H), 2.72 (d, <i>J</i> = 16.43 Hz, 1H), 2.61 (d, <i>J</i> = 16.43 Hz, 1H), 1.33 (s, 9H), 1.07 (s, 3H), 1.01 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 356, 359 (M + 1); analytical HPLC purity 97 area %, retention time 4.691 min.</div></div><div id="sec5_59_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> Step B</h4><div class="NLM_p last">A round-bottom flask equipped with a N<sub>2</sub> inlet, rubber septum, and an internal temperature probe was charged with a solution of diisopropylamine (3.44 mL, 24.5 mmol) in THF (25 mL). The solution was cooled to −78 °C and treated dropwise with <i>n</i>-butyllithium 2.5 M in hexanes (9.78 mL, 24.5 mmol). Once the addition was complete, the cooling bath was replaced with an ice bath, and the mixture was allowed to stir at 0 °C for 40 min. Meanwhile a separate round-bottom flask equipped with a N<sub>2</sub> inlet, rubber septum, and an internal temperature probe was charged with a solution of methyl acetate (2.04 mL, 25.6 mmol) in THF (20 mL). The mixture was cooled to −78 °C. Then the above-prepared LDA solution in THF was slowly added to this solution via a cannula, maintaining internal temperature below −74 °C. The resulting mixture was stirred at −78 °C for 1 h and treated dropwise with a solution of (<i>E</i>)-<i>N</i>-(7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-ylidene)-2-methylpropane-2-sulfinamide (4.15 g, 11.6 mmol) in THF (70 mL) at a rate such that the internal temperature did not excess −74 °C. Once the addition was complete, the mixture was stirred at −78 °C for 3 h. The mixture was then poured into a saturated NaHCO<sub>3</sub> solution (100 mL) and extracted into EtOAc (3 × 50 mL). The organic layers were combined, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude isolated was purified by flash chromatography on silica gel (Ready Sep 220 g), eluting with a step gradient of 20% EtOAc/hexane (to recover unreacted SM) and then with 30%EtOAc/hexane followed by 50% EtOAc/hexane to provide methyl 2-((1<i>R</i>)-7-bromo-1-(1,1-dimethylethylsulfinamido)-3,3-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetate as a white solid (2.28 g, 45% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65 (d, <i>J</i> = 2.35 Hz, 1H), 7.36 (dd, <i>J</i><sub>1</sub> = 7.82 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.06 (d, <i>J</i> = 8.22 Hz, 1H), 5.36 (s, 1H), 3.60 (s, 3H), 3.05 (d, <i>J</i> = 15.65 Hz, 1H), 2.86 (d, <i>J</i> = 16.04 Hz, 1H), 2.54 (d, <i>J</i> = 15.65 Hz, 1H), 2.48–2.46 (m, 1H), 2.36-d, <i>J</i> = 14.87 Hz, 1H), 1.94 (d, <i>J</i> = 14.87 Hz, 1H), 1.12 (s, 9H), 0.98 (s, 3H), 0.92 (s, 3); FIMS (APCI+) <i>m</i>/<i>z</i> 429.8, 431.8; analytical HPLC purity 100 area %, retention time 4.473 min.</div></div><div id="sec5_59_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Step C</h4><div class="NLM_p last">A solution of methyl 2-(7-bromo-1-(1,1-dimethylethylsulfinamido)-3,3-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetate (2.27 g, 5.27 mmol) in dioxane (10 mL) was treated with 4 M HCl in dioxane (6.59 mL, 26.4 mmol). The resulting solution was stirred at room temperature for 2.5 h. The solvent was removed in vacuo, and the residue was evaporated from DCM. The residue obtained was dried under high vacuum for 30 min to provide methyl 2-(1-amino-7-bromo-3,3-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetate (1.7 g, 5.21 mmol, 98.8% yield) as a pale yellow gum. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.75 (d, <i>J</i> = 1.96 Hz, 1H), 7.31 (dd, <i>J</i><sub>1</sub> = 1.96 Hz, <i>J</i><sub>2</sub> = 7.83 Hz, 1H), 7.02 (d, <i>J</i> = 8.22 Hz, 1H), 3.51 (s, 3H), 2.79 (d, <i>J</i> = 15.26 Hz, 1H), 2.71 (d, <i>J</i> = 14.87 Hz, 1H), 2.45–2.41 (m, 2H), 1.97 (d, <i>J</i> = 14.06 Hz, 1H), 1.63 (dd, <i>J</i><sub>1</sub> = 14.06 Hz, <i>J</i><sub>2</sub> = 1.57 Hz, 1H), 0.99 (s, 3H), 0.89 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 325.8, 327.7 (M + 1).</div></div><div id="sec5_59_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Step D</h4><div class="NLM_p last">A suspension of methyl 2-(1-amino-7-bromo-3,3-dimethyl-1,2,3,4-tetrahydronaphthalen-1-yl)acetate (500 mg, 1.53 mmol), EDCI (529 mg, 2.76 mmol), and methyl carbamothioylcarbamate (<b>10</b>) (437 mg, 2.30 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (7663 μL, 1.53 mmol) was treated with <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (1303 μL, 7.66 mmol) and stirred at ambient temperature for 18 h. The mixture was poured into water (50 mL) and extracted with EtOAc (3 × 40 mL). The organic layers were combined, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue obtained was crystallized from MeOH to provide <i>tert</i>-butyl 7-bromo-1′,3,3-trimethyl-6′-oxo-3,4,5′,6′-tetrahydro-1′<i>H</i>,2<i>H</i>-spiro[naphthalene-1,4′-pyrimidine]-2′-ylcarbamate (480 mg, 69.5% yield) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.962 (s, 1H), 7.91 (d, <i>J</i> = 1.96 Hz, 1H), 7.50 (dd, <i>J</i><sub>1</sub> = 8.22 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.15 (d, <i>J</i> = 8.22 Hz, 1H), 3.48 (d, <i>J</i> = 15.65 Hz, 1H), 3.16 (s, 3H), 2.11 (dd, <i>J</i><sub>1</sub> = 15.65 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 1.92 (d, <i>J</i> = 14.08 Hz, 1H), 1.76 (d, <i>J</i> = 14.09 Hz, 1H), 1.36 (s, 2H), 0.99 (s, 3H), 0.87 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 450, 451 (M + 1) with bromine isotope.</div></div><div id="sec5_59_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Step E</h4><div class="NLM_p last"><i>tert</i>-Butyl 7-bromo-1′,3,3-trimethyl-6′-oxo-3,4,5′,6′-tetrahydro-1′<i>H</i>,2<i>H</i>-spiro[naphthalene-1,4′-pyrimidine]-2′-ylcarbamate (63 mg, 0.14 mmol), 5-chloropyridin-3-ylboronic acid (26 mg, 0.17 mmol), dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (5.8 mg, 0.0070 mmol), 20% aqueous Na<sub>2</sub>CO<sub>3</sub> (259 μL, 0.49 mmol), and 1,4-dioxane (1399 μL, 0.14 mmol) were processed according to the method described for the synthesis of 7-(5-chloropyridin-3-yl)-3,3-dimethyl-3,4,5′,6′-tetrahydro-2<i>H</i>-spiro[naphthalene-1,4′-[1,3]thiazin]-2′-amine to provide deprotected 2′-amino-7-(5-chloropyridin-3-yl)-1′,3,3-trimethyl-3,4-dihydro-1′<i>H</i>,2<i>H</i>-spiro[naphthalene-1,4′-pyrimidin]-6′(5′<i>H</i>)-one (42 mg, 0.11 mmol, 78% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.76 (s, 1H), 8.95 (d, <i>J</i> = 1.96 Hz, 1H), 8.64 (d, <i>J</i> = 2.34 Hz, 1H), 8.33 (t, <i>J</i> = 1.96 Hz, 1H), 8.16 (d, <i>J</i> = 1.96 Hz, 1H), 7.80 (dd, <i>J</i><sub>1</sub> = 8.22 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.33 (d, <i>J</i> = 7.83 Hz, 1H), 3.77 (d, <i>J</i> = 16.04 Hz, 1H), 3.28 (s, 3H), 2.81 (d, <i>J</i> = 16.82 Hz, 1H), 2.67 (d, <i>J</i> = 16.04 Hz, 1H), 2.60 (d, <i>J</i> = 16.44 Hz, 1H), 2.04 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 1.57 Hz, 1H), 1.82 (d, <i>J</i> = 14.09 Hz, 1H), 1.03 (s, 3H), 0.94 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 283 (M + 1).</div></div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> 7-(2-Fluoropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (<b><i>rac</i>-</b><b>62</b>)</h3><div id="sec5_60_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> Step A</h4><div class="NLM_p last">NaH (94.8 mg, 3.95 mmol) was added to DMSO (6 mL) in a round-bottom flask. The mixture was heated to 75 °C and stirred for 30 min. The mixture was cooled to 0 °C, and methyltriphenylphosphonium bromide (1411 mg, 3.95 mmol) was added dropwise in warm DMSO (4 mL). After the mixture was stirred for 15 min, 7-bromo-3,3-dimethyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one (500 mg, 1.98 mmol) in DMSO (4 mL) was added dropwise. The mixture was allowed to warm to ambient temperature and stirred overnight. The mixture was diluted with ethyl acetate and water. The layers were separated, and the organics were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The material was purified on silica gel. Elution with hexanes to yield 7-bromo-3,3-dimethyl-1-methylene-1,2,3,4-tetrahydronaphthalene (300 mg, 1.19 mmol, 60.5% yield).</div></div><div id="sec5_60_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> Step B</h4><div class="NLM_p last">7-Bromo-3,3-dimethyl-1-methylene-1,2,3,4-tetrahydronaphthalene (300 mg, 1.19 mmol) was diluted with diethyl ether (3 mL) followed by the addition of silver cyanate (537 mg, 3.58 mmol). The mixture was placed under nitrogen and cooled to 0 °C. I<sub>2</sub> (303 mg, 1.19 mmol) was added, and the mixture was stirred for 1 h, warming to ambient temperature. The mixture was filtered through glass microfiber paper and concentrated. The residue was diluted with acetone (3 mL) and NH<sub>4</sub>OH (600 μL). The mixture was stirred overnight. The mixture was diluted with ethyl acetate and water. The layers were separated, and the organics were dried over MgSO<sub>4</sub>, filtered, and concentrated. The material was purified on reverse phase HPLC, eluting with 5–95% acetonitrile/water (0.1% TFA) monitoring at 220 nm to afford 7-bromo-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (70 mg, 0.226 mmol, 19% yield).</div></div><div id="sec5_60_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> Step C</h4><div class="NLM_p last">7-Bromo-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (25 mg, 0.081 mmol) and 2-fluoropyridin-3-ylboronic acid (23 mg, 0.16 mmol) were diluted with dioxane (500 μL) followed by the addition of Pd(PPh<sub>3</sub>)<sub>4</sub> (0.93 mg, 0.000 81 mmol) and Na<sub>2</sub>CO<sub>3</sub> (121 μL, 0.24 mmol). The mixture was purged with argon, sealed, heated to 85 °C, and stirred for 12 h. The mixture was loaded onto silica gel and eluted with 1–10% methanol/DCM (1% NH<sub>4</sub>OH) to yield 7-(2-fluoropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (25 mg, 0.077 mmol, 95% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.17 (m, 1H), 7.85 (m, 1H), 7.44 (s, 1H), 7.35 (m, 1H), 7.23 (m, 1H), 7.11 (d, <i>J</i> = 7.8 Hz, 1H), 4.37 (s, 2H), 2.7 (d, <i>J</i> = 16 Hz, 1H), 2.56 (d, <i>J</i> = 16 Hz, 1H), 2.05 (d, <i>J</i> = 13.7 Hz, 1H), 1.84 (d, <i>J</i> = 13.7 Hz, 1H), 1.1 (s, 3H), 0.97 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 326.1 (M + 1).</div></div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> 3,3-Dimethyl-7-(pyrimidin-5-yl)-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (<b><i>rac</i>-</b><b>63</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>63</b> was synthesized in the same fashion as compound <b>62</b>, replacing 2-fluoropyridin-3-ylboronic acid with pyrimidin-5-ylboronic acid to afford 3,3-dimethyl-7-(pyrimidin-5-yl)-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (18 mg, 0.058 mmol, 72% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.2 (s, 1H), 8.9 (s, 2H), 7.46 (d, <i>J</i> = 1.96 Hz, 1H), 7.37 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 4.35 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 4.3 Hz, 2H), 2.7 (d, 16.4 Hz, 1H), 2.57 (dd, <i>J</i><sub>1</sub> = 16.4 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 2.06 (d, <i>J</i> = 13.7 Hz, 1H), 1.86 (dd, <i>J</i><sub>1</sub> = 13.7 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 1.1 (s, 3H), 0.98 (s, 3H); <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 160.2 (C), 157.3 (CH), 154.8 (CH), 154.8 (CH), 142.5 (C), 136.8 (C), 134.3 (C), 132.8 (C), 130.2 (CH), 125.8 (CH), 125.7 (CH), 83.0 (CH<sub>2</sub>), 69.6 (C), 50.6 (CH<sub>2</sub>), 44.1 (CH<sub>2</sub>), 30.5 (C), 30.3–27.5 (CH<sub>3</sub>); LCMS (APCI+) <i>m</i>/<i>z</i> 309.1 (M + 1).</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> 7-(5-Fluoropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (<b><i>rac</i>-</b><b>61</b>)</h3><div class="NLM_p last"><b><i>rac</i>-</b><b>61</b> was synthesized in the same fashion as compound <b>62</b>, substituting 2-fluoropyridin-3-ylboronic acid for (5-fluoropyridin-3-yl)boronic acid to afford 7-(5-fluoropyridin-3-yl)-3,3-dimethyl-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (10 mg, 0.031 mmol, 38% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.65 (m, 1H), 8.42 (d, <i>J</i> = 2.7 Hz, 1H), 7.55 (m, 1H), 7.45 (d, <i>J</i><sub>1</sub> = 1.56 Hz, 1H), 7.35 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.9 Hz, 1H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 4.35 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 4.3 Hz, 2H), 2.7 (d, 16 Hz, 1H), 2.57 (dd, <i>J</i><sub>1</sub> = 16 Hz, <i>J</i><sub>2</sub> = 1.2 Hz, 1H), 2.06 (d, <i>J</i> = 14 Hz, 1H), 1.86 (dd, <i>J</i><sub>1</sub> = 14 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 1.1 (s, 3H), 0.98 (s, 3H); LCMS (APCI+) <i>m</i>/<i>z</i> 326.1 (M + 1).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> (<i>R</i>)-2′-Amino-6-(5-chloropyridin-3-yl)-1′,2,2-trimethylspiro[chroman-4,4′-imidazol]-5′(1′<i>H</i>)-one (<b>(<i>R</i>)-34</b>)</h3><div class="NLM_p last">The racemic compound <b>34</b> was separated by SFC chromatography using a Chrialpak AD-H (2 cm × 15 cm) 901061 column. The column was eluted with 15% ethanol (0.2% DEA)/CO<sub>2</sub> at 100 mL/min (100 bar). This afforded complete separation of the single enantiomer <b>(<i>R</i>)-34</b> (>99% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.57 (d, <i>J</i><sub>1</sub> = 1.95 Hz, 1H), 8.48, (d, <i>J</i><sub>1</sub> = 2.34 Hz, 1H), 7.71 (t, <i>J</i><sub>1</sub> = 2.15 Hz, 1H), 7.37 (dd, <i>J</i><sub>1</sub> = 8.59 Hz, <i>J</i><sub>2</sub> = 2.34 Hz, 1H), 6.97 (d, <i>J</i><sub>1</sub> = 8.59 Hz, 1H), 6.94 (s, 1H), 3.21 (s, 3H), 2.55 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.97 (d, <i>J</i><sub>1</sub> = 14.1 Hz, 1H), 1.53 (s, 3H), 1.43 (s, 3H); <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 179.5 (C), 155.7 (C), 154.5 (C), 146.6 (CH), 145.7 (CH), 137.3 (C), 133.6 (CH), 132.0 (C), 129.2 (C), 128.8 (CH), 125.9 (CH), 121.4 (C), 119.6 (CH), 74.3 (C), 64.5 (C), 43.9 (CH<sub>2</sub>), 29.8–25.0 (CH<sub>3</sub>), 26.1 (CH<sub>3</sub>); LCMS (APCI+) <i>m</i>/<i>z</i> 371.2 (M + 1).</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> (<i>R</i>)-3-(2-Amino-1,3′,3′-trimethyl-5-oxo-1,3′,4′,5-tetrahydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalene]-7′-yl)benzonitrile (<b>(<i>R</i>)-45</b>)</h3><div class="NLM_p last">The racemic compound <b>45</b> was separated by SFC chromatography using a Chiralcel OD-H (3 cm × 15 cm) 07-8754 column, eluting with 40% methanol (0.1% DEA)/CO<sub>2</sub> at 100 bar at a flow rate of 80 mL/min (injection volume 2 mL, 53 mg/mL methanol). This afforded the single enantiomer <b>(<i>R</i>)-45</b> (>99% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 7.74 (d, <i>J</i> = 1.56 Hz, 1H), 7.69 (d, <i>J</i> = 7.83 Hz, 1H), 7.61–7.58 (m, 1H), 7.50 (t, <i>J</i> = 7.83 Hz, 1H), 7.39 (dd, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 2.25 Hz, 1H), 7.21 (d, <i>J</i> = 7.83 Hz, 1H), 7.06 (d, <i>J</i> = 1.56 Hz, 1H), 3.21 (s, 3H), 2.83 (d, <i>J</i> = 15.65 Hz, 1H), 2.61 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.29 (d, <i>J</i> = 14.09 Hz, 1H), 1.81 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.17 (s, 3H0, 1.02 (s, 3H); <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 178.5 (C), 156.0 (C), 141.8 (C), 137.8 (C), 137.4 (C), 134.5 (C), 131.5 (CH), 130.7 (CH), 130.7 (CH), 130.7 (CH), 129.6 (CH), 127.3 (CH), 125.3 (CH), 118.8 (C), 112.9 (C), 65.8 (C), 47.0 (CH<sub>2</sub>), 43.4 (CH<sub>2</sub>), 31.1–25.9 (CH<sub>3</sub>), 29.6 (C), 25.9 (CH<sub>3</sub>). LCMS (APCI+) <i>m</i>/<i>z</i> 359 (M + 1), retention time 2.263 min.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> (<i>R</i>)-2-Amino-7′-(2-fluoropyridin-3-yl)-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (<b>(<i>R</i>)-46</b>)</h3><div class="NLM_p last">The title compound was prepared according to the procedures of compound <b>(<i>R</i>)-50</b>, in which 2-fluoropyridin-3-ylboronic acid was used in place of pyrimidin-5-ylboronic acid in step B. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.16 (dd, <i>J</i><sub>1</sub> = 7.04 Hz, <i>J</i><sub>2</sub> = 1.56 Hz, 1H), 7.80–7.75 (m, 1H), 7.42 (dt, <i>J</i><sub>1</sub> = 7.83 Hz, <i>J</i><sub>2</sub> = 1.56 Hz,1H), 7.26–7.23 (m, 1H), 7.27 (d, <i>J</i> = 7.82 Hz, 1H), 7.10 (s, 1H), 3.20 (s, 3H), 2.82 (d, <i>J</i> = 15.65 Hz, 1H), 2.62 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.31 (d, <i>J</i> = 14.09 Hz, 1H), 1.83 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 3.13 Hz, 1H), 1.17 (s, 3H), 1.03 (s, 3H). <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 177.1 (C), 160 (C), 157.8 (C), 146.4 (CH), 140.5 (CH), 137.7 (C), 132.7 (C), 132.7 (C), 130.5 (CH), 129.3 (CH), 126.8 (CH), 123 (C), 121.8 (CH), 65.1 (C), 46.8 (CH<sub>2</sub>), 43.2 (CH<sub>2</sub>), 31.2–25.8 (CH<sub>3</sub>), 29.5 (C), 25.8 (CH<sub>3</sub>). LCMS (APCI+) <i>m</i>/<i>z</i> 353.2 (M + 1), retention time 2.099 min.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> (<i>R</i>)-2-Amino-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one. (<b>(<i>R</i>)-50</b>)</h3><div id="sec5_66_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> Step A</h4><div class="NLM_p last">SFC separation of racemic 2-amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (133 g, 397 mmol) was performed on a Lux Cellulose-4 (3 × 25 cm) column, eluting with 35% methanol (0.1%NH<sub>4</sub>OH)/CO<sub>2</sub> at 100 bar at a flow rate of 200 mL/min (injection volume 2 mL, 309 mg/mL methanol). The peaks isolated were analyzed on a Lux Cellulose-4 (0.46 cm × 5 cm, 3 μm) column, eluting with 25% methanol (0.1% NH<sub>4</sub>OH)/CO<sub>2</sub> at 120 bar (flow rate 5 mL/min, 210 nm). From this separation, (<i>R</i>)-2-amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (peak 1, 46.55 g, chemical purity >99%, >99% ee) was isolated.</div></div><div id="sec5_66_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> Step B</h4><div class="NLM_p last">(<i>R</i>)-2-Amino-7′-bromo-1,3′,3′-trimethyl-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (1.00 g, 2.97 mmol), pyrimidin-5-ylboronic acid (0.479 g, 3.87 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.0859 g, 0.0744 mmol) were combined with 15 mL of dioxane and 2 M Na<sub>2</sub>CO<sub>3</sub> (3.72 mL, 7.44 mmol) (both degassed with nitrogen sparge for 30 min prior to use), and the reaction mixture was heated in a 100 °C reaction block and stirred for 17 h. The reaction mixture was then concentrated, and the residue was combined with ethyl acetate and water. The mixture was extracted 2× with ethyl acetate, and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude was purified on silica gel (5–20% MeOH in dichloromethane gradient) to give (<i>R</i>)-2-amino-1,3′,3′-trimethyl-7′-(pyrimidin-5-yl)-3′,4′-dihydro-2′<i>H</i>-spiro[imidazole-4,1′-naphthalen]-5(1<i>H</i>)-one (0.755 g, 2.25 mmol, 75.7% yield) as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.16 (s, 1H), 8.85 (s, 2H), 7.42 (dd, <i>J</i> = −7.83 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 7.09 (d, <i>J</i> = 1.56 Hz, 1H), 3.22 (s, 3H), 2.86 (d, <i>J</i> = 15.65 Hz, 1H), 2.63 (dd, <i>J</i><sub>1</sub> = 16.43 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 2.29 (d, 14.08 Hz, 1H), 1.84 (dd, <i>J</i><sub>1</sub> = 14.09 Hz, <i>J</i><sub>2</sub> = 2.35 Hz, 1H), 1.18 (s, 3H), 1.03 (s, 3H). <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 178.0 (C), 157.5 (CH), 155.7 (C), 154.8 (CH), 154.8 (CH), 138.1 (C), 135.3 (C), 133.8 (C), 133.1 (C), 131.1 (CH), 126.9 (CH), 125.3 (CH), 66.0 (C), 46.8 (CH<sub>2</sub>), 43.4 (CH<sub>2</sub>), 31.1–26.0 (CH<sub>3</sub>), 29.6 (C), 26.0 (CH<sub>3</sub>); LCMS (APCI+) <i>m</i>/<i>z</i> 336.2 (M + 1)+, retention time 1.905 min (5 min run).</div></div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> (<i>R</i>)-3,3-Dimethyl-7-(pyrimidin-5-yl)-3,4-dihydro-2<i>H</i>,5′<i>H</i>-spiro[naphthalene-1,4′-oxazol]-2′-amine (<b>(<i>R</i>)-63</b>)</h3><div class="NLM_p last">The racemic compound <b>63</b> was separated by SFC chromatography using a chiral column (Chiralpak AD-H, 2 cm × 15 cm), eluting with 35% methanol (20 nM NH<sub>3</sub>)/CO<sub>2</sub>, 100 bar, 60 mL/min and monitored at 220 nm to afford the title compound (>99% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.2 (s, 1H), 8.9 (s, 2H), 7.46 (d, <i>J</i> = 1.96 Hz, 1H), 7.37 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.96 Hz, 1H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 4.35 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 4.3 Hz, 2H), 2.7 (d, 16.4 Hz, 1H), 2.57 (dd, <i>J</i><sub>1</sub> = 16.4 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 2.06 (d, <i>J</i> = 13.7 Hz, 1H), 1.86 (dd, <i>J</i><sub>1</sub> = 13.7 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 1.1 (s, 3H), 0.98 (s, 3H); <sup>13</sup>C NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 160.2 (C), 157.3 (CH), 154.8 (CH), 154.8 (CH), 142.5 (C), 136.8 (C), 134.4 (C), 132.7 (C), 130.2 (CH), 125.8 (CH), 125.6 (CH), 83.0 (CH<sub>2</sub>), 69.5 (C), 50.6 (CH<sub>2</sub>), 44.0 (CH<sub>2</sub>), 30.5 (C), 30.3–27.4 (CH<sub>3</sub>); LCMS (APCI+) <i>m</i>/<i>z</i> 309.1 (M + 1).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4002154" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin W. Hunt</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#600b0516090e4e08150e1420011212011902090f100801120d014e030f0d"><span class="__cf_email__" data-cfemail="2a414f5c434404425f445e6a4b58584b534843455a424b58474b04494547">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam W. Cook</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan J. Watts</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher T. Clark</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Vigers</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darin Smith</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew T. Metcalf</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Indrani W. Gunawardana</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Burkard</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">April A. Cox</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary K. Geck Do</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darrin Dutcher</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen A. Thomas</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sumeet Rana</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas C. Kallan</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert K. DeLisle</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James P. Rizzi</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Regal</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Sammond</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Groneberg</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Siu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans Purkey</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison Marlow</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingrong Liu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tony P. Tang</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder,
Colorado 80301, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d639e9607-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i151">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Andrew Allen (Array BioPharma) for multidimensional NMR spectroscopy support and chiral HPLC methods development. We thank Chris Hamman (Genentech) and Mengling Wong (Genentech) for chiral separation.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i152" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i152"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i153" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i153"> Abbreviations Used</h2><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">LLC-PK1</td><td class="NLM_def"><p class="first last">Lilly Laboratories cell porcine kidney</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>u</sub></td><td class="NLM_def"><p class="first last">unbound clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>free</sub></td><td class="NLM_def"><p class="first last">unbound concentration</p></td></tr><tr><td class="NLM_term">P<i>i</i> (e.g., P3, P2′)</td><td class="NLM_def"><p class="first last">amino acid residue from N to C terminus of the polypeptide substrate</p></td></tr><tr><td class="NLM_term">S<i>i</i> (e.g., S3, S2′)</td><td class="NLM_def"><p class="first last">binding subsite</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i154">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s Association.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease facts and figures</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1016%2Fj.jalz.2012.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22404854" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=131-168&author=Alzheimer%E2%80%99s+Association.&title=Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.02.001%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2012%26volume%3D8%26spage%3D131%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Comer, M.</span><span> </span><span class="NLM_article-title">French lessons: leadership in Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1016%2Fj.jalz.2008.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=19118810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FkslCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=61-65&author=M.+Comer&title=French+lessons%3A+leadership+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">French lessons: leadership in Alzheimer's disease</span></div><div class="casAuthors">Comer Meryl</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaLkaqDf7XyHqj_yg7twvpfW6udTcc2ebIe91g2bOSvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FkslCmug%253D%253D&md5=d0518ba22a0931b1a0b6b0cee35907dd</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2008.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2008.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DComer%26aufirst%3DM.%26atitle%3DFrench%2520lessons%253A%2520leadership%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3D61%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> The response of the United States is markedly more modest: U.S. Department of Health & Human Services. National Plan To Address Alzheimer’s Disease (2nd draft). <a href="http://aspe.hhs.gov/daltcp/napa/NatlPlan.shtml" class="extLink">http://aspe.hhs.gov/daltcp/napa/NatlPlan.shtml</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+response+of+the+United+States+is+markedly+more+modest%3A+U.S.+Department+of+Health+%26+Human+Services.+National+Plan+To+Address+Alzheimer%E2%80%99s+Disease+%282nd+draft%29.+http%3A%2F%2Faspe.hhs.gov%2Fdaltcp%2Fnapa%2FNatlPlan.shtml."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jarvis, L. M.</span><span> </span><span class="NLM_article-title">Tough times for neuroscience R&D</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=22-25&author=L.+M.+Jarvis&title=Tough+times+for+neuroscience+R%26D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DL.%2BM.%26atitle%3DTough%2520times%2520for%2520neuroscience%2520R%2526D%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2012%26volume%3D90%26spage%3D22%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strooper, B. D.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+M.+Merckenauthor=B.+D.+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%2BM.%26aulast%3DStrooper%26aufirst%3DB.%2BD.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blusztajn, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: implications for initial events in amyloid plaque formation</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1006%2Fnbdi.1996.0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=9173910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK28Xis1Kqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=16-32&author=C.+A.+Lemereauthor=J.+K.+Blusztajnauthor=H.+Yamaguchiauthor=T.+Wisniewskiauthor=T.+C.+Saidoauthor=D.+J.+Selkoe&title=Sequence+of+deposition+of+heterogeneous+amyloid+beta-peptides+and+APOE+in+Down+syndrome%3A+implications+for+initial+events+in+amyloid+plaque+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation</span></div><div class="casAuthors">Lemere, C. A.; Blusztajn, J. K.; Yamaguchi, H.; Wisniewski, T.; Saido, T. C.; Selkoe, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-32</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Patients with trisomy 21 [Down syndrome (DS)] progressively develop amyloid β-protein (Aβ) deposits and then other features of Alzheimer's disease (AD), apparently due to increased gene dosage and thus expression of the β-amyloid precursor protein.  Because the neuropathol. phenotype in older DS subjects closely resembles that of AD, the examn. of DS brains of increasing age provides a unique model of the progression of AD.  Here, we characterized the deposition of several Aβ peptides and apolipoprotein E in formalin-fixed brain sections from 29 DS subjects between 3 and 73 yr old.  Amyloid plaque no. and the percentage of cortical area they occupied were quantified by computerized image anal.  Aβ ending at amino acid 42 (Aβ42) was the earliest form of Aβ deposited in DS cortex.  It was obsd. in 7 of 16 young (3-30 yr) subjects, with the earliest deposition occurring at age 12.  Aβ ending at residue 40 (Aβ40) was not detected until ∼age 30, a time when degenerating neurites around Aβ immunoreactive (IR) plaques were first obsd., and the frequency of Aβ40 IR plaques then rose with age.  Even in old (51-73 yr) DS subjects, Aβ42 IR plaques were always more abundant than Aβ40 IR plaques.  Aβ peptides starting at aspartate 1 or pyroglutamate 3 were detected in small subsets of compacted, neuritic plaques beginning around age 30 and rose with age, the latter species always exceeding the former.  Thus, the N-termini of the Aβ42 peptides abundantly deposited in very young DS subjects remain unknown.  Apo E was detectable in a small subset of Aβ42 IR plaques beginning at age 12 and rose steadily with age; it clearly followed the deposition of Aβ.  Our anal. of very young DS brains suggests that amyloid plaque formation begins with Aβ42-ending peptides, and the no. and percentage of cortical area of Aβ42 plaques increase very little with advancing age, while other heterogeneous Aβ species and Apo E progressively accrue onto plaques contg. Aβ42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHmc60yMj5LVg90H21EOLACvtfcHk0lhqOxxTQdeDWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis1Kqt7k%253D&md5=25f3d5a87695a498b46cd0b1deb610b6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1996.0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1996.0003%26sid%3Dliteratum%253Aachs%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DBlusztajn%26aufirst%3DJ.%2BK.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DSequence%2520of%2520deposition%2520of%2520heterogeneous%2520amyloid%2520beta-peptides%2520and%2520APOE%2520in%2520Down%2520syndrome%253A%2520implications%2520for%2520initial%2520events%2520in%2520amyloid%2520plaque%2520formation%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1996%26volume%3D3%26spage%3D16%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Brouillette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caillierez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zommer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves-Pires, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buée, L.</span><span> </span><span class="NLM_article-title">Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β<sub>1–42</sub> oligomers are revealed in vivo by using a novel animal model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">7852</span><span class="NLM_x">–</span> <span class="NLM_lpage">7861</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1523%2FJNEUROSCI.5901-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22674261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFSmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=7852-7861&author=J.+Brouilletteauthor=R.+Caillierezauthor=N.+Zommerauthor=C.+Alves-Piresauthor=I.+Benilovaauthor=D.+Blumauthor=B.+Strooperauthor=L.+Bu%C3%A9e&title=Neurotoxicity+and+memory+deficits+induced+by+soluble+low-molecular-weight+amyloid-%CE%B21%E2%80%9342+oligomers+are+revealed+in+vivo+by+using+a+novel+animal+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model</span></div><div class="casAuthors">Brouillette, Jonathan; Caillierez, Raphaelle; Zommer, Nadege; Alves-Pires, Claire; Benilova, Iryna; Blum, David; De Strooper, Bart; Buee, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7852-7861</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal and synaptic degeneration are the best pathol. correlates for memory decline in Alzheimer's disease (AD).  Although the accumulation of sol. low-mol.-wt. amyloid-β (Aβ) oligomers has been suggested to trigger neurodegeneration in AD, animal models overexpressing or infused with Aβ lack neuronal loss at the onset of memory deficits.  Using a novel in vivo approach, we found that repeated hippocampal injections of small sol. Aβ1-42 oligomers in awake, freely moving mice were able to induce marked neuronal loss, tau hyperphosphorylation, and deficits in hippocampus-dependent memory.  The neurotoxicity of small Aβ1-42 species was obsd. in vivo as well as in vitro in assocn. with increased caspase-3 activity and reduced levels of the NMDA receptor subunit NR2B.  We found that the sequestering agent transthyretin is able to bind the toxic Aβ1-42 species and attenuated the loss of neurons and memory deficits.  Our novel mouse model provides evidence that small, sol. Aβ1-42 oligomers are able to induce extensive neuronal loss in vivo and initiate a cascade of events that mimic the key neuropathol. hallmarks of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprsaWczZqDYbVg90H21EOLACvtfcHk0lhXunpleJcrBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFSmu7k%253D&md5=c7d829dce0ef886cb0b2b56668552c8e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5901-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5901-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DBrouillette%26aufirst%3DJ.%26aulast%3DCaillierez%26aufirst%3DR.%26aulast%3DZommer%26aufirst%3DN.%26aulast%3DAlves-Pires%26aufirst%3DC.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DStrooper%26aufirst%3DB.%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26atitle%3DNeurotoxicity%2520and%2520memory%2520deficits%2520induced%2520by%2520soluble%2520low-molecular-weight%2520amyloid-%25CE%25B21%25E2%2580%259342%2520oligomers%2520are%2520revealed%2520in%2520vivo%2520by%2520using%2520a%2520novel%2520animal%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D7852%26epage%3D7861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lhXunpleJcrBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as beta-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lhXunpleJcrBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520beta-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, J.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein beta-secretase from human brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=J.+Varghese&title=Purification+and+cloning+of+amyloid+precursor+protein+beta-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DVarghese%26aufirst%3DJ.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520beta-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the trans-membrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+trans-membrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520trans-membrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashier, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashierauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+beta-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashier%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+beta-secretase+site+of+beta-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520beta-secretase%2520site%2520of%2520beta-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lh2aw-q8jh8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">BACE1 is the major beta-secretase for generation of Abeta peptides by neurons</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2F85064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=11224536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=233-234&author=H.+Caiauthor=Y.+Wangauthor=D.+McCarthyauthor=H.+Wenauthor=D.+R.+Borcheltauthor=D.+L.+Priceauthor=P.+C.+Wong&title=BACE1+is+the+major+beta-secretase+for+generation+of+Abeta+peptides+by+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 is the major β-secretase for generation of Aβ peptides by neurons</span></div><div class="casAuthors">Cai, Huaibin; Wang, Yanshu; McCarthy, Diane; Wen, Hongjin; Borchelt, David R.; Price, Donald L.; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-234</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Secretion of Alzheimer's disease (AD) Aβ peptides (Aβ1-40/42 and Aβ11-40) is abolished in cultures of BACE1-deficient cortical neurons; BACE1-deficient is one of the two β-secretases involved in generating AD Aβ peptides.  This study also establishes that BACE1-deficient is the principal neuronal protease required to cleave amyloid precursor protein (APP) at the +1 and +11 sites that generate N-termini of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvJeMWCAU69rVg90H21EOLACvtfcHk0ljWTsLuEHqcJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D&md5=fd3d6b77770735ed2b12687281fc511e</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2F85064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85064%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMcCarthy%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DH.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DBACE1%2520is%2520the%2520major%2520beta-secretase%2520for%2520generation%2520of%2520Abeta%2520peptides%2520by%2520neurons%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D233%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.+C.+Louisauthor=Q.+Yanauthor=W.+G.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+beta-secretase%2C+have+normal+phenotype+and+abolished+beta-amyloid+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0ljWTsLuEHqcJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%252C%2520have%2520normal%2520phenotype%2520and%2520abolished%2520beta-amyloid%2520generation%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roberds, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappenman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shopp, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintrup, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span> </span><span class="NLM_article-title">BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1093%2Fhmg%2F10.12.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=11406613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1317-1324&author=S.+L.+Roberdsauthor=J.+Andersonauthor=G.+Basiauthor=M.+J.+Bienkowskiauthor=D.+G.+Branstetterauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=N.+L.+Frigonauthor=D.+Gamesauthor=K.+Huauthor=K.+Johnson-Woodauthor=K.+E.+Kappenmanauthor=T.+T.+Kawabeauthor=I.+Kolaauthor=R.+Kuehnauthor=M.+Leeauthor=W.+Liuauthor=R.+Motterauthor=N.+F.+Nicholsauthor=M.+Powerauthor=D.+W.+Robertsonauthor=D.+Schenkauthor=M.+Schoorauthor=G.+M.+Shoppauthor=M.+E.+Shuckauthor=S.+Sinhaauthor=K.+A.+Svenssonauthor=G.+Tatsunoauthor=H.+Tintrupauthor=J.+Wijsmanauthor=S.+Wrightauthor=L.+McConlogue&title=BACE+knockout+mice+are+healthy+despite+lacking+the+primary+beta-secretase+activity+in+brain%3A+implications+for+Alzheimer%E2%80%99s+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics</span></div><div class="casAuthors">Roberds, Steven L.; Anderson, John; Basi, Guriqbal; Bienkowski, Michael J.; Branstetter, Daniel G.; Chen, Karen S.; Freedman, Stephen B.; Frigon, Normand L.; Games, Dora; Hu, Kang; Johnson-Wood, Kelly; Kappenman, Karl E.; Kawabe, Thomas T.; Kola, Ismail; Kuehn, Ralf; Lee, Michael; Liu, Weiqun; Motter, Ruth; Nichols, Nanette F.; Power, Michael; Robertson, David W.; Schenk, Dale; Schoor, Michael; Shopp, George M.; Shuck, Mary E.; Sinha, Sukanto; Svensson, Kjell A.; Tatsuno, Gwen; Tintrup, Hartmut; Wijsman, John; Wright, Sarah; McConlogue, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1317-1324</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain.  The major components of plaque, β-amyloid peptides (Aβs), are produced from amyloid precursor protein (APP) by the activity of β- and γ-secretases.  β-Secretase activity cleaves APP to define the N-terminus of the Aβ1-x peptides and, therefore, has been a long-sought therapeutic target for treatment of AD.  The gene encoding a β-secretase for beta-site APP cleaving enzyme (BACE) was identified recently.  However, it was not known whether BACE was the primary β-secretase in mammalian brain nor whether inhibition of β-secretase might have effects in mammals that would preclude its utility as a therapeutic target.  In the work described herein, the authors generated two lines of BACE knockout mice and characterized them for pathol., β-secretase activity and Aβ prodn.  These mice appeared to develop normally and showed no consistent phenotypic differences from their wild-type littermates, including overall normal tissue morphol. and brain histochem., normal blood and urine chemistries, normal blood-cell compn., and no overt behavioral and neuromuscular effects.  Brain and primary cortical cultures from BACE knockout mice showed no detectable β-secretase activity, and primary cortical cultures from BACE knockout mice produced much less Aβ from APP.  The findings that BACE is the primary β-secretase activity in brain and that loss of β-secretase activity produces no profound phenotypic defects with a concomitant redn. in β-amyloid peptide clearly indicate that BACE is an excellent therapeutic target for treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ78rSt6xEe7Vg90H21EOLACvtfcHk0lhWrHAmtHETew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D&md5=c18a9ff9f800eebd994476badc6ec1bc</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.12.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.12.1317%26sid%3Dliteratum%253Aachs%26aulast%3DRoberds%26aufirst%3DS.%2BL.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBasi%26aufirst%3DG.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DFrigon%26aufirst%3DN.%2BL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DKappenman%26aufirst%3DK.%2BE.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DKola%26aufirst%3DI.%26aulast%3DKuehn%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DNichols%26aufirst%3DN.%2BF.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSchoor%26aufirst%3DM.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTintrup%26aufirst%3DH.%26aulast%3DWijsman%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DMcConlogue%26aufirst%3DL.%26atitle%3DBACE%2520knockout%2520mice%2520are%2520healthy%2520despite%2520lacking%2520the%2520primary%2520beta-secretase%2520activity%2520in%2520brain%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1317%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T.</span><span> </span><span class="NLM_article-title">Developing β-secretase inhibitors for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1111%2Fj.1471-4159.2011.07476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22122681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=71-83&issue=Suppl.+1&author=A.+K.+Ghoshauthor=M.+Brindisisauthor=T.+Tang&title=Developing+%CE%B2-secretase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Developing β-secretase inhibitors for treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Secretase (memapsin 2; BACE-1) is the first protease in the processing of amyloid precursor protein leading to the prodn. of amyloid-β (Aβ) in the brain.  It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer's disease (AD).  Therefore, β-secretase is a major therapeutic target for the development of inhibitor drugs.  During the past decade, steady progress has been made in the evolution of β-secretase inhibitors toward better drug properties.  Recent inhibitors are potent, selective and have been shown to penetrate the blood-brain barrier to inhibit Aβ levels in the brains of exptl. animals.  Moreover, continuous administration of a β-secretase inhibitor was shown to rescue age-related cognitive decline in transgenic AD mice.  A small no. of β-secretase inhibitors have also entered early phase clin. trials.  These developments offer some optimism for the clin. development of a disease-modifying drug for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvY0fxn2hBubVg90H21EOLACvtfcHk0lhWrHAmtHETew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D&md5=186d6ccadd1c207ecd7aaa9cb7584684</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07476.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisis%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DT.%26atitle%3DDeveloping%2520%25CE%25B2-secretase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl.%25201%26spage%3D71%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stachel, S. J.</span><span> </span><span class="NLM_article-title">Progress toward the development of a viable BACE-1 inhibitor</span> <span class="citation_source-journal">Drug. Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=101-110&author=S.+J.+Stachel&title=Progress+toward+the+development+of+a+viable+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520toward%2520the%2520development%2520of%2520a%2520viable%2520BACE-1%2520inhibitor%26jtitle%3DDrug.%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1002%2Fmed.20132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18651582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=295-338&author=R.+Silvestri&title=Boom+in+the+development+of+non-peptidic+beta-secretase+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-338</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  β-Amyloid cleaving enzyme-1 (BACE1) has become a significant target for the therapy of Alzheimer's disease.  After the discovery of the first non-peptidomimetic β-secretase inhibitors by Takeda Chems. in 2001, several research teams focused on SAR development of these agents.  The non-peptidic BACE1 inhibitors may potentially overcome the classical problems assocd. with the peptide structure of first generation, such as blood-brain barrier crossing, poor oral bioavailability and susceptibility to P-glycoprotein transport.  In the past 6 years a boom in research of non-peptidic BACE1 inhibitors has disseminated findings over hundreds of publications and patents.  The rapidly growing literature has been reviewed with particular emphasis on literature of pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmzl8ONz3LVg90H21EOLACvtfcHk0liIjX9OLN1ixg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D&md5=1e92f25f055def1c1c56b3650f4cc40a</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1002%2Fmed.20132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20132%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DBoom%2520in%2520the%2520development%2520of%2520non-peptidic%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D295%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkateswara Rao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavande, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure-based design of highly selective β-secretase inhibitors: synthesis, biological evaluation, and protein–ligand X-ray crystal structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9195</span><span class="NLM_x">–</span> <span class="NLM_lpage">9207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3008823" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9195-9207&author=A.+K.+Ghoshauthor=K.+Venkateswara+Raoauthor=N.+D.+Yadavauthor=D.+D.+Andersonauthor=N.+Gavandeauthor=X.+Huangauthor=S.+Terzyanauthor=J.+Tang&title=Structure-based+design+of+highly+selective+%CE%B2-secretase+inhibitors%3A+synthesis%2C+biological+evaluation%2C+and+protein%E2%80%93ligand+X-ray+crystal+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1021%2Fjm3008823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008823%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DVenkateswara%2BRao%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DN.%2BD.%26aulast%3DAnderson%26aufirst%3DD.%2BD.%26aulast%3DGavande%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520highly%2520selective%2520%25CE%25B2-secretase%2520inhibitors%253A%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520protein%25E2%2580%2593ligand%2520X-ray%2520crystal%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9195%26epage%3D9207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriemen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span> </span><span class="NLM_article-title">A potent and orally efficacious, hydroxyethylamine-based inhibitor of β-secretase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3000148" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=886-891&author=M.+R.+Kallerauthor=S.+S.+Harriedauthor=B.+Albrechtauthor=P.+Amaranteauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=R.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+Graceffaauthor=C.+Hickmanauthor=T.+Juddauthor=C.+Kriemenauthor=D.+Laauthor=V.+Liauthor=P.+Lopezauthor=Y.+Luoauthor=C.+Masseauthor=H.+Monenscheinauthor=T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=T.+Williamsonauthor=S.+Woodauthor=M.+Xueauthor=B.+Yangauthor=J.+Zhangauthor=V.+Patelauthor=W.+Zhongauthor=S.+Hitchcock&title=A+potent+and+orally+efficacious%2C+hydroxyethylamine-based+inhibitor+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1021%2Fml3000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000148%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DAlbrecht%26aufirst%3DB.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DC.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKriemen%26aufirst%3DC.%26aulast%3DLa%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHitchcock%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520efficacious%252C%2520hydroxyethylamine-based%2520inhibitor%2520of%2520%25CE%25B2-secretase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D886%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11g"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambroise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer’s disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9224</span><span class="NLM_x">–</span> <span class="NLM_lpage">9239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9224-9239&author=M.+A.+Brodneyauthor=G.+Barreiroauthor=K.+Ogilvieauthor=E.+Hajos-Korcsokauthor=J.+Murrayauthor=F.+Vajdosauthor=C.+Ambroiseauthor=C.+Christoffersenauthor=K.+Fisherauthor=L.+Lanyonauthor=J.+Liuauthor=C.+E.+Nolanauthor=J.+M.+Withkaauthor=K.+A.+Borzilleriauthor=I.+Efremovauthor=C.+E.+Oborskiauthor=A.+Vargheseauthor=B.+T.+O%E2%80%99Neill&title=Spirocyclic+sulfamides+as+%CE%B2-secretase+1+%28BACE-1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+utilization+of+structure+based+drug+design%2C+WaterMap%2C+and+CNS+penetration+studies+to+identify+centrally+efficacious+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1021%2Fjm3009426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009426%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DAmbroise%26aufirst%3DC.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DVarghese%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DSpirocyclic%2520sulfamides%2520as%2520%25CE%25B2-secretase%25201%2520%2528BACE-1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520utilization%2520of%2520structure%2520based%2520drug%2520design%252C%2520WaterMap%252C%2520and%2520CNS%2520penetration%2520studies%2520to%2520identify%2520centrally%2520efficacious%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9224%26epage%3D9239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgnurPUM81JjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brankov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhija, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmerhorst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadimitriou, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakoczy, P. E.</span><span> </span><span class="NLM_article-title">Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3031</span><span class="NLM_x">–</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=3031-3038&author=D.+Zhangauthor=M.+Brankovauthor=M.+T.+Makhijaauthor=T.+Robertsonauthor=E.+Helmerhorstauthor=J.+M.+Papadimitriouauthor=P.+E.+Rakoczy&title=Correlation+between+inactive+cathepsin+D+expression+and+retinal+changes+in+mcd2%2Fmcd2+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBrankov%26aufirst%3DM.%26aulast%3DMakhija%26aufirst%3DM.%2BT.%26aulast%3DRobertson%26aufirst%3DT.%26aulast%3DHelmerhorst%26aufirst%3DE.%26aulast%3DPapadimitriou%26aufirst%3DJ.%2BM.%26aulast%3DRakoczy%26aufirst%3DP.%2BE.%26atitle%3DCorrelation%2520between%2520inactive%2520cathepsin%2520D%2520expression%2520and%2520retinal%2520changes%2520in%2520mcd2%252Fmcd2%2520transgenic%2520mice%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2005%26volume%3D46%26spage%3D3031%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koike, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Schaeffer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waguri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kametaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kominami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Figura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, Y.</span><span> </span><span class="NLM_article-title">Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6898</span><span class="NLM_x">–</span> <span class="NLM_lpage">6906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=6898-6906&author=M.+Koikeauthor=H.+Nakanishiauthor=P.+Saftigauthor=J.+Ezakiauthor=K.+Isaharaauthor=Y.+Ohsawaauthor=W.+Schulz-Schaefferauthor=T.+Watanabeauthor=S.+Waguriauthor=S.+Kametakaauthor=M.+Shibataauthor=K.+Yamamotoauthor=E.+Kominamiauthor=C.+Petersauthor=K.+von+Figuraauthor=Y.+Uchiyama&title=Cathepsin+D+deficiency+induces+lysosomal+storage+with+ceroid+lipofuscin+in+mouse+CNS+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DH.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DEzaki%26aufirst%3DJ.%26aulast%3DIsahara%26aufirst%3DK.%26aulast%3DOhsawa%26aufirst%3DY.%26aulast%3DSchulz-Schaeffer%26aufirst%3DW.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DKametaka%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3Dvon%2BFigura%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DY.%26atitle%3DCathepsin%2520D%2520deficiency%2520induces%2520lysosomal%2520storage%2520with%2520ceroid%2520lipofuscin%2520in%2520mouse%2520CNS%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D15%26spage%3D6898%26epage%3D6906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmahl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mossmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Figura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span> </span><span class="NLM_article-title">Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3599</span><span class="NLM_x">–</span> <span class="NLM_lpage">3608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=3599-3608&author=P.+Saftigauthor=M.+Hetmanauthor=W.+Schmahlauthor=K.+Weberauthor=L.+Heineauthor=H.+Mossmannauthor=A.+K%C3%B6sterauthor=B.+Hessauthor=M.+Eversauthor=K.+von+Figuraauthor=C.+Peters&title=Mice+deficient+for+the+lysosomal+proteinase+cathepsin+D+exhibit+progressive+atrophy+of+the+intestinal+mucosa+and+profound+destruction+of+lymphoid+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHetman%26aufirst%3DM.%26aulast%3DSchmahl%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DK.%26aulast%3DHeine%26aufirst%3DL.%26aulast%3DMossmann%26aufirst%3DH.%26aulast%3DK%25C3%25B6ster%26aufirst%3DA.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DEvers%26aufirst%3DM.%26aulast%3Dvon%2BFigura%26aufirst%3DK.%26aulast%3DPeters%26aufirst%3DC.%26atitle%3DMice%2520deficient%2520for%2520the%2520lysosomal%2520proteinase%2520cathepsin%2520D%2520exhibit%2520progressive%2520atrophy%2520of%2520the%2520intestinal%2520mucosa%2520and%2520profound%2520destruction%2520of%2520lymphoid%2520cells%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D3599%26epage%3D3608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschlich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">Blood–brain barrier permeation: molecular parameters governing passive diffusion</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1007%2Fs002329900434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=9767674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=1998&pages=201-211&author=H.+Fischerauthor=R.+Gottschlichauthor=A.+Seelig&title=Blood%E2%80%93brain+barrier+permeation%3A+molecular+parameters+governing+passive+diffusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier permeation: molecular parameters governing passive diffusion</span></div><div class="casAuthors">Fischer, H.; Gottschlich, R.; Seelig, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">Fifty-three compds. with clin. established ability to cross or not to cross the blood-brain barrier by passive diffusion were characterized by means of surface activity measurements in terms of three parameters, i.e., the air-water partition coeff., Kaw, the crit. micelle concn., CMCD, and the cross-sectional area, AD.  A three-dimensional plot in which the surface area, AD, is plotted as a function of Kaw-1 and CMCD shows essentially three groups of compds.: (i) very hydrophobic compds. with large air-water partition coeffs. and large cross-sectional areas, AD > 80 Å2, which do not cross the blood-brain barrier, (ii) compds. with lower air-water partition coeffs. and an av. cross-sectional area, AD ≃ 50 Å2, which easily cross the blood-brain barrier, and (iii) hydrophilic compds. with low air-water partition coeffs. (AD < 50 Å2) which cross the blood-brain barrier only if applied at high concns.  It was shown that the lipid membrane-water partition coeff., Klw, measured previously, can be correlated with the air-water partition coeff. if the addnl. work against the internal lateral bilayer pressure, πbi = 34 ± 4 mN/m, is taken into account.  The partitioning into anisotropic lipid membranes decreases exponentially with increasing cross-sectional areas, AD, according to Klw = const. Kaw exp(-ADπbi/kT), where kT is the thermal energy.  The cross-sectional area of the mol. oriented at a hydrophilic-hydrophobic interface is thus the main determinant for membrane permeation provided the mol. is surface active and has a pKa > 4 for acids and a pKa < 10 for bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvYrDWv9GpI7Vg90H21EOLACvtfcHk0lh3AsQivtIzHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D&md5=a549eaf6f7ce81af291868899e3d0ab0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs002329900434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900434%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DGottschlich%26aufirst%3DR.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520permeation%253A%2520molecular%2520parameters%2520governing%2520passive%2520diffusion%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1998%26volume%3D165%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Properties estimated with ChemDraw Ultra, version 12.0.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebDzmYY3KrVyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lh3AsQivtIzHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0ligs86BF0cBoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.-M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.-L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lgvQhtK4CtT2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28a%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528a%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17g&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17gR"><div class="casContent"><span class="casTitleNuber">17g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lgvQhtK4CtT2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit17g&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+Ohbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17hR"><div class="casContent"><span class="casTitleNuber">17h</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0li_bazCCBvCoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit17h&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DOhberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17i&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17i&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17i&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17iR"><div class="casContent"><span class="casTitleNuber">17i</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0li_bazCCBvCoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit17i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17j&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17jR"><div class="casContent"><span class="casTitleNuber">17j</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0li_bazCCBvCoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit17j&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0lg196YMHTciRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lg196YMHTciRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">In a recent patent review, spirocyclic molecules from a Vitae patent application were disclosed:</p></div><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. Z.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Z.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lg196YMHTciRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%2BZ.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Buckle, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houge-Frydrych, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedder, J. M.</span><span> </span><span class="NLM_article-title">Relaxant activity of 4-amido-3,4-dihydro-2<i>H</i>-1-benzopyran-3-ols and 4-amido-2<i>H</i>-1-benzopyrans on guinea pig isolated trachealis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00173a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=3028-3034&author=D.+R.+Buckleauthor=J.+R.+Archauthor=A.+E.+Fenwickauthor=C.+S.+Houge-Frydrychauthor=I.+L.+Pintoauthor=D.+G.+Smithauthor=S.+G.+Taylorauthor=J.+M.+Tedder&title=Relaxant+activity+of+4-amido-3%2C4-dihydro-2H-1-benzopyran-3-ols+and+4-amido-2H-1-benzopyrans+on+guinea+pig+isolated+trachealis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm00173a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00173a019%26sid%3Dliteratum%253Aachs%26aulast%3DBuckle%26aufirst%3DD.%2BR.%26aulast%3DArch%26aufirst%3DJ.%2BR.%26aulast%3DFenwick%26aufirst%3DA.%2BE.%26aulast%3DHouge-Frydrych%26aufirst%3DC.%2BS.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DTaylor%26aufirst%3DS.%2BG.%26aulast%3DTedder%26aufirst%3DJ.%2BM.%26atitle%3DRelaxant%2520activity%2520of%25204-amido-3%252C4-dihydro-2H-1-benzopyran-3-ols%2520and%25204-amido-2H-1-benzopyrans%2520on%2520guinea%2520pig%2520isolated%2520trachealis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D3028%26epage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vuligonda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standeven, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandraratna, R. A.</span><span> </span><span class="NLM_article-title">A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=743-748&author=V.+Vuligondaauthor=A.+M.+Standevenauthor=M.+Escobarauthor=R.+A.+Chandraratna&title=A+new+class+of+potent+RAR+antagonists%3A+dihydroanthracenyl%2C+benzochromenyl+and+benzothiochromenyl+retinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVuligonda%26aufirst%3DV.%26aulast%3DStandeven%26aufirst%3DA.%2BM.%26aulast%3DEscobar%26aufirst%3DM.%26aulast%3DChandraratna%26aufirst%3DR.%2BA.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520RAR%2520antagonists%253A%2520dihydroanthracenyl%252C%2520benzochromenyl%2520and%2520benzothiochromenyl%2520retinoids%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D743%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagliardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of pyran oxygen and amide nitrogen replacement analogues of the potassium channel activator cromakalim</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3261</span><span class="NLM_x">–</span> <span class="NLM_lpage">3267</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00115a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=3261-3267&author=V.+A.+Ashwoodauthor=F.+Cassidyauthor=J.+M.+Evansauthor=S.+Gagliardiauthor=G.+Stemp&title=Synthesis+and+antihypertensive+activity+of+pyran+oxygen+and+amide+nitrogen+replacement+analogues+of+the+potassium+channel+activator+cromakalim"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjm00115a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00115a015%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DCassidy%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DJ.%2BM.%26aulast%3DGagliardi%26aufirst%3DS.%26aulast%3DStemp%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%2520pyran%2520oxygen%2520and%2520amide%2520nitrogen%2520replacement%2520analogues%2520of%2520the%2520potassium%2520channel%2520activator%2520cromakalim%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D3261%26epage%3D3267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wittekind, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poos, G. I.</span><span> </span><span class="NLM_article-title">Ring cleavage reactions of <i>trans</i>-2-amino-3a,4,5,6,7,7a-hexahydrobenzoxazole</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1960&pages=444-446&author=R.+R.+Wittekindauthor=J.+D.+Rosenauauthor=G.+I.+Poos&title=Ring+cleavage+reactions+of+trans-2-amino-3a%2C4%2C5%2C6%2C7%2C7a-hexahydrobenzoxazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittekind%26aufirst%3DR.%2BR.%26aulast%3DRosenau%26aufirst%3DJ.%2BD.%26aulast%3DPoos%26aufirst%3DG.%2BI.%26atitle%3DRing%2520cleavage%2520reactions%2520of%2520trans-2-amino-3a%252C4%252C5%252C6%252C7%252C7a-hexahydrobenzoxazole%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1960%26volume%3D26%26spage%3D444%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cohen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, B. L.</span><span> </span><span class="NLM_article-title">Synthesis of 2-amino-5,6-didydro-4<i>H</i>-1,3-thiazines and related compounds by acid catalyzed cyclization of allylic isothiuronium salts</span> <span class="citation_source-journal">J. Heterocycl. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1977&pages=717-23&author=N.+Cohenauthor=B.+L.+Banner&title=Synthesis+of+2-amino-5%2C6-didydro-4H-1%2C3-thiazines+and+related+compounds+by+acid+catalyzed+cyclization+of+allylic+isothiuronium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DBanner%26aufirst%3DB.%2BL.%26atitle%3DSynthesis%2520of%25202-amino-5%252C6-didydro-4H-1%252C3-thiazines%2520and%2520related%2520compounds%2520by%2520acid%2520catalyzed%2520cyclization%2520of%2520allylic%2520isothiuronium%2520salts%26jtitle%3DJ.%2520Heterocycl.%2520Chem%26date%3D1977%26volume%3D14%26spage%3D717%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of α-amino acid derivatives incorporating a broad range of substitution patterns by enolate additions to <i>tert</i>-butanesulfinyl imines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7819</span><span class="NLM_x">–</span> <span class="NLM_lpage">7832</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo025957u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=7819-7832&author=T.+P.+Tangauthor=J.+A.+Ellman&title=Asymmetric+synthesis+of+%CE%B1-amino+acid+derivatives+incorporating+a+broad+range+of+substitution+patterns+by+enolate+additions+to+tert-butanesulfinyl+imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo025957u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025957u%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%25CE%25B1-amino%2520acid%2520derivatives%2520incorporating%2520a%2520broad%2520range%2520of%2520substitution%2520patterns%2520by%2520enolate%2520additions%2520to%2520tert-butanesulfinyl%2520imines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D7819%26epage%3D7832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The preference for phenyl meta substitution and the 3-pyridyl interaction with the Ser229 bridging water molecule parallels the findings of biaryl and nonspirocyclic cores. See ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">We found several (but not all) literature compounds to be much more potent against CatD in our assay than reported. Furthermore, outsourced CatD assays were found to be unreliable, as analogue <b>(</b><i><b>R</b></i><b>)-34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, 1.7 μM vs CatD) was found to be inactive at 30 μM at two contract research organizations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Fernandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gattass, C. R.</span><span> </span><span class="NLM_article-title">Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1/ABCC1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801389m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1214-1218&author=J.+Fernandesauthor=C.+R.+Gattass&title=Topological+polar+surface+area+defines+substrate+transport+by+multidrug+resistance+associated+protein+1+%28MRP1%2FABCC1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Topological Polar Surface Area Defines Substrate Transport by Multidrug Resistance Associated Protein 1 (MRP1/ABCC1)</span></div><div class="casAuthors">Fernandes, Janaina; Gattass, Cerli R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1214-1218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance-assocd. protein 1 (MRP1/ABCC1) is a very promiscuous transporter.  Herein we used topol. polar surface area (TPSA), a descriptor defined as the sum of surfaces of polar atoms in a mol., to analyze drug transport by MRP1.  We suggested that compds. with high TPSA are transported while those with low TPSA are not.  The conjugation to GSH increases TPSA values favoring transport.  A strong correlation between TPSA and transport properties (Km) was also found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURdbfCvdSBrVg90H21EOLACvtfcHk0liTr6O0z3tReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWgurY%253D&md5=b1791be3b8836619e55d716716d3a85a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm801389m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801389m%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DJ.%26aulast%3DGattass%26aufirst%3DC.%2BR.%26atitle%3DTopological%2520polar%2520surface%2520area%2520defines%2520substrate%2520transport%2520by%2520multidrug%2520resistance%2520associated%2520protein%25201%2520%2528MRP1%252FABCC1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1214%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">The p<i>K</i><sub>a</sub> of the 2-aminoheterocycles may play a role: </p></div><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine p<i>K</i><sub>a</sub> in enzyme inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1885-1889&author=H.+A.+Rajapakseauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=J.+C.+Barrowauthor=G.+B.+McGaugheyauthor=S.+Munshiauthor=S.+R.+Lindsleyauthor=M.+B.+Youngauthor=P.+L.+Ngoauthor=M.+K.+Hollowayauthor=M.+T.+Laiauthor=A.+S.+Espesethauthor=X.+P.+Shiauthor=D.+Colussiauthor=B.+Pietrakauthor=M.+C.+Crouthamelauthor=K.+Tugushevaauthor=Q.+Huangauthor=M.+Xuauthor=A.+J.+Simonauthor=L.+Kuoauthor=D.+J.+Hazudaauthor=S.+Grahamauthor=J.+P.+Vacca&title=SAR+of+tertiary+carbinamine+derived+BACE1+inhibitors%3A+role+of+aspartate+ligand+amine+pKa+in+enzyme+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DSAR%2520of%2520tertiary%2520carbinamine%2520derived%2520BACE1%2520inhibitors%253A%2520role%2520of%2520aspartate%2520ligand%2520amine%2520pKa%2520in%2520enzyme%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1885%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lgzkO2ofIiO9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Compounds with medium to high permeability (<i>P</i><sub>app</sub> > 4) demonstrated acceptable pharmacokinetics. Compounds with low permeability (<i>P</i><sub>app</sub> < 4) were not generally evaluated in pharmacokinetic studies.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Preliminary experiments indicate a role for aldehyde oxidase in the CL of pyridine and pyrimidine moieties.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Beck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1023%2FA%3A1022850113083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=12675155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFars7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=637-644&author=M.+Beckauthor=V.+Biglauthor=S.+Rossner&title=Guinea+pigs+as+a+nontransgenic+model+for+APP+processing+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Guinea Pigs as a Nontransgenic Model for APP Processing in Vitro and in Vivo</span></div><div class="casAuthors">Beck, Mike; Bigl, Volker; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">637-644</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized, amongst others, by the appearance of vascular and parenchymal β-amyloid deposits in brain.  Such aggregates are mainly composed of β-amyloid peptides, which are derived by proteolytic processing of a larger amyloid precursor protein (APP).  APP is highly conserved among mammalian species, but exptl. studies in rodents are often hampered by the humble APP-processing in the amyloidogenic pathway and by the inability of rodent β-amyloid peptides to form higher mol. aggregates such as sol. oligomers and insol. β-amyloid plaques.  Thus, there is need for in vitro and in vivo model systems that allow identification of factors that increase amyloidogenic APP processing and accelerate β-amyloid plaque formation and testing the potency of pharmacol. manipulations to ameliorate β-amyloid load in brain.  Transgenic mice that overexpress human APP contg. AD-assocd. mutations that favor the amyloidogenic pathway of APP processing represent such a model.  However, mutations of the APP gene are not frequent in AD and, therefore, the mechanisms of β-amyloid plaque formation, the compn. of β-amyloid plaques, and the accompanying tissue response in brain of these animals may be different from that in AD.  In contrast, guinea pigs express β-amyloid peptides of the human sequence and appear to represent a more physiol. model to examine the long-term effects of exptl. manipulations on APP processing and β-amyloid plaque formation in vivo.  Addnl., APP processing in guinea pig primary neuronal cultures has been shown to be similar to cultures of human origin.  In this article we highlight the advantages and limitations of using guinea pigs as exptl. models to study APP processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFL4QNBkRjrVg90H21EOLACvtfcHk0lgzkO2ofIiO9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFars7s%253D&md5=1c574bca3392c3faeb7b177adfc962fa</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022850113083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022850113083%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DBigl%26aufirst%3DV.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGuinea%2520pigs%2520as%2520a%2520nontransgenic%2520model%2520for%2520APP%2520processing%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DNeurochem.%2520Res.%26date%3D2003%26volume%3D28%26spage%3D637%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagishita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiura, S.</span><span> </span><span class="NLM_article-title">β-Secretase inhibitor potency is decreased by aberrant β-cleavage location of the “Swedish mutant” amyloid precursor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=1634-1642&author=H.+Yamakawaauthor=S.+Yagishitaauthor=E.+Futaiauthor=S.+Ishiura&title=%CE%B2-Secretase+inhibitor+potency+is+decreased+by+aberrant+%CE%B2-cleavage+location+of+the+%E2%80%9CSwedish+mutant%E2%80%9D+amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamakawa%26aufirst%3DH.%26aulast%3DYagishita%26aufirst%3DS.%26aulast%3DFutai%26aufirst%3DE.%26aulast%3DIshiura%26aufirst%3DS.%26atitle%3D%25CE%25B2-Secretase%2520inhibitor%2520potency%2520is%2520decreased%2520by%2520aberrant%2520%25CE%25B2-cleavage%2520location%2520of%2520the%2520%25E2%2580%259CSwedish%2520mutant%25E2%2580%259D%2520amyloid%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D1634%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2Fnm1295-1291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=7489411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1291-1296&author=C.+Haassauthor=C.+A.+Lemereauthor=A.+Capellauthor=M.+Citronauthor=P.+Seubertauthor=D.+Schenkauthor=L.+Lannfeltauthor=D.+J.+Selkoe&title=The+Swedish+mutation+causes+early-onset+Alzheimer%E2%80%99s+disease+by+%CE%B2-secretase+cleavage+within+the+secretory+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway</span></div><div class="casAuthors">Haass, Christian; Lemere, Cynthia A.; Capell, Anja; Citron, Martin; Seubert, Peter; Schenk, Dale; Lannfelt, Lars; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1291-6</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the β-amyloid precursor protein (βAPP).  A double mutation found in a Swedish family is located before the amyloid β-peptide (Aβ) region of βAPP and results in the increased prodn. and secretion of Aβ.  Here the authors show that the increased prodn. of Aβ results from a cellular mechanism, which differs substantially from that responsible for the prodn. of Aβ from wild-type βAPP.  In the latter case, Aβ generation requires reinternalization and recycling of βAPP.  In the case of the Swedish mutation the N-terminal β-secretase cleavage of Aβ occurs in Golgi-derived vesicles, most likely within secretory vesicles.  Therefore, this cleavage occurs in the same compartment as the α-secretase cleavage, which normally prevents Aβ prodn., explaining the increased Aβ generation by a competition between α- and β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwY2_Dmv4aPrVg90H21EOLACvtfcHk0liVWUGg38mtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D&md5=af21095fbb11e8dfc6ffb0b9f9afb38b</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1038%2Fnm1295-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1295-1291%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DCapell%26aufirst%3DA.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Swedish%2520mutation%2520causes%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520%25CE%25B2-secretase%2520cleavage%2520within%2520the%2520secretory%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D1291%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">The γ-secretase inhibitor semagacestat was utilized for assay validation, providing 58% CSF Aβ reduction at 3 h with a 60 mg/kg oral dose in guinea pig.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv, E.</span><span> </span><span class="NLM_article-title">Cathepsins S, B and L with aminopeptidases display β-secretase activity associated with the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=2011&pages=555-69&author=I.+Schechterauthor=E.+Ziv&title=Cathepsins+S%2C+B+and+L+with+aminopeptidases+display+%CE%B2-secretase+activity+associated+with+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DZiv%26aufirst%3DE.%26atitle%3DCathepsins%2520S%252C%2520B%2520and%2520L%2520with%2520aminopeptidases%2520display%2520%25CE%25B2-secretase%2520activity%2520associated%2520with%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Chem.%26date%3D2011%26volume%3D392%26spage%3D555%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hook, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funkelstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hook, G.</span><span> </span><span class="NLM_article-title">Cysteine Cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer’s disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1824</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=89-104&author=V.+Hookauthor=L.+Funkelsteinauthor=J.+Wegrzynauthor=S.+Barkauthor=M.+Kindyauthor=G.+Hook&title=Cysteine+Cathepsins+in+the+secretory+vesicle+produce+active+peptides%3A+cathepsin+L+generates+peptide+neurotransmitters+and+cathepsin+B+produces+beta-amyloid+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHook%26aufirst%3DV.%26aulast%3DFunkelstein%26aufirst%3DL.%26aulast%3DWegrzyn%26aufirst%3DJ.%26aulast%3DBark%26aufirst%3DS.%26aulast%3DKindy%26aufirst%3DM.%26aulast%3DHook%26aufirst%3DG.%26atitle%3DCysteine%2520Cathepsins%2520in%2520the%2520secretory%2520vesicle%2520produce%2520active%2520peptides%253A%2520cathepsin%2520L%2520generates%2520peptide%2520neurotransmitters%2520and%2520cathepsin%2520B%2520produces%2520beta-amyloid%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1824%26spage%3D89%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+an+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0liVWUGg38mtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520an%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D,A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+Debartoloauthor=D%2CA.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0liVWUGg38mtww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDebartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD%252CA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Sarasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedro, P.</span><span> </span><span class="NLM_article-title">Natural non-transgenic animal models for research in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.2174%2F156720509787602834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=19355852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Ois7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=171-178&author=M.+Sarasaauthor=P.+Pedro&title=Natural+non-transgenic+animal+models+for+research+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Non-transgenic animal models for research in Alzheimer's disease</span></div><div class="casAuthors">Sarasa, Manuel; Pesini, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The most common animal models currently used for Alzheimer disease (AD) research are transgenic mice that express a mutant form of human Aβ precursor protein (APP) and/or some of the enzymes implicated in their metabolic processing.  However, these transgenic mice carry their own APP and APP-processing enzymes, which may interfere in the prodn. of different amyloid-beta (Aβ) peptides encoded by the human transgenes.  Addnl., the genetic backgrounds of the different transgenic mice are a possible confounding factor with regard to crucial aspects of AD that they may (or may not) reproduce.  Thus, although the usefulness of transgenic mice is undisputed, we hypothesized that addnl. relevant information on the physiopathol. of AD could be obtained from other natural non-transgenic models.  We have analyzed the chick embryo and the dog, which may be better exptl. models because their enzymic machinery for processing APP is almost identical to that of humans.  The chick embryo is extremely easy to access and manipulate.  It could be an advantageous natural model in which to study the cell biol. and developmental function of APP and a potential assay system for drugs that regulate APP processing.  The dog suffers from an age-related syndrome of cognitive dysfunction that naturally reproduces key aspects of AD including Aβ cortical pathol., neuronal degeneration and learning and memory disabilities.  However, dense core neuritic plaques and neurofibrillary tangles have not been consistently demonstrated in the dog.  Thus, these species may be natural models with which to study the biol. of AD, and could also serve as assay systems for Aβ-targeted drugs or new therapeutic strategies against this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqisxU0H5w3y7Vg90H21EOLACvtfcHk0lgEBgoVDeXQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Ois7o%253D&md5=85b170622b0ee4a7b6f387813fc9d021</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F156720509787602834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720509787602834%26sid%3Dliteratum%253Aachs%26aulast%3DSarasa%26aufirst%3DM.%26aulast%3DPedro%26aufirst%3DP.%26atitle%3DNatural%2520non-transgenic%2520animal%2520models%2520for%2520research%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2009%26volume%3D6%26spage%3D171%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The γ-secretase inhibitor semagacestat was utilized for assay validation, providing 40% CSF Aβ reduction at 3 h with a 60 mg/kg oral dose in rat.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0lgEBgoVDeXQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devanarayan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeiser, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span> </span><span class="NLM_article-title">First demonstration of cerebrospinal fluid and plasma Aβ lowering with oral administration of a β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1124%2Fjpet.108.143628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18854490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=131-140&author=S.+Sankaranarayananauthor=M.+A.+Holahanauthor=D.+Colussiauthor=M.+C.+Crouthamelauthor=V.+Devanarayanauthor=J.+Ellisauthor=A.+Espesethauthor=A.+T.+Gatesauthor=S.+L.+Grahamauthor=A.+R.+Gregroauthor=D.+Hazudaauthor=J.+H.+Hochmanauthor=K.+Hollowayauthor=L.+Jinauthor=J.+Kahanaauthor=M.+T.+Laiauthor=J.+Linebergerauthor=G.+McGaugheyauthor=K.+P.+Mooreauthor=P.+Nantermetauthor=B.+Pietrakauthor=E.+A.+Priceauthor=H.+Rajapakseauthor=S.+Staufferauthor=M.+A.+Steinbeiserauthor=G.+Seabrookauthor=H.+G.+Selnickauthor=X.+P.+Shiauthor=M.+G.+Stantonauthor=J.+Swestockauthor=K.+Tugushevaauthor=K.+X.+Tylerauthor=J.+P.+Vaccaauthor=J.+Wongauthor=G.+Wuauthor=M.+Xuauthor=J.+J.+Cookauthor=A.+J.+Simon&title=First+demonstration+of+cerebrospinal+fluid+and+plasma+A%CE%B2+lowering+with+oral+administration+of+a+%CE%B2-site+amyloid+precursor+protein-cleaving+enzyme+1+inhibitor+in+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">First demonstration of cerebrospinal fluid and plasma Aβ lowering with oral administration of a β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates</span></div><div class="casAuthors">Sankaranarayanan, Sethu; Holahan, Marie A.; Colussi, Dennis; Crouthamel, Ming-Chih; Devanarayan, Viswanath; Ellis, Joan; Espeseth, Amy; Gates, Adam T.; Graham, Samuel L.; Gregro, Allison R.; Hazuda, Daria; Hochman, Jerome H.; Holloway, Katharine; Jin, Lixia; Kahana, Jason; Lai, Ming-tain; Lineberger, Janet; McGaughey, Georgia; Moore, Keith P.; Nantermet, Philippe; Pietrak, Beth; Price, Eric A.; Rajapakse, Hemaka; Stauffer, Shaun; Steinbeiser, Melissa A.; Seabrook, Guy; Selnick, Harold G.; Shi, Xiao-Ping; Stanton, Matthew G.; Swestock, John; Tugusheva, Katherine; Tyler, Keala X.; Vacca, Joseph P.; Wong, Jacky; Wu, Guoxin; Xu, Min; Cook, Jacquelynn J.; Simon, Adam J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-140</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein (APP)-cleaving enzyme (BACE) 1 cleavage of amyloid precursor protein is an essential step in the generation of the potentially neurotoxic and amyloidogenic Aβ42 peptides in Alzheimer's disease.  Although previous mouse studies have shown brain Aβ lowering after BACE1 inhibition, extension of such studies to nonhuman primates or man was precluded by poor potency, brain penetration, and pharmacokinetics of available inhibitors.  In this study, a novel tertiary carbinamine BACE1 inhibitor, tertiary carbinamine (TC)-1, was assessed in a unique cisterna magna ported rhesus monkey model, where the temporal dynamics of Aβ in cerebrospinal fluid (CSF) and plasma could be evaluated.  TC-1, a potent inhibitor (IC50 ∼ 0.4 nM), has excellent passive membrane permeability, low susceptibility to P-glycoprotein transport, and lowered brain Aβ levels in a mouse model.  I.v. infusion of TC-1 led to a significant but transient lowering of CSF and plasma Aβ levels in conscious rhesus monkeys because it underwent CYP3A4-mediated metab.  Oral codosing of TC-1 with ritonavir, a potent CYP3A4 inhibitor, twice daily over 3.5 days in rhesus monkeys led to sustained plasma TC-1 exposure and a significant and sustained redn. in CSF sAPPβ, Aβ40, Aβ42, and plasma Aβ40 levels.  CSF Aβ42 lowering showed an EC50 of ∼20 nM with respect to the CSF [TC-1] levels, demonstrating excellent concordance with its potency in a cell-based assay.  These results demonstrate the first in vivo proof of concept of CSF Aβ lowering after oral administration of a BACE1 inhibitor in a nonhuman primate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqnKtfwYLbwbVg90H21EOLACvtfcHk0lgfqGaBx8ZLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFyltw%253D%253D&md5=bbbf7d925fabdae45d82fd01741c3eb6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143628%26sid%3Dliteratum%253Aachs%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DDevanarayan%26aufirst%3DV.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DGates%26aufirst%3DA.%2BT.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DHolloway%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKahana%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DNantermet%26aufirst%3DP.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DRajapakse%26aufirst%3DH.%26aulast%3DStauffer%26aufirst%3DS.%26aulast%3DSteinbeiser%26aufirst%3DM.%2BA.%26aulast%3DSeabrook%26aufirst%3DG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DTyler%26aufirst%3DK.%2BX.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26atitle%3DFirst%2520demonstration%2520of%2520cerebrospinal%2520fluid%2520and%2520plasma%2520A%25CE%25B2%2520lowering%2520with%2520oral%2520administration%2520of%2520a%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein-cleaving%2520enzyme%25201%2520inhibitor%2520in%2520nonhuman%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D131%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High yield expression of human BACE constructs in <i>Eschericia coli</i> for refolding, purification, and high resolution diffracting crystal forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131-143&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+yield+expression+of+human+BACE+constructs+in+Eschericia+coli+for+refolding%2C+purification%2C+and+high+resolution+diffracting+crystal+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0lgfqGaBx8ZLpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520yield%2520expression%2520of%2520human%2520BACE%2520constructs%2520in%2520Eschericia%2520coli%2520for%2520refolding%252C%2520purification%252C%2520and%2520high%2520resolution%2520diffracting%2520crystal%2520forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosfim</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_contrib-group">Read, R. J.; Sussman, J. L.</span>, Eds.;  <span class="citation_source-book">NATO Science Series II: Mathematics, Physics, and Chemistry 245</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powellauthor=R.+J.+Read&author=J.+L.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosfim%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%2BJ.%26btitle%3DNATO%2520Science%2520Series%2520II%253A%2520Mathematics%252C%2520Physics%252C%2520and%2520Chemistry%2520245%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0ljCbbMgk2cE6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljCbbMgk2cE6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11f','cit11g'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':[],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e','cit17f','cit17g','cit17h','cit17i','cit17j'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20a','cit20b','cit20c'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':[],'ref30':[],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':[],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Jinan Wang, Baohua Yin, Laixue Pang, Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Weiliang Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanism of Binding Selectivity of Inhibitors toward BACE1 and BACE2 Revealed by Multiple Short Molecular Dynamics Simulations and Free-Energy Predictions. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4303-4318. <a href="https://doi.org/10.1021/acschemneuro.9b00348" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00348%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMolecular%252BMechanism%252Bof%252BBinding%252BSelectivity%252Bof%252BInhibitors%252Btoward%252BBACE1%252Band%252BBACE2%252BRevealed%252Bby%252BMultiple%252BShort%252BMolecular%252BDynamics%252BSimulations%252Band%252BFree-Energy%252BPredictions%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D23092019%26date%3D02102019%26date%3D23092019%26volume%3D10%26issue%3D10%26spage%3D4303%26epage%3D4318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada, Genta Tadano, Takahiko Yamamoto, Kenji Nakahara, Kouki Fuchino, Hisanori Ito, Naoki Kanegawa, Diederik Moechars, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 5080-5095. <a href="https://doi.org/10.1021/acs.jmedchem.9b00309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BSelective%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BTargeting%252Bthe%252BFlap%252Bto%252BGain%252BSelectivity%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16022019%26date%3D13052019%26date%3D25042019%26volume%3D62%26issue%3D10%26spage%3D5080%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yanyan Yu, Tianxiao Yin, Qiwen Peng, Lingna Kong, Chenglin Li, Daoquan Tang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoxing Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous Monitoring of Amyloid-β (Aβ) Oligomers and Fibrils for Effectively Evaluating the Dynamic Process of Aβ Aggregation. </span><span class="cited-content_cbyCitation_journal-name">ACS Sensors</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 471-478. <a href="https://doi.org/10.1021/acssensors.8b01493" title="DOI URL">https://doi.org/10.1021/acssensors.8b01493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssensors.8b01493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssensors.8b01493%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sensors%26atitle%3DSimultaneous%252BMonitoring%252Bof%252BAmyloid-%2525CE%2525B2%252B%252528A%2525CE%2525B2%252529%252BOligomers%252Band%252BFibrils%252Bfor%252BEffectively%252BEvaluating%252Bthe%252BDynamic%252BProcess%252Bof%252BA%2525CE%2525B2%252BAggregation%26aulast%3DYu%26aufirst%3DYanyan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27112018%26date%3D29012019%26date%3D12022019%26date%3D29012019%26volume%3D4%26issue%3D2%26spage%3D471%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenji Nakahara, Kouki Fuchino, Kazuo Komano, Naoya Asada, Genta Tadano, Tsuyoshi Hasegawa, Takahiko Yamamoto, Yusuke Sako, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5525-5546. <a href="https://doi.org/10.1021/acs.jmedchem.8b00011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BCentrally%252BActive%252B6-Substituted%252B5-Fluoro-1%25252C3-dihydro-oxazine%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bvia%252BActive%252BConformation%252BStabilization%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04012018%26date%3D14062018%26date%3D18052018%26volume%3D61%26issue%3D13%26spage%3D5525%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kouki Fuchino, Yasunori Mitsuoka, Moriyasu Masui, Noriyuki Kurose, Shuhei Yoshida, Kazuo Komano, Takahiko Yamamoto, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Hirofumi Miyajima, Shuichi Hiroyama, Kiyotaka Koyabu, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5122-5137. <a href="https://doi.org/10.1021/acs.jmedchem.8b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BNovel%252B1%25252C3-Oxazine%252BBased%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%25253A%252BIncorporation%252Bof%252Ba%252BDouble%252BBond%252BTo%252BReduce%252BP-gp%252BEfflux%252BLeading%252Bto%252BRobust%252BA%2525CE%2525B2%252BReduction%252Bin%252Bthe%252BBrain%26aulast%3DFuchino%26aufirst%3DKouki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01012018%26date%3D23052018%26date%3D07052018%26volume%3D61%26issue%3D12%26spage%3D5122%26epage%3D5137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrik Johansson, Karin Kaspersson, Ian K. Gurrell, Elisabeth Bäck, Susanna Eketjäll, Clay W. Scott, Gvido Cebers, Philip Thorne, Michael J. McKenzie, Haydn Beaton, Paul Davey, Karin Kolmodin, Jörg Holenz, Mark E. Duggan, Samantha Budd Haeberlein, <span class="NLM_string-name hlFld-ContribAuthor">Roland W. Bürli</span>. </span><span class="cited-content_cbyCitation_article-title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3491-3502. <a href="https://doi.org/10.1021/acs.jmedchem.7b01716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252B%2525CE%2525B2-Secretase-1%252BInhibitors%252Bwith%252BImproved%252BIsoform%252BSelectivity%26aulast%3DJohansson%26aufirst%3DPatrik%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21112017%26date%3D10042018%26date%3D04042018%26volume%3D61%26issue%3D8%26spage%3D3491%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fengli  Qu</span>, <span class="hlFld-ContribAuthor ">Minghui  Yang</span>, and <span class="hlFld-ContribAuthor ">Avraham  Rasooly</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Signal Amplification Electrochemical Biosensor for Monitoring the Activity and Inhibition of the Alzheimer’s Related Protease β-Secretase. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2016,</strong> <em>88 </em>
                                    (21)
                                     , 10559-10565. <a href="https://doi.org/10.1021/acs.analchem.6b02659" title="DOI URL">https://doi.org/10.1021/acs.analchem.6b02659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.6b02659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.6b02659%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DDual%252BSignal%252BAmplification%252BElectrochemical%252BBiosensor%252Bfor%252BMonitoring%252Bthe%252BActivity%252Band%252BInhibition%252Bof%252Bthe%252BAlzheimer%2525E2%252580%252599s%252BRelated%252BProtease%252B%2525CE%2525B2-Secretase%26aulast%3DQu%26aufirst%3DFengli%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12072016%26date%3D21092016%26date%3D17102016%26date%3D01112016%26date%3D21092016%26volume%3D88%26issue%3D21%26spage%3D10559%26epage%3D10565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, and <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Free Energy Perturbation for the Design of BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (9)
                                     , 1856-1871. <a href="https://doi.org/10.1021/acs.jcim.6b00220" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DApplication%252Bof%252BFree%252BEnergy%252BPerturbation%252Bfor%252Bthe%252BDesign%252Bof%252BBACE1%252BInhibitors%26aulast%3DCiordia%26aufirst%3DMyriam%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19042016%26date%3D24082016%26date%3D26092016%26date%3D08082016%26volume%3D56%26issue%3D9%26spage%3D1856%26epage%3D1871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Guoqing  Li</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Robert D.  Mazzola</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Grzelak</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Prescott T.  Leach</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Maria S.  Michener</span>, <span class="hlFld-ContribAuthor ">Brad  Smith</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Diane  Grotz</span>, <span class="hlFld-ContribAuthor ">Leonard  Favreau</span>, <span class="hlFld-ContribAuthor ">Kaushik  Mitra</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3231-3248. <a href="https://doi.org/10.1021/acs.jmedchem.5b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ban%252BIminoheterocyclic%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE%252529%252BInhibitor%252Bthat%252BLowers%252BCentral%252BA%2525CE%2525B2%252Bin%252BNonhuman%252BPrimates%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23122015%26date%3D22032016%26date%3D14042016%26date%3D03032016%26volume%3D59%26issue%3D7%26spage%3D3231%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentine G.  Nenajdenko</span>, <span class="hlFld-ContribAuthor ">Vasiliy M.  Muzalevskiy</span>, and <span class="hlFld-ContribAuthor ">Aleksey V.  Shastin</span>  . </span><span class="cited-content_cbyCitation_article-title">Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (2)
                                     , 973-1050. <a href="https://doi.org/10.1021/cr500465n" title="DOI URL">https://doi.org/10.1021/cr500465n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500465n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500465n%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPolyfluorinated%252BEthanes%252Bas%252BVersatile%252BFluorinated%252BC2-Building%252BBlocks%252Bfor%252BOrganic%252BSynthesis%26aulast%3DNenajdenko%26aufirst%3DValentine%2BG.%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D15102013%26date%3D16012015%26date%3D28012015%26volume%3D115%26issue%3D2%26spage%3D973%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Brad  Newhouse</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Susan P.  Rhodes</span>, <span class="hlFld-ContribAuthor ">Karin D.  Brown</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Otten</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">April A.  Cox</span>, <span class="hlFld-ContribAuthor ">Mary K.  Geck Do</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Robert K.  DeLisle</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Albion D.  Wright</span>, <span class="hlFld-ContribAuthor ">Robert  Groneberg</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10112-10129. <a href="https://doi.org/10.1021/jm5015132" title="DOI URL">https://doi.org/10.1021/jm5015132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5015132%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D8-Tetrahydropyran-2-yl%252BChromans%25253A%252BHighly%252BSelective%252BBeta-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%26aulast%3DThomas%26aufirst%3DAllen%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01102014%26date%3D26112014%26date%3D11122014%26date%3D20112014%26volume%3D57%26issue%3D23%26spage%3D10112%26epage%3D10129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew  Wright</span>, and <span class="hlFld-ContribAuthor ">Cornelis E. C. A.  Hop</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (20)
                                     , 8238-8248. <a href="https://doi.org/10.1021/jm5007935" title="DOI URL">https://doi.org/10.1021/jm5007935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5007935%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BUse%252Bof%252BPlasma%252BProtein%252Band%252BTissue%252BBinding%252BData%252Bin%252BDrug%252BDesign%26aulast%3DLiu%26aufirst%3DXingrong%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D22052014%26date%3D06082014%26date%3D23102014%26date%3D30072014%26volume%3D57%26issue%3D20%26spage%3D8238%26epage%3D8248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Douglas  Sammond</span>, <span class="hlFld-ContribAuthor ">Tony P.  Tang</span>, <span class="hlFld-ContribAuthor ">Susan P.  Rhodes</span>, <span class="hlFld-ContribAuthor ">Andrew T.  Metcalf</span>, <span class="hlFld-ContribAuthor ">Karin D.  Brown</span>, <span class="hlFld-ContribAuthor ">Jennifer N.  Otten</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">April A.  Cox</span>, <span class="hlFld-ContribAuthor ">Mary K. Geck  Do</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Robert K.  DeLisle</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Albion D.  Wright</span>, <span class="hlFld-ContribAuthor ">Robert  Groneberg</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, and <span class="hlFld-ContribAuthor ">Indrani W.  Gunawardana</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 878-902. <a href="https://doi.org/10.1021/jm401635n" title="DOI URL">https://doi.org/10.1021/jm401635n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401635n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B7-Tetrahydropyran-2-yl%252BChromans%25253A%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%252BThat%252BReduce%252BAmyloid%252B%2525CE%2525B2-Protein%252B%252528A%2525CE%2525B2%252529%252Bin%252Bthe%252BCentral%252BNervous%252BSystem%26aulast%3DThomas%26aufirst%3DAllen%2BA.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D21102013%26date%3D22012014%26date%3D13022014%26date%3D07012014%26volume%3D57%26issue%3D3%26spage%3D878%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shruti  Gupta</span>, <span class="hlFld-ContribAuthor ">Devendra  Parihar</span>, <span class="hlFld-ContribAuthor ">Mokshada  Shah</span>, <span class="hlFld-ContribAuthor ">Shivali  Yadav</span>, <span class="hlFld-ContribAuthor ">Husain  Managori</span>, <span class="hlFld-ContribAuthor ">Shovonlal  Bhowmick</span>, <span class="hlFld-ContribAuthor ">Preeti Chunarkar  Patil</span>, <span class="hlFld-ContribAuthor ">Siham A.  Alissa</span>, <span class="hlFld-ContribAuthor ">Saikh Mohammad  Wabaidur</span>, <span class="hlFld-ContribAuthor ">Md Ataul  Islam</span>. </span><span class="cited-content_cbyCitation_article-title">Computational screening of promising beta-secretase 1 inhibitors through multi-step molecular docking and molecular dynamics simulations - Pharmacoinformatics approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1205 </em>, 127660. <a href="https://doi.org/10.1016/j.molstruc.2019.127660" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.127660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.127660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.127660%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DComputational%252Bscreening%252Bof%252Bpromising%252Bbeta-secretase%252B1%252Binhibitors%252Bthrough%252Bmulti-step%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252B-%252BPharmacoinformatics%252Bapproach%26aulast%3DGupta%26aufirst%3DShruti%26date%3D2020%26volume%3D1205%26spage%3D127660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vytautas  Gapsys</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Matteo  Aldeghi</span>, <span class="hlFld-ContribAuthor ">Daniel  Seeliger</span>, <span class="hlFld-ContribAuthor ">Herman  van Vlijmen</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Bert L.  de Groot</span>. </span><span class="cited-content_cbyCitation_article-title">Large scale relative protein ligand binding affinities using non-equilibrium alchemy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 1140-1152. <a href="https://doi.org/10.1039/C9SC03754C" title="DOI URL">https://doi.org/10.1039/C9SC03754C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC03754C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC03754C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DLarge%252Bscale%252Brelative%252Bprotein%252Bligand%252Bbinding%252Baffinities%252Busing%252Bnon-equilibrium%252Balchemy%26aulast%3DGapsys%26aufirst%3DVytautas%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D4%26spage%3D1140%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuju  Yuan</span>, <span class="hlFld-ContribAuthor ">Hongwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xie  Zhang</span>, <span class="hlFld-ContribAuthor ">Pengyun  Huang</span>, <span class="hlFld-ContribAuthor ">Rong  Liu</span>, <span class="hlFld-ContribAuthor ">You-Qiang  Song</span>, <span class="hlFld-ContribAuthor ">Wutian  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi-Xiu  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Association Between Axonopathy and Amyloid Plaques in the Spinal Cord of the Transgenic Mice of Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2019,</strong> <em>409 </em>, 152-161. <a href="https://doi.org/10.1016/j.neuroscience.2019.04.037" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2019.04.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2019.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2019.04.037%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DAssociation%252BBetween%252BAxonopathy%252Band%252BAmyloid%252BPlaques%252Bin%252Bthe%252BSpinal%252BCord%252Bof%252Bthe%252BTransgenic%252BMice%252Bof%252BAlzheimer%252527s%252BDisease%26aulast%3DYuan%26aufirst%3DQiuju%26date%3D2019%26volume%3D409%26spage%3D152%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit  Ganeshpurkar</span>, <span class="hlFld-ContribAuthor ">Rayala  Swetha</span>, <span class="hlFld-ContribAuthor ">Devendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Gore P.  Gangaram</span>, <span class="hlFld-ContribAuthor ">Ravi  Singh</span>, <span class="hlFld-ContribAuthor ">Gopichand  Gutti</span>, <span class="hlFld-ContribAuthor ">Srabanti  Jana</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashok  Kumar</span>, <span class="hlFld-ContribAuthor ">Sushil K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 501-533. <a href="https://doi.org/10.2174/1568026619666190304153353" title="DOI URL">https://doi.org/10.2174/1568026619666190304153353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190304153353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190304153353%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DProtein-Protein%252BInteractions%252Band%252BAggregation%252BInhibitors%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGaneshpurkar%26aufirst%3DAnkit%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D501%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying‑Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Jian‑Qin  Xie</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Rong‑Zhi  Zhang</span>, <span class="hlFld-ContribAuthor ">Sheng‑Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Yan‑Hong  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 gene silencing alleviates isoflurane anesthesia‑induced postoperative cognitive dysfunction in immature rats by activating the PI3K/Akt signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Molecular Medicine Reports</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/mmr.2018.9453" title="DOI URL">https://doi.org/10.3892/mmr.2018.9453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/mmr.2018.9453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fmmr.2018.9453%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Medicine%2520Reports%26atitle%3DBACE1%252Bgene%252Bsilencing%252Balleviates%252Bisoflurane%252Banesthesia%2525E2%252580%252591induced%252Bpostoperative%252Bcognitive%252Bdysfunction%252Bin%252Bimmature%252Brats%252Bby%252Bactivating%252Bthe%252BPI3K%25252FAkt%252Bsignaling%252Bpathway%26aulast%3DWang%26aufirst%3DYing%25E2%2580%2591Bin%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Pirotte</span>, <span class="hlFld-ContribAuthor ">Xavier  Florence</span>, <span class="hlFld-ContribAuthor ">Eric  Goffin</span>, <span class="hlFld-ContribAuthor ">Philippe  Lebrun</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering Structure-Activity Relationships in a Series of 2,2-Dimethylchromans Acting as Inhibitors of Insulin Release and Smooth Muscle Relaxants. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (21)
                                     , 1810-1817. <a href="https://doi.org/10.1002/cmdc.201700409" title="DOI URL">https://doi.org/10.1002/cmdc.201700409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700409%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDeciphering%252BStructure-Activity%252BRelationships%252Bin%252Ba%252BSeries%252Bof%252B2%25252C2-Dimethylchromans%252BActing%252Bas%252BInhibitors%252Bof%252BInsulin%252BRelease%252Band%252BSmooth%252BMuscle%252BRelaxants%26aulast%3DPirotte%26aufirst%3DBernard%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D21%26spage%3D1810%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingliang  Nie</span>, <span class="hlFld-ContribAuthor ">Cungui  Cheng</span>, <span class="hlFld-ContribAuthor ">Gangguo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Remote Aryldifluoroalkylation of Alkenyl Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (7)
                                     , 1924-1928. <a href="https://doi.org/10.1002/ange.201611697" title="DOI URL">https://doi.org/10.1002/ange.201611697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201611697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201611697%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPalladium-Catalyzed%252BRemote%252BAryldifluoroalkylation%252Bof%252BAlkenyl%252BAldehydes%26aulast%3DNie%26aufirst%3DXingliang%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D7%26spage%3D1924%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingliang  Nie</span>, <span class="hlFld-ContribAuthor ">Cungui  Cheng</span>, <span class="hlFld-ContribAuthor ">Gangguo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Remote Aryldifluoroalkylation of Alkenyl Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (7)
                                     , 1898-1902. <a href="https://doi.org/10.1002/anie.201611697" title="DOI URL">https://doi.org/10.1002/anie.201611697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201611697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201611697%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPalladium-Catalyzed%252BRemote%252BAryldifluoroalkylation%252Bof%252BAlkenyl%252BAldehydes%26aulast%3DNie%26aufirst%3DXingliang%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D7%26spage%3D1898%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Low</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Mark R.  Fielden</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">E.  Allen Sickmier</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Jonathan  Werner</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1196-1206. <a href="https://doi.org/10.1039/C7MD00106A" title="DOI URL">https://doi.org/10.1039/C7MD00106A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00106A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00106A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthene%252B%2525CE%2525B2-amyloid%252Bcleaving%252Benzyme%252B%252528BACE%252529%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Bagainst%252BCathepsin%252BD%26aulast%3DLow%26aufirst%3DJonathan%2BD.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1196%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel K.  Chambers</span>, <span class="hlFld-ContribAuthor ">Tanweer A.  Khan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino heterocycle aspartyl protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (22)
                                     , 4970-4985. <a href="https://doi.org/10.1039/C5OB01842K" title="DOI URL">https://doi.org/10.1039/C5OB01842K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01842K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01842K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bheterocycle%252Baspartyl%252Bprotease%252Binhibitors%26aulast%3DChambers%26aufirst%3DRachel%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D22%26spage%3D4970%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Mateu</span>, <span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">María  Sánchez-Roselló</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Michiel  Van Gool</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>. </span><span class="cited-content_cbyCitation_article-title">A Versatile Approach to CF
              3
              -Containing 2-Pyrrolidones by Tandem Michael Addition-Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (33)
                                     , 11719-11726. <a href="https://doi.org/10.1002/chem.201501662" title="DOI URL">https://doi.org/10.1002/chem.201501662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201501662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201501662%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BVersatile%252BApproach%252Bto%252BCF%252B3%252B-Containing%252B2-Pyrrolidones%252Bby%252BTandem%252BMichael%252BAddition-Cyclization%25253A%252BExemplification%252Bin%252Bthe%252BSynthesis%252Bof%252BAmidine%252BClass%252BBACE1%252BInhibitors%26aulast%3DMateu%26aufirst%3DNatalia%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D33%26spage%3D11719%26epage%3D11726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshihiko  Tashima</span>. </span><span class="cited-content_cbyCitation_article-title">Intriguing possibilities and beneficial aspects of transporter-conscious drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4119-4131. <a href="https://doi.org/10.1016/j.bmc.2015.06.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIntriguing%252Bpossibilities%252Band%252Bbeneficial%252Baspects%252Bof%252Btransporter-conscious%252Bdrug%252Bdesign%26aulast%3DTashima%26aufirst%3DToshihiko%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4119%26epage%3D4131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Takahashi</span>, <span class="hlFld-ContribAuthor ">Shuguang  Ma</span>, <span class="hlFld-ContribAuthor ">Qin  Yue</span>, <span class="hlFld-ContribAuthor ">Heasook  Kim-Kang</span>, <span class="hlFld-ContribAuthor ">Yijun  Yi</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Kallan</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Cornelis E. C. A.  Hop</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">Dose-dependent exposure and metabolism of GNE-892, a β-secretase inhibitor, in monkeys: contributions by P450, AO, and P-gp. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Drug Metabolism and Pharmacokinetics</span><span> <strong>2015,</strong> <em>40 </em>
                                    (2)
                                     , 171-185. <a href="https://doi.org/10.1007/s13318-014-0198-5" title="DOI URL">https://doi.org/10.1007/s13318-014-0198-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13318-014-0198-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13318-014-0198-5%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Drug%2520Metabolism%2520and%2520Pharmacokinetics%26atitle%3DDose-dependent%252Bexposure%252Band%252Bmetabolism%252Bof%252BGNE-892%25252C%252Ba%252B%2525CE%2525B2-secretase%252Binhibitor%25252C%252Bin%252Bmonkeys%25253A%252Bcontributions%252Bby%252BP450%25252C%252BAO%25252C%252Band%252BP-gp%26aulast%3DTakahashi%26aufirst%3DRyan%26date%3D2015%26date%3D2014%26volume%3D40%26issue%3D2%26spage%3D171%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">Chester  Yuan</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Vu  Ma</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Ted C.  Judd</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">May  Xue</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Jason  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Timothy S.  Powers</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Werner</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Nancy E.  Everds</span>, <span class="hlFld-ContribAuthor ">Steven L.  Vonderfecht</span>, <span class="hlFld-ContribAuthor ">Robert T.  Dunn</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 767-774. <a href="https://doi.org/10.1016/j.bmcl.2014.12.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthenes%252Bas%252Borally%252Befficacious%252B%2525CE%2525B2-secretase%252Binhibitors%252Bfor%252Bthe%252Bpotential%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChen%26aufirst%3DJian%2BJeffrey%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D767%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Jian  Hu</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Su-Yi  Li</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Kelvin D.G.  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of spiro chromanone-tetrahydrothiophenes with three contiguous stereocenters via sulfa-Michael/aldol cascade reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (1)
                                     , 105-108. <a href="https://doi.org/10.1016/j.tetlet.2014.11.026" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.11.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.11.026%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252Bspiro%252Bchromanone-tetrahydrothiophenes%252Bwith%252Bthree%252Bcontiguous%252Bstereocenters%252Bvia%252Bsulfa-Michael%25252Faldol%252Bcascade%252Breactions%26aulast%3DHu%26aufirst%3DYa-Jian%26date%3D2015%26volume%3D56%26issue%3D1%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Rajasekhar</span>, <span class="hlFld-ContribAuthor ">Malabika  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">T.  Govindaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2015,</strong> <em>51 </em>
                                    (70)
                                     , 13434-13450. <a href="https://doi.org/10.1039/C5CC05264E" title="DOI URL">https://doi.org/10.1039/C5CC05264E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC05264E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC05264E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DFunction%252Band%252Btoxicity%252Bof%252Bamyloid%252Bbeta%252Band%252Brecent%252Btherapeutic%252Binterventions%252Btargeting%252Bamyloid%252Bbeta%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DRajasekhar%26aufirst%3DK.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D70%26spage%3D13434%26epage%3D13450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos I.  Stathakis</span>, <span class="hlFld-ContribAuthor ">Efstratios  Neokosmidis</span>, <span class="hlFld-ContribAuthor ">Theocharis V.  Koftis</span>. </span><span class="cited-content_cbyCitation_article-title">A Scalable Synthesis of the Antidepressant Agomelatine by a Tandem Allylic Chlorination-Isomerization Process. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (29)
                                     , 6376-6379. <a href="https://doi.org/10.1002/ejoc.201402886" title="DOI URL">https://doi.org/10.1002/ejoc.201402886</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402886%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BScalable%252BSynthesis%252Bof%252Bthe%252BAntidepressant%252BAgomelatine%252Bby%252Ba%252BTandem%252BAllylic%252BChlorination-Isomerization%252BProcess%26aulast%3DStathakis%26aufirst%3DChristos%2BI.%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D29%26spage%3D6376%26epage%3D6379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>, <span class="hlFld-ContribAuthor ">Lina  Chan</span>, <span class="hlFld-ContribAuthor ">Malcolm P.  Huestis</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Michael  Burkard</span>, <span class="hlFld-ContribAuthor ">Mary  Geck Do</span>, <span class="hlFld-ContribAuthor ">Julie  Harris</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Sumeet  Rana</span>, <span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Guy P.A.  Vigers</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (11)
                                     , 2477-2480. <a href="https://doi.org/10.1016/j.bmcl.2014.04.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Band%252BPK%25252FPD%252Bstudies%252Bof%252Ba%252Bseries%252Bof%252Bspirocyclic%252Bpyranochromene%252BBACE1%252Binhibitors%26aulast%3DVolgraf%26aufirst%3DMatthew%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2477%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hana  Prokopcova</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (9)
                                     , 2033-2045. <a href="https://doi.org/10.1016/j.bmcl.2014.03.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.03.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bevolution%252Bof%252Bamidine-based%252Bbrain%252Bpenetrant%252BBACE1%252Binhibitors%26aulast%3DOehlrich%26aufirst%3DDaniel%26date%3D2014%26volume%3D24%26issue%3D9%26spage%3D2033%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan  Takahashi</span>, <span class="hlFld-ContribAuthor ">Shuguang  Ma</span>, <span class="hlFld-ContribAuthor ">Alan  Deese</span>, <span class="hlFld-ContribAuthor ">Qin  Yue</span>, <span class="hlFld-ContribAuthor ">Heasook  Kim-Kang</span>, <span class="hlFld-ContribAuthor ">Yijun  Yi</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Kallan</span>, <span class="hlFld-ContribAuthor ">Cornelis E.C.A.  Hop</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidating the Mechanism of Cytochrome P450–Mediated Pyrimidine Ring Conversion to Pyrazole Metabolites with the BACE1 Inhibitor GNE-892 in Rats. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2014,</strong> <em>42 </em>
                                    (5)
                                     , 890-898. <a href="https://doi.org/10.1124/dmd.114.057141" title="DOI URL">https://doi.org/10.1124/dmd.114.057141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.114.057141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.114.057141%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DElucidating%252Bthe%252BMechanism%252Bof%252BCytochrome%252BP450%2525E2%252580%252593Mediated%252BPyrimidine%252BRing%252BConversion%252Bto%252BPyrazole%252BMetabolites%252Bwith%252Bthe%252BBACE1%252BInhibitor%252BGNE-892%252Bin%252BRats%26aulast%3DTakahashi%26aufirst%3DRyan%26date%3D2014%26date%3D2014%26volume%3D42%26issue%3D5%26spage%3D890%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramón  Cacabelos</span>, <span class="hlFld-ContribAuthor ">Pablo  Cacabelos</span>, <span class="hlFld-ContribAuthor ">Clara  Torrellas</span>, <span class="hlFld-ContribAuthor ">Iván  Tellado</span>, <span class="hlFld-ContribAuthor ">Juan C.  Carril</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacogenomics of Alzheimer’s Disease: Novel Therapeutic Strategies for Drug Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 323-556. <a href="https://doi.org/10.1007/978-1-4939-0956-8_13" title="DOI URL">https://doi.org/10.1007/978-1-4939-0956-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-0956-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-0956-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacogenomics%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BNovel%252BTherapeutic%252BStrategies%252Bfor%252BDrug%252BDevelopment%26aulast%3DCacabelos%26aufirst%3DRam%25C3%25B3n%26date%3D2014%26date%3D2014%26spage%3D323%26epage%3D556%26pub%3DSpringer%2520New%2520York%26atitle%3DPharmacogenomics%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DYan%26aufirst%3DQing%26date%3D2014%26volume%3D1175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hung-Jin  Huang</span>, <span class="hlFld-ContribAuthor ">Cheng-Chun  Lee</span>, <span class="hlFld-ContribAuthor ">Calvin Yu-Chian  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico
              Design of BACE1 Inhibitor for Alzheimer’s Disease by Traditional Chinese Medicine. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2014,</strong> <em>2014 </em>, 1-14. <a href="https://doi.org/10.1155/2014/741703" title="DOI URL">https://doi.org/10.1155/2014/741703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/741703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F741703%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DIn%252BSilico%252BDesign%252Bof%252BBACE1%252BInhibitor%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bby%252BTraditional%252BChinese%252BMedicine%26aulast%3DHuang%26aufirst%3DHung-Jin%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malcolm P.  Huestis</span>, <span class="hlFld-ContribAuthor ">Wendy  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew  Volgraf</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Christine  Yu</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Darin  Smith</span>, <span class="hlFld-ContribAuthor ">Guy  Vigers</span>, <span class="hlFld-ContribAuthor ">Darrin  Dutcher</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>. </span><span class="cited-content_cbyCitation_article-title">Diethylaminosulfur trifluoride-mediated intramolecular cyclization of 2-hydroxycycloalkylureas to fused bicyclic aminooxazoline compounds and evaluation of their biochemical activity against β-secretase-1 (BACE-1). </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (43)
                                     , 5802-5807. <a href="https://doi.org/10.1016/j.tetlet.2013.07.136" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.07.136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.07.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.07.136%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDiethylaminosulfur%252Btrifluoride-mediated%252Bintramolecular%252Bcyclization%252Bof%252B2-hydroxycycloalkylureas%252Bto%252Bfused%252Bbicyclic%252Baminooxazoline%252Bcompounds%252Band%252Bevaluation%252Bof%252Btheir%252Bbiochemical%252Bactivity%252Bagainst%252B%2525CE%2525B2-secretase-1%252B%252528BACE-1%252529%26aulast%3DHuestis%26aufirst%3DMalcolm%2BP.%26date%3D2013%26volume%3D54%26issue%3D43%26spage%3D5802%26epage%3D5807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray cocrystal structure of BACE1 and <b>1a</b>. The surface of the protein is colored by electrostatic potential. Part of the flexible “flap” including Tyr14 is visible at the top of the image. The two key active site aspartic acids, Asp32 and Asp228, are also labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aminohydantoins<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) For X = O, S: (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, KCN, DMA, 80 °C. For X = CH<sub>2</sub>: (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, KCN, EtOH, 150 °C (steel pressure bomb). (b) K<sub>2</sub>CO<sub>3</sub>, RX, DMF, rt; (c) Lawesson’s reagent, toluene, reflux; (d) NH<sub>3</sub>, <sup><i>t</i></sup>BuOOH, MeOH, H<sub>2</sub>O, rt; (e) R′B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C; (f) BocNH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, THF, rt; (g) TFA, DCM, rt; (h) 5-methylfuran-2-carbonyl chloride, Et<sub>3</sub>N, DCM, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Tetrahydronaphthalone and Difluoronaphthalene Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CrO<sub>3</sub>, <sup><i>t</i></sup>BuOOH, DCM, rt; (b) 5-pyrimidinylboronic acid, PdCl<sub>2</sub>(dppf)·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C; (c) bis(2-methoxyethyl)aminosulfur trifluoride, DCE, rt.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Aminooxazoline and Aminothiazoline Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe reagent, PhMe or DCM, rt. (b) For X═O: AgOCN, I<sub>2</sub>, THF, ether, 0 °C. (c) For X═S: AgSCN, I<sub>2</sub>, THF, ether, 0 °C. (d) NH<sub>3</sub>, MeOH, THF, rt; (e) RB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aminothiazine and Aminodihydropyrimidinone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) vinylmagnesium bromide, THF, 0 °C; (b) Thionyl chloride, hexanes, 0 °C; (c) thiourea, CH<sub>3</sub>CN, 0–50 °C; (d) TFA, MsOH, 0 °C to rt; (e) 5-chloropyridine-3-boronic acid, PdCl<sub>2</sub>(dppf)·DCM, Na<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 80 °C; (f) <i><sup>t</sup></i>BuSONH<sub>2</sub>, Ti(OEt)<sub>4</sub>, THF, reflux; (g) methyl acetate, LDA, THF, −78 °C; (h) HCl, dioxane, rt; (i) EDCI, 10, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, DMF, rt.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structures of BACE1 and <b>12</b>, <b>13</b>, and <b>(</b><i><b>R</b></i><b>)-50</b>. Only density for the (<i>R</i>)-enantiomers of racemates <b>12</b> and <b>13</b> was detectable in the BACE1 protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/medium/jm-2013-002154_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0014.jpeg" id="rightTab-GRAPHIC-d639e2650-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Monkey pharmacodynamics of <b>(</b><i><b>R</b></i><b>)-50</b> (Aβ<sub>1–40</sub> lowering). CSF concentration of Aβ<sub>1–40</sub> (baseline normalized, left <i>Y</i>-axis, broken line) and <b>(</b><i><b>R</b></i><b>)-50</b> (right <i>Y</i>-axis, solid line) following single 100 mg/kg oral dose of <b>(</b><i><b>R</b></i><b>)-50</b> in cynomolgus monkeys. Data points represent mean and SD from 12 animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-8/jm4002154/production/images/large/jm-2013-002154_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4002154&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i154">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s Association.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease facts and figures</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1016%2Fj.jalz.2012.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22404854" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=131-168&author=Alzheimer%E2%80%99s+Association.&title=Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.02.001%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2012%26volume%3D8%26spage%3D131%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Comer, M.</span><span> </span><span class="NLM_article-title">French lessons: leadership in Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1016%2Fj.jalz.2008.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=19118810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FkslCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=61-65&author=M.+Comer&title=French+lessons%3A+leadership+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">French lessons: leadership in Alzheimer's disease</span></div><div class="casAuthors">Comer Meryl</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaLkaqDf7XyHqj_yg7twvpfW6udTcc2eZCDpMvEkzPP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FkslCmug%253D%253D&md5=d0518ba22a0931b1a0b6b0cee35907dd</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2008.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2008.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DComer%26aufirst%3DM.%26atitle%3DFrench%2520lessons%253A%2520leadership%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3D61%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> The response of the United States is markedly more modest: U.S. Department of Health & Human Services. National Plan To Address Alzheimer’s Disease (2nd draft). <a href="http://aspe.hhs.gov/daltcp/napa/NatlPlan.shtml" class="extLink">http://aspe.hhs.gov/daltcp/napa/NatlPlan.shtml</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+response+of+the+United+States+is+markedly+more+modest%3A+U.S.+Department+of+Health+%26+Human+Services.+National+Plan+To+Address+Alzheimer%E2%80%99s+Disease+%282nd+draft%29.+http%3A%2F%2Faspe.hhs.gov%2Fdaltcp%2Fnapa%2FNatlPlan.shtml."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jarvis, L. M.</span><span> </span><span class="NLM_article-title">Tough times for neuroscience R&D</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=22-25&author=L.+M.+Jarvis&title=Tough+times+for+neuroscience+R%26D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DL.%2BM.%26atitle%3DTough%2520times%2520for%2520neuroscience%2520R%2526D%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2012%26volume%3D90%26spage%3D22%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strooper, B. D.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+M.+Merckenauthor=B.+D.+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%2BM.%26aulast%3DStrooper%26aufirst%3DB.%2BD.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blusztajn, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: implications for initial events in amyloid plaque formation</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1006%2Fnbdi.1996.0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=9173910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK28Xis1Kqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=16-32&author=C.+A.+Lemereauthor=J.+K.+Blusztajnauthor=H.+Yamaguchiauthor=T.+Wisniewskiauthor=T.+C.+Saidoauthor=D.+J.+Selkoe&title=Sequence+of+deposition+of+heterogeneous+amyloid+beta-peptides+and+APOE+in+Down+syndrome%3A+implications+for+initial+events+in+amyloid+plaque+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation</span></div><div class="casAuthors">Lemere, C. A.; Blusztajn, J. K.; Yamaguchi, H.; Wisniewski, T.; Saido, T. C.; Selkoe, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-32</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Patients with trisomy 21 [Down syndrome (DS)] progressively develop amyloid β-protein (Aβ) deposits and then other features of Alzheimer's disease (AD), apparently due to increased gene dosage and thus expression of the β-amyloid precursor protein.  Because the neuropathol. phenotype in older DS subjects closely resembles that of AD, the examn. of DS brains of increasing age provides a unique model of the progression of AD.  Here, we characterized the deposition of several Aβ peptides and apolipoprotein E in formalin-fixed brain sections from 29 DS subjects between 3 and 73 yr old.  Amyloid plaque no. and the percentage of cortical area they occupied were quantified by computerized image anal.  Aβ ending at amino acid 42 (Aβ42) was the earliest form of Aβ deposited in DS cortex.  It was obsd. in 7 of 16 young (3-30 yr) subjects, with the earliest deposition occurring at age 12.  Aβ ending at residue 40 (Aβ40) was not detected until ∼age 30, a time when degenerating neurites around Aβ immunoreactive (IR) plaques were first obsd., and the frequency of Aβ40 IR plaques then rose with age.  Even in old (51-73 yr) DS subjects, Aβ42 IR plaques were always more abundant than Aβ40 IR plaques.  Aβ peptides starting at aspartate 1 or pyroglutamate 3 were detected in small subsets of compacted, neuritic plaques beginning around age 30 and rose with age, the latter species always exceeding the former.  Thus, the N-termini of the Aβ42 peptides abundantly deposited in very young DS subjects remain unknown.  Apo E was detectable in a small subset of Aβ42 IR plaques beginning at age 12 and rose steadily with age; it clearly followed the deposition of Aβ.  Our anal. of very young DS brains suggests that amyloid plaque formation begins with Aβ42-ending peptides, and the no. and percentage of cortical area of Aβ42 plaques increase very little with advancing age, while other heterogeneous Aβ species and Apo E progressively accrue onto plaques contg. Aβ42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqHmc60yMj5LVg90H21EOLACvtfcHk0lgmh2jf6HfmZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xis1Kqt7k%253D&md5=25f3d5a87695a498b46cd0b1deb610b6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1996.0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1996.0003%26sid%3Dliteratum%253Aachs%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DBlusztajn%26aufirst%3DJ.%2BK.%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DSequence%2520of%2520deposition%2520of%2520heterogeneous%2520amyloid%2520beta-peptides%2520and%2520APOE%2520in%2520Down%2520syndrome%253A%2520implications%2520for%2520initial%2520events%2520in%2520amyloid%2520plaque%2520formation%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1996%26volume%3D3%26spage%3D16%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Brouillette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caillierez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zommer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves-Pires, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buée, L.</span><span> </span><span class="NLM_article-title">Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β<sub>1–42</sub> oligomers are revealed in vivo by using a novel animal model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">7852</span><span class="NLM_x">–</span> <span class="NLM_lpage">7861</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1523%2FJNEUROSCI.5901-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22674261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFSmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=7852-7861&author=J.+Brouilletteauthor=R.+Caillierezauthor=N.+Zommerauthor=C.+Alves-Piresauthor=I.+Benilovaauthor=D.+Blumauthor=B.+Strooperauthor=L.+Bu%C3%A9e&title=Neurotoxicity+and+memory+deficits+induced+by+soluble+low-molecular-weight+amyloid-%CE%B21%E2%80%9342+oligomers+are+revealed+in+vivo+by+using+a+novel+animal+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model</span></div><div class="casAuthors">Brouillette, Jonathan; Caillierez, Raphaelle; Zommer, Nadege; Alves-Pires, Claire; Benilova, Iryna; Blum, David; De Strooper, Bart; Buee, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7852-7861</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal and synaptic degeneration are the best pathol. correlates for memory decline in Alzheimer's disease (AD).  Although the accumulation of sol. low-mol.-wt. amyloid-β (Aβ) oligomers has been suggested to trigger neurodegeneration in AD, animal models overexpressing or infused with Aβ lack neuronal loss at the onset of memory deficits.  Using a novel in vivo approach, we found that repeated hippocampal injections of small sol. Aβ1-42 oligomers in awake, freely moving mice were able to induce marked neuronal loss, tau hyperphosphorylation, and deficits in hippocampus-dependent memory.  The neurotoxicity of small Aβ1-42 species was obsd. in vivo as well as in vitro in assocn. with increased caspase-3 activity and reduced levels of the NMDA receptor subunit NR2B.  We found that the sequestering agent transthyretin is able to bind the toxic Aβ1-42 species and attenuated the loss of neurons and memory deficits.  Our novel mouse model provides evidence that small, sol. Aβ1-42 oligomers are able to induce extensive neuronal loss in vivo and initiate a cascade of events that mimic the key neuropathol. hallmarks of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprsaWczZqDYbVg90H21EOLACvtfcHk0lgmh2jf6HfmZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFSmu7k%253D&md5=c7d829dce0ef886cb0b2b56668552c8e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5901-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5901-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DBrouillette%26aufirst%3DJ.%26aulast%3DCaillierez%26aufirst%3DR.%26aulast%3DZommer%26aufirst%3DN.%26aulast%3DAlves-Pires%26aufirst%3DC.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DStrooper%26aufirst%3DB.%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26atitle%3DNeurotoxicity%2520and%2520memory%2520deficits%2520induced%2520by%2520soluble%2520low-molecular-weight%2520amyloid-%25CE%25B21%25E2%2580%259342%2520oligomers%2520are%2520revealed%2520in%2520vivo%2520by%2520using%2520a%2520novel%2520animal%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D7852%26epage%3D7861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lgmh2jf6HfmZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as beta-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0ljAyvC_R9vk-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520beta-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, J.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein beta-secretase from human brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=J.+Varghese&title=Purification+and+cloning+of+amyloid+precursor+protein+beta-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DVarghese%26aufirst%3DJ.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520beta-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the trans-membrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+trans-membrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520trans-membrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashier, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashierauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+beta-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashier%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">1456</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=1456-1460&author=X.+Linauthor=G.+Koelschauthor=S.+Wuauthor=D.+Downsauthor=A.+Dashtiauthor=J.+Tang&title=Human+aspartic+protease+memapsin+2+cleaves+the+beta-secretase+site+of+beta-amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DDashti%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DHuman%2520aspartic%2520protease%2520memapsin%25202%2520cleaves%2520the%2520beta-secretase%2520site%2520of%2520beta-amyloid%2520precursor%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D1456%26epage%3D1460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lhe14CHKhFAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">BACE1 is the major beta-secretase for generation of Abeta peptides by neurons</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2F85064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=11224536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=233-234&author=H.+Caiauthor=Y.+Wangauthor=D.+McCarthyauthor=H.+Wenauthor=D.+R.+Borcheltauthor=D.+L.+Priceauthor=P.+C.+Wong&title=BACE1+is+the+major+beta-secretase+for+generation+of+Abeta+peptides+by+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 is the major β-secretase for generation of Aβ peptides by neurons</span></div><div class="casAuthors">Cai, Huaibin; Wang, Yanshu; McCarthy, Diane; Wen, Hongjin; Borchelt, David R.; Price, Donald L.; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-234</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Secretion of Alzheimer's disease (AD) Aβ peptides (Aβ1-40/42 and Aβ11-40) is abolished in cultures of BACE1-deficient cortical neurons; BACE1-deficient is one of the two β-secretases involved in generating AD Aβ peptides.  This study also establishes that BACE1-deficient is the principal neuronal protease required to cleave amyloid precursor protein (APP) at the +1 and +11 sites that generate N-termini of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvJeMWCAU69rVg90H21EOLACvtfcHk0lhe14CHKhFAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbc%253D&md5=fd3d6b77770735ed2b12687281fc511e</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2F85064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85064%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMcCarthy%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DH.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DBACE1%2520is%2520the%2520major%2520beta-secretase%2520for%2520generation%2520of%2520Abeta%2520peptides%2520by%2520neurons%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D233%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.+C.+Louisauthor=Q.+Yanauthor=W.+G.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+beta-secretase%2C+have+normal+phenotype+and+abolished+beta-amyloid+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0lhe14CHKhFAiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%252C%2520have%2520normal%2520phenotype%2520and%2520abolished%2520beta-amyloid%2520generation%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roberds, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branstetter, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappenman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shopp, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintrup, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijsman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span> </span><span class="NLM_article-title">BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1093%2Fhmg%2F10.12.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=11406613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1317-1324&author=S.+L.+Roberdsauthor=J.+Andersonauthor=G.+Basiauthor=M.+J.+Bienkowskiauthor=D.+G.+Branstetterauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=N.+L.+Frigonauthor=D.+Gamesauthor=K.+Huauthor=K.+Johnson-Woodauthor=K.+E.+Kappenmanauthor=T.+T.+Kawabeauthor=I.+Kolaauthor=R.+Kuehnauthor=M.+Leeauthor=W.+Liuauthor=R.+Motterauthor=N.+F.+Nicholsauthor=M.+Powerauthor=D.+W.+Robertsonauthor=D.+Schenkauthor=M.+Schoorauthor=G.+M.+Shoppauthor=M.+E.+Shuckauthor=S.+Sinhaauthor=K.+A.+Svenssonauthor=G.+Tatsunoauthor=H.+Tintrupauthor=J.+Wijsmanauthor=S.+Wrightauthor=L.+McConlogue&title=BACE+knockout+mice+are+healthy+despite+lacking+the+primary+beta-secretase+activity+in+brain%3A+implications+for+Alzheimer%E2%80%99s+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics</span></div><div class="casAuthors">Roberds, Steven L.; Anderson, John; Basi, Guriqbal; Bienkowski, Michael J.; Branstetter, Daniel G.; Chen, Karen S.; Freedman, Stephen B.; Frigon, Normand L.; Games, Dora; Hu, Kang; Johnson-Wood, Kelly; Kappenman, Karl E.; Kawabe, Thomas T.; Kola, Ismail; Kuehn, Ralf; Lee, Michael; Liu, Weiqun; Motter, Ruth; Nichols, Nanette F.; Power, Michael; Robertson, David W.; Schenk, Dale; Schoor, Michael; Shopp, George M.; Shuck, Mary E.; Sinha, Sukanto; Svensson, Kjell A.; Tatsuno, Gwen; Tintrup, Hartmut; Wijsman, John; Wright, Sarah; McConlogue, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1317-1324</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain.  The major components of plaque, β-amyloid peptides (Aβs), are produced from amyloid precursor protein (APP) by the activity of β- and γ-secretases.  β-Secretase activity cleaves APP to define the N-terminus of the Aβ1-x peptides and, therefore, has been a long-sought therapeutic target for treatment of AD.  The gene encoding a β-secretase for beta-site APP cleaving enzyme (BACE) was identified recently.  However, it was not known whether BACE was the primary β-secretase in mammalian brain nor whether inhibition of β-secretase might have effects in mammals that would preclude its utility as a therapeutic target.  In the work described herein, the authors generated two lines of BACE knockout mice and characterized them for pathol., β-secretase activity and Aβ prodn.  These mice appeared to develop normally and showed no consistent phenotypic differences from their wild-type littermates, including overall normal tissue morphol. and brain histochem., normal blood and urine chemistries, normal blood-cell compn., and no overt behavioral and neuromuscular effects.  Brain and primary cortical cultures from BACE knockout mice showed no detectable β-secretase activity, and primary cortical cultures from BACE knockout mice produced much less Aβ from APP.  The findings that BACE is the primary β-secretase activity in brain and that loss of β-secretase activity produces no profound phenotypic defects with a concomitant redn. in β-amyloid peptide clearly indicate that BACE is an excellent therapeutic target for treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ78rSt6xEe7Vg90H21EOLACvtfcHk0lgZ6AIIvQTfUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslSrurs%253D&md5=c18a9ff9f800eebd994476badc6ec1bc</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.12.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.12.1317%26sid%3Dliteratum%253Aachs%26aulast%3DRoberds%26aufirst%3DS.%2BL.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBasi%26aufirst%3DG.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DBranstetter%26aufirst%3DD.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DFrigon%26aufirst%3DN.%2BL.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DKappenman%26aufirst%3DK.%2BE.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DKola%26aufirst%3DI.%26aulast%3DKuehn%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DNichols%26aufirst%3DN.%2BF.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DD.%2BW.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSchoor%26aufirst%3DM.%26aulast%3DShopp%26aufirst%3DG.%2BM.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTintrup%26aufirst%3DH.%26aulast%3DWijsman%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DMcConlogue%26aufirst%3DL.%26atitle%3DBACE%2520knockout%2520mice%2520are%2520healthy%2520despite%2520lacking%2520the%2520primary%2520beta-secretase%2520activity%2520in%2520brain%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1317%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T.</span><span> </span><span class="NLM_article-title">Developing β-secretase inhibitors for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1111%2Fj.1471-4159.2011.07476.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22122681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=71-83&issue=Suppl.+1&author=A.+K.+Ghoshauthor=M.+Brindisisauthor=T.+Tang&title=Developing+%CE%B2-secretase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Developing β-secretase inhibitors for treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">71-83</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  β-Secretase (memapsin 2; BACE-1) is the first protease in the processing of amyloid precursor protein leading to the prodn. of amyloid-β (Aβ) in the brain.  It is believed that high levels of brain Aβ are responsible for the pathogenesis of Alzheimer's disease (AD).  Therefore, β-secretase is a major therapeutic target for the development of inhibitor drugs.  During the past decade, steady progress has been made in the evolution of β-secretase inhibitors toward better drug properties.  Recent inhibitors are potent, selective and have been shown to penetrate the blood-brain barrier to inhibit Aβ levels in the brains of exptl. animals.  Moreover, continuous administration of a β-secretase inhibitor was shown to rescue age-related cognitive decline in transgenic AD mice.  A small no. of β-secretase inhibitors have also entered early phase clin. trials.  These developments offer some optimism for the clin. development of a disease-modifying drug for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvY0fxn2hBubVg90H21EOLACvtfcHk0lgZ6AIIvQTfUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns78%253D&md5=186d6ccadd1c207ecd7aaa9cb7584684</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07476.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07476.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisis%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DT.%26atitle%3DDeveloping%2520%25CE%25B2-secretase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl.%25201%26spage%3D71%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stachel, S. J.</span><span> </span><span class="NLM_article-title">Progress toward the development of a viable BACE-1 inhibitor</span> <span class="citation_source-journal">Drug. Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=101-110&author=S.+J.+Stachel&title=Progress+toward+the+development+of+a+viable+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520toward%2520the%2520development%2520of%2520a%2520viable%2520BACE-1%2520inhibitor%26jtitle%3DDrug.%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1002%2Fmed.20132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18651582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=295-338&author=R.+Silvestri&title=Boom+in+the+development+of+non-peptidic+beta-secretase+%28BACE1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-338</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  β-Amyloid cleaving enzyme-1 (BACE1) has become a significant target for the therapy of Alzheimer's disease.  After the discovery of the first non-peptidomimetic β-secretase inhibitors by Takeda Chems. in 2001, several research teams focused on SAR development of these agents.  The non-peptidic BACE1 inhibitors may potentially overcome the classical problems assocd. with the peptide structure of first generation, such as blood-brain barrier crossing, poor oral bioavailability and susceptibility to P-glycoprotein transport.  In the past 6 years a boom in research of non-peptidic BACE1 inhibitors has disseminated findings over hundreds of publications and patents.  The rapidly growing literature has been reviewed with particular emphasis on literature of pharmaceutical companies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpbmzl8ONz3LVg90H21EOLACvtfcHk0lgZ6AIIvQTfUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Knsbs%253D&md5=1e92f25f055def1c1c56b3650f4cc40a</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1002%2Fmed.20132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20132%26sid%3Dliteratum%253Aachs%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DBoom%2520in%2520the%2520development%2520of%2520non-peptidic%2520beta-secretase%2520%2528BACE1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D295%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkateswara Rao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavande, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzyan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Structure-based design of highly selective β-secretase inhibitors: synthesis, biological evaluation, and protein–ligand X-ray crystal structure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9195</span><span class="NLM_x">–</span> <span class="NLM_lpage">9207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3008823" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9195-9207&author=A.+K.+Ghoshauthor=K.+Venkateswara+Raoauthor=N.+D.+Yadavauthor=D.+D.+Andersonauthor=N.+Gavandeauthor=X.+Huangauthor=S.+Terzyanauthor=J.+Tang&title=Structure-based+design+of+highly+selective+%CE%B2-secretase+inhibitors%3A+synthesis%2C+biological+evaluation%2C+and+protein%E2%80%93ligand+X-ray+crystal+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1021%2Fjm3008823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008823%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DVenkateswara%2BRao%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DN.%2BD.%26aulast%3DAnderson%26aufirst%3DD.%2BD.%26aulast%3DGavande%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DTerzyan%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520highly%2520selective%2520%25CE%25B2-secretase%2520inhibitors%253A%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520protein%25E2%2580%2593ligand%2520X-ray%2520crystal%2520structure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9195%26epage%3D9207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriemen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span> </span><span class="NLM_article-title">A potent and orally efficacious, hydroxyethylamine-based inhibitor of β-secretase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3000148" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=886-891&author=M.+R.+Kallerauthor=S.+S.+Harriedauthor=B.+Albrechtauthor=P.+Amaranteauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=R.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+Graceffaauthor=C.+Hickmanauthor=T.+Juddauthor=C.+Kriemenauthor=D.+Laauthor=V.+Liauthor=P.+Lopezauthor=Y.+Luoauthor=C.+Masseauthor=H.+Monenscheinauthor=T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=T.+Williamsonauthor=S.+Woodauthor=M.+Xueauthor=B.+Yangauthor=J.+Zhangauthor=V.+Patelauthor=W.+Zhongauthor=S.+Hitchcock&title=A+potent+and+orally+efficacious%2C+hydroxyethylamine-based+inhibitor+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1021%2Fml3000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000148%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DAlbrecht%26aufirst%3DB.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DC.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKriemen%26aufirst%3DC.%26aulast%3DLa%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHitchcock%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520efficacious%252C%2520hydroxyethylamine-based%2520inhibitor%2520of%2520%25CE%25B2-secretase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D886%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11g"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambroise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer’s disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9224</span><span class="NLM_x">–</span> <span class="NLM_lpage">9239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9224-9239&author=M.+A.+Brodneyauthor=G.+Barreiroauthor=K.+Ogilvieauthor=E.+Hajos-Korcsokauthor=J.+Murrayauthor=F.+Vajdosauthor=C.+Ambroiseauthor=C.+Christoffersenauthor=K.+Fisherauthor=L.+Lanyonauthor=J.+Liuauthor=C.+E.+Nolanauthor=J.+M.+Withkaauthor=K.+A.+Borzilleriauthor=I.+Efremovauthor=C.+E.+Oborskiauthor=A.+Vargheseauthor=B.+T.+O%E2%80%99Neill&title=Spirocyclic+sulfamides+as+%CE%B2-secretase+1+%28BACE-1%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+utilization+of+structure+based+drug+design%2C+WaterMap%2C+and+CNS+penetration+studies+to+identify+centrally+efficacious+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1021%2Fjm3009426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009426%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DAmbroise%26aufirst%3DC.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DVarghese%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DSpirocyclic%2520sulfamides%2520as%2520%25CE%25B2-secretase%25201%2520%2528BACE-1%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520utilization%2520of%2520structure%2520based%2520drug%2520design%252C%2520WaterMap%252C%2520and%2520CNS%2520penetration%2520studies%2520to%2520identify%2520centrally%2520efficacious%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9224%26epage%3D9239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgaG0bO95QiVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brankov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makhija, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmerhorst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadimitriou, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakoczy, P. E.</span><span> </span><span class="NLM_article-title">Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3031</span><span class="NLM_x">–</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=3031-3038&author=D.+Zhangauthor=M.+Brankovauthor=M.+T.+Makhijaauthor=T.+Robertsonauthor=E.+Helmerhorstauthor=J.+M.+Papadimitriouauthor=P.+E.+Rakoczy&title=Correlation+between+inactive+cathepsin+D+expression+and+retinal+changes+in+mcd2%2Fmcd2+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DBrankov%26aufirst%3DM.%26aulast%3DMakhija%26aufirst%3DM.%2BT.%26aulast%3DRobertson%26aufirst%3DT.%26aulast%3DHelmerhorst%26aufirst%3DE.%26aulast%3DPapadimitriou%26aufirst%3DJ.%2BM.%26aulast%3DRakoczy%26aufirst%3DP.%2BE.%26atitle%3DCorrelation%2520between%2520inactive%2520cathepsin%2520D%2520expression%2520and%2520retinal%2520changes%2520in%2520mcd2%252Fmcd2%2520transgenic%2520mice%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2005%26volume%3D46%26spage%3D3031%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koike, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Schaeffer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waguri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kametaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kominami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Figura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, Y.</span><span> </span><span class="NLM_article-title">Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">6898</span><span class="NLM_x">–</span> <span class="NLM_lpage">6906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=6898-6906&author=M.+Koikeauthor=H.+Nakanishiauthor=P.+Saftigauthor=J.+Ezakiauthor=K.+Isaharaauthor=Y.+Ohsawaauthor=W.+Schulz-Schaefferauthor=T.+Watanabeauthor=S.+Waguriauthor=S.+Kametakaauthor=M.+Shibataauthor=K.+Yamamotoauthor=E.+Kominamiauthor=C.+Petersauthor=K.+von+Figuraauthor=Y.+Uchiyama&title=Cathepsin+D+deficiency+induces+lysosomal+storage+with+ceroid+lipofuscin+in+mouse+CNS+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoike%26aufirst%3DM.%26aulast%3DNakanishi%26aufirst%3DH.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DEzaki%26aufirst%3DJ.%26aulast%3DIsahara%26aufirst%3DK.%26aulast%3DOhsawa%26aufirst%3DY.%26aulast%3DSchulz-Schaeffer%26aufirst%3DW.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DWaguri%26aufirst%3DS.%26aulast%3DKametaka%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DKominami%26aufirst%3DE.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3Dvon%2BFigura%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DY.%26atitle%3DCathepsin%2520D%2520deficiency%2520induces%2520lysosomal%2520storage%2520with%2520ceroid%2520lipofuscin%2520in%2520mouse%2520CNS%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D15%26spage%3D6898%26epage%3D6906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmahl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mossmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Figura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span> </span><span class="NLM_article-title">Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3599</span><span class="NLM_x">–</span> <span class="NLM_lpage">3608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=3599-3608&author=P.+Saftigauthor=M.+Hetmanauthor=W.+Schmahlauthor=K.+Weberauthor=L.+Heineauthor=H.+Mossmannauthor=A.+K%C3%B6sterauthor=B.+Hessauthor=M.+Eversauthor=K.+von+Figuraauthor=C.+Peters&title=Mice+deficient+for+the+lysosomal+proteinase+cathepsin+D+exhibit+progressive+atrophy+of+the+intestinal+mucosa+and+profound+destruction+of+lymphoid+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHetman%26aufirst%3DM.%26aulast%3DSchmahl%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DK.%26aulast%3DHeine%26aufirst%3DL.%26aulast%3DMossmann%26aufirst%3DH.%26aulast%3DK%25C3%25B6ster%26aufirst%3DA.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DEvers%26aufirst%3DM.%26aulast%3Dvon%2BFigura%26aufirst%3DK.%26aulast%3DPeters%26aufirst%3DC.%26atitle%3DMice%2520deficient%2520for%2520the%2520lysosomal%2520proteinase%2520cathepsin%2520D%2520exhibit%2520progressive%2520atrophy%2520of%2520the%2520intestinal%2520mucosa%2520and%2520profound%2520destruction%2520of%2520lymphoid%2520cells%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26spage%3D3599%26epage%3D3608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschlich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">Blood–brain barrier permeation: molecular parameters governing passive diffusion</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1007%2Fs002329900434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=9767674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=1998&pages=201-211&author=H.+Fischerauthor=R.+Gottschlichauthor=A.+Seelig&title=Blood%E2%80%93brain+barrier+permeation%3A+molecular+parameters+governing+passive+diffusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier permeation: molecular parameters governing passive diffusion</span></div><div class="casAuthors">Fischer, H.; Gottschlich, R.; Seelig, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">Fifty-three compds. with clin. established ability to cross or not to cross the blood-brain barrier by passive diffusion were characterized by means of surface activity measurements in terms of three parameters, i.e., the air-water partition coeff., Kaw, the crit. micelle concn., CMCD, and the cross-sectional area, AD.  A three-dimensional plot in which the surface area, AD, is plotted as a function of Kaw-1 and CMCD shows essentially three groups of compds.: (i) very hydrophobic compds. with large air-water partition coeffs. and large cross-sectional areas, AD > 80 Å2, which do not cross the blood-brain barrier, (ii) compds. with lower air-water partition coeffs. and an av. cross-sectional area, AD ≃ 50 Å2, which easily cross the blood-brain barrier, and (iii) hydrophilic compds. with low air-water partition coeffs. (AD < 50 Å2) which cross the blood-brain barrier only if applied at high concns.  It was shown that the lipid membrane-water partition coeff., Klw, measured previously, can be correlated with the air-water partition coeff. if the addnl. work against the internal lateral bilayer pressure, πbi = 34 ± 4 mN/m, is taken into account.  The partitioning into anisotropic lipid membranes decreases exponentially with increasing cross-sectional areas, AD, according to Klw = const. Kaw exp(-ADπbi/kT), where kT is the thermal energy.  The cross-sectional area of the mol. oriented at a hydrophilic-hydrophobic interface is thus the main determinant for membrane permeation provided the mol. is surface active and has a pKa > 4 for acids and a pKa < 10 for bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvYrDWv9GpI7Vg90H21EOLACvtfcHk0lgaG0bO95QiVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D&md5=a549eaf6f7ce81af291868899e3d0ab0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs002329900434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900434%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DGottschlich%26aufirst%3DR.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520permeation%253A%2520molecular%2520parameters%2520governing%2520passive%2520diffusion%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1998%26volume%3D165%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Properties estimated with ChemDraw Ultra, version 12.0.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebuMnmaRTDtRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljCdoUsSfgtBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0ljCdoUsSfgtBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.-M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.-L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lgy7Z29vAFSzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28a%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528a%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17g&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17gR"><div class="casContent"><span class="casTitleNuber">17g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lixrdTHJFZ2Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit17g&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+Ohbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17hR"><div class="casContent"><span class="casTitleNuber">17h</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0lixrdTHJFZ2Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit17h&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DOhberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17i&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17i&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17i&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17iR"><div class="casContent"><span class="casTitleNuber">17i</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0liZVDFRU3E2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit17i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17j&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17jR"><div class="casContent"><span class="casTitleNuber">17j</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0liZVDFRU3E2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit17j&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0liZVDFRU3E2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0liysAGcGCZjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">In a recent patent review, spirocyclic molecules from a Vitae patent application were disclosed:</p></div><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. Z.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Z.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0liysAGcGCZjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%2BZ.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Buckle, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houge-Frydrych, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedder, J. M.</span><span> </span><span class="NLM_article-title">Relaxant activity of 4-amido-3,4-dihydro-2<i>H</i>-1-benzopyran-3-ols and 4-amido-2<i>H</i>-1-benzopyrans on guinea pig isolated trachealis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00173a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=3028-3034&author=D.+R.+Buckleauthor=J.+R.+Archauthor=A.+E.+Fenwickauthor=C.+S.+Houge-Frydrychauthor=I.+L.+Pintoauthor=D.+G.+Smithauthor=S.+G.+Taylorauthor=J.+M.+Tedder&title=Relaxant+activity+of+4-amido-3%2C4-dihydro-2H-1-benzopyran-3-ols+and+4-amido-2H-1-benzopyrans+on+guinea+pig+isolated+trachealis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm00173a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00173a019%26sid%3Dliteratum%253Aachs%26aulast%3DBuckle%26aufirst%3DD.%2BR.%26aulast%3DArch%26aufirst%3DJ.%2BR.%26aulast%3DFenwick%26aufirst%3DA.%2BE.%26aulast%3DHouge-Frydrych%26aufirst%3DC.%2BS.%26aulast%3DPinto%26aufirst%3DI.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DTaylor%26aufirst%3DS.%2BG.%26aulast%3DTedder%26aufirst%3DJ.%2BM.%26atitle%3DRelaxant%2520activity%2520of%25204-amido-3%252C4-dihydro-2H-1-benzopyran-3-ols%2520and%25204-amido-2H-1-benzopyrans%2520on%2520guinea%2520pig%2520isolated%2520trachealis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D3028%26epage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vuligonda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standeven, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandraratna, R. A.</span><span> </span><span class="NLM_article-title">A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=743-748&author=V.+Vuligondaauthor=A.+M.+Standevenauthor=M.+Escobarauthor=R.+A.+Chandraratna&title=A+new+class+of+potent+RAR+antagonists%3A+dihydroanthracenyl%2C+benzochromenyl+and+benzothiochromenyl+retinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVuligonda%26aufirst%3DV.%26aulast%3DStandeven%26aufirst%3DA.%2BM.%26aulast%3DEscobar%26aufirst%3DM.%26aulast%3DChandraratna%26aufirst%3DR.%2BA.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520RAR%2520antagonists%253A%2520dihydroanthracenyl%252C%2520benzochromenyl%2520and%2520benzothiochromenyl%2520retinoids%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D743%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassidy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagliardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span> </span><span class="NLM_article-title">Synthesis and antihypertensive activity of pyran oxygen and amide nitrogen replacement analogues of the potassium channel activator cromakalim</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">3261</span><span class="NLM_x">–</span> <span class="NLM_lpage">3267</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00115a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=3261-3267&author=V.+A.+Ashwoodauthor=F.+Cassidyauthor=J.+M.+Evansauthor=S.+Gagliardiauthor=G.+Stemp&title=Synthesis+and+antihypertensive+activity+of+pyran+oxygen+and+amide+nitrogen+replacement+analogues+of+the+potassium+channel+activator+cromakalim"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjm00115a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00115a015%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DCassidy%26aufirst%3DF.%26aulast%3DEvans%26aufirst%3DJ.%2BM.%26aulast%3DGagliardi%26aufirst%3DS.%26aulast%3DStemp%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520antihypertensive%2520activity%2520of%2520pyran%2520oxygen%2520and%2520amide%2520nitrogen%2520replacement%2520analogues%2520of%2520the%2520potassium%2520channel%2520activator%2520cromakalim%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D3261%26epage%3D3267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wittekind, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poos, G. I.</span><span> </span><span class="NLM_article-title">Ring cleavage reactions of <i>trans</i>-2-amino-3a,4,5,6,7,7a-hexahydrobenzoxazole</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1960&pages=444-446&author=R.+R.+Wittekindauthor=J.+D.+Rosenauauthor=G.+I.+Poos&title=Ring+cleavage+reactions+of+trans-2-amino-3a%2C4%2C5%2C6%2C7%2C7a-hexahydrobenzoxazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittekind%26aufirst%3DR.%2BR.%26aulast%3DRosenau%26aufirst%3DJ.%2BD.%26aulast%3DPoos%26aufirst%3DG.%2BI.%26atitle%3DRing%2520cleavage%2520reactions%2520of%2520trans-2-amino-3a%252C4%252C5%252C6%252C7%252C7a-hexahydrobenzoxazole%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1960%26volume%3D26%26spage%3D444%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cohen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, B. L.</span><span> </span><span class="NLM_article-title">Synthesis of 2-amino-5,6-didydro-4<i>H</i>-1,3-thiazines and related compounds by acid catalyzed cyclization of allylic isothiuronium salts</span> <span class="citation_source-journal">J. Heterocycl. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1977&pages=717-23&author=N.+Cohenauthor=B.+L.+Banner&title=Synthesis+of+2-amino-5%2C6-didydro-4H-1%2C3-thiazines+and+related+compounds+by+acid+catalyzed+cyclization+of+allylic+isothiuronium+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DN.%26aulast%3DBanner%26aufirst%3DB.%2BL.%26atitle%3DSynthesis%2520of%25202-amino-5%252C6-didydro-4H-1%252C3-thiazines%2520and%2520related%2520compounds%2520by%2520acid%2520catalyzed%2520cyclization%2520of%2520allylic%2520isothiuronium%2520salts%26jtitle%3DJ.%2520Heterocycl.%2520Chem%26date%3D1977%26volume%3D14%26spage%3D717%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Asymmetric synthesis of α-amino acid derivatives incorporating a broad range of substitution patterns by enolate additions to <i>tert</i>-butanesulfinyl imines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">7819</span><span class="NLM_x">–</span> <span class="NLM_lpage">7832</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo025957u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=7819-7832&author=T.+P.+Tangauthor=J.+A.+Ellman&title=Asymmetric+synthesis+of+%CE%B1-amino+acid+derivatives+incorporating+a+broad+range+of+substitution+patterns+by+enolate+additions+to+tert-butanesulfinyl+imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo025957u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025957u%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%25CE%25B1-amino%2520acid%2520derivatives%2520incorporating%2520a%2520broad%2520range%2520of%2520substitution%2520patterns%2520by%2520enolate%2520additions%2520to%2520tert-butanesulfinyl%2520imines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D7819%26epage%3D7832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The preference for phenyl meta substitution and the 3-pyridyl interaction with the Ser229 bridging water molecule parallels the findings of biaryl and nonspirocyclic cores. See ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">We found several (but not all) literature compounds to be much more potent against CatD in our assay than reported. Furthermore, outsourced CatD assays were found to be unreliable, as analogue <b>(</b><i><b>R</b></i><b>)-34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, 1.7 μM vs CatD) was found to be inactive at 30 μM at two contract research organizations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Fernandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gattass, C. R.</span><span> </span><span class="NLM_article-title">Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1/ABCC1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1214</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801389m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1214-1218&author=J.+Fernandesauthor=C.+R.+Gattass&title=Topological+polar+surface+area+defines+substrate+transport+by+multidrug+resistance+associated+protein+1+%28MRP1%2FABCC1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Topological Polar Surface Area Defines Substrate Transport by Multidrug Resistance Associated Protein 1 (MRP1/ABCC1)</span></div><div class="casAuthors">Fernandes, Janaina; Gattass, Cerli R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1214-1218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance-assocd. protein 1 (MRP1/ABCC1) is a very promiscuous transporter.  Herein we used topol. polar surface area (TPSA), a descriptor defined as the sum of surfaces of polar atoms in a mol., to analyze drug transport by MRP1.  We suggested that compds. with high TPSA are transported while those with low TPSA are not.  The conjugation to GSH increases TPSA values favoring transport.  A strong correlation between TPSA and transport properties (Km) was also found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURdbfCvdSBrVg90H21EOLACvtfcHk0li6-Ta8wnXqHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWgurY%253D&md5=b1791be3b8836619e55d716716d3a85a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm801389m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801389m%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DJ.%26aulast%3DGattass%26aufirst%3DC.%2BR.%26atitle%3DTopological%2520polar%2520surface%2520area%2520defines%2520substrate%2520transport%2520by%2520multidrug%2520resistance%2520associated%2520protein%25201%2520%2528MRP1%252FABCC1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1214%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">The p<i>K</i><sub>a</sub> of the 2-aminoheterocycles may play a role: </p></div><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine p<i>K</i><sub>a</sub> in enzyme inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1885-1889&author=H.+A.+Rajapakseauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=J.+C.+Barrowauthor=G.+B.+McGaugheyauthor=S.+Munshiauthor=S.+R.+Lindsleyauthor=M.+B.+Youngauthor=P.+L.+Ngoauthor=M.+K.+Hollowayauthor=M.+T.+Laiauthor=A.+S.+Espesethauthor=X.+P.+Shiauthor=D.+Colussiauthor=B.+Pietrakauthor=M.+C.+Crouthamelauthor=K.+Tugushevaauthor=Q.+Huangauthor=M.+Xuauthor=A.+J.+Simonauthor=L.+Kuoauthor=D.+J.+Hazudaauthor=S.+Grahamauthor=J.+P.+Vacca&title=SAR+of+tertiary+carbinamine+derived+BACE1+inhibitors%3A+role+of+aspartate+ligand+amine+pKa+in+enzyme+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DSAR%2520of%2520tertiary%2520carbinamine%2520derived%2520BACE1%2520inhibitors%253A%2520role%2520of%2520aspartate%2520ligand%2520amine%2520pKa%2520in%2520enzyme%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1885%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lhbXXiUUJmaAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Compounds with medium to high permeability (<i>P</i><sub>app</sub> > 4) demonstrated acceptable pharmacokinetics. Compounds with low permeability (<i>P</i><sub>app</sub> < 4) were not generally evaluated in pharmacokinetic studies.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Preliminary experiments indicate a role for aldehyde oxidase in the CL of pyridine and pyrimidine moieties.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Beck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span> </span><span class="NLM_article-title">Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1023%2FA%3A1022850113083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=12675155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFars7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=637-644&author=M.+Beckauthor=V.+Biglauthor=S.+Rossner&title=Guinea+pigs+as+a+nontransgenic+model+for+APP+processing+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Guinea Pigs as a Nontransgenic Model for APP Processing in Vitro and in Vivo</span></div><div class="casAuthors">Beck, Mike; Bigl, Volker; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">637-644</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized, amongst others, by the appearance of vascular and parenchymal β-amyloid deposits in brain.  Such aggregates are mainly composed of β-amyloid peptides, which are derived by proteolytic processing of a larger amyloid precursor protein (APP).  APP is highly conserved among mammalian species, but exptl. studies in rodents are often hampered by the humble APP-processing in the amyloidogenic pathway and by the inability of rodent β-amyloid peptides to form higher mol. aggregates such as sol. oligomers and insol. β-amyloid plaques.  Thus, there is need for in vitro and in vivo model systems that allow identification of factors that increase amyloidogenic APP processing and accelerate β-amyloid plaque formation and testing the potency of pharmacol. manipulations to ameliorate β-amyloid load in brain.  Transgenic mice that overexpress human APP contg. AD-assocd. mutations that favor the amyloidogenic pathway of APP processing represent such a model.  However, mutations of the APP gene are not frequent in AD and, therefore, the mechanisms of β-amyloid plaque formation, the compn. of β-amyloid plaques, and the accompanying tissue response in brain of these animals may be different from that in AD.  In contrast, guinea pigs express β-amyloid peptides of the human sequence and appear to represent a more physiol. model to examine the long-term effects of exptl. manipulations on APP processing and β-amyloid plaque formation in vivo.  Addnl., APP processing in guinea pig primary neuronal cultures has been shown to be similar to cultures of human origin.  In this article we highlight the advantages and limitations of using guinea pigs as exptl. models to study APP processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFL4QNBkRjrVg90H21EOLACvtfcHk0lhbXXiUUJmaAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFars7s%253D&md5=1c574bca3392c3faeb7b177adfc962fa</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022850113083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022850113083%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DBigl%26aufirst%3DV.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGuinea%2520pigs%2520as%2520a%2520nontransgenic%2520model%2520for%2520APP%2520processing%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DNeurochem.%2520Res.%26date%3D2003%26volume%3D28%26spage%3D637%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagishita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiura, S.</span><span> </span><span class="NLM_article-title">β-Secretase inhibitor potency is decreased by aberrant β-cleavage location of the “Swedish mutant” amyloid precursor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1634</span><span class="NLM_x">–</span> <span class="NLM_lpage">1642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=1634-1642&author=H.+Yamakawaauthor=S.+Yagishitaauthor=E.+Futaiauthor=S.+Ishiura&title=%CE%B2-Secretase+inhibitor+potency+is+decreased+by+aberrant+%CE%B2-cleavage+location+of+the+%E2%80%9CSwedish+mutant%E2%80%9D+amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamakawa%26aufirst%3DH.%26aulast%3DYagishita%26aufirst%3DS.%26aulast%3DFutai%26aufirst%3DE.%26aulast%3DIshiura%26aufirst%3DS.%26atitle%3D%25CE%25B2-Secretase%2520inhibitor%2520potency%2520is%2520decreased%2520by%2520aberrant%2520%25CE%25B2-cleavage%2520location%2520of%2520the%2520%25E2%2580%259CSwedish%2520mutant%25E2%2580%259D%2520amyloid%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D1634%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1038%2Fnm1295-1291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=7489411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1291-1296&author=C.+Haassauthor=C.+A.+Lemereauthor=A.+Capellauthor=M.+Citronauthor=P.+Seubertauthor=D.+Schenkauthor=L.+Lannfeltauthor=D.+J.+Selkoe&title=The+Swedish+mutation+causes+early-onset+Alzheimer%E2%80%99s+disease+by+%CE%B2-secretase+cleavage+within+the+secretory+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway</span></div><div class="casAuthors">Haass, Christian; Lemere, Cynthia A.; Capell, Anja; Citron, Martin; Seubert, Peter; Schenk, Dale; Lannfelt, Lars; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1291-6</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the β-amyloid precursor protein (βAPP).  A double mutation found in a Swedish family is located before the amyloid β-peptide (Aβ) region of βAPP and results in the increased prodn. and secretion of Aβ.  Here the authors show that the increased prodn. of Aβ results from a cellular mechanism, which differs substantially from that responsible for the prodn. of Aβ from wild-type βAPP.  In the latter case, Aβ generation requires reinternalization and recycling of βAPP.  In the case of the Swedish mutation the N-terminal β-secretase cleavage of Aβ occurs in Golgi-derived vesicles, most likely within secretory vesicles.  Therefore, this cleavage occurs in the same compartment as the α-secretase cleavage, which normally prevents Aβ prodn., explaining the increased Aβ generation by a competition between α- and β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwY2_Dmv4aPrVg90H21EOLACvtfcHk0lhbXXiUUJmaAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D&md5=af21095fbb11e8dfc6ffb0b9f9afb38b</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1038%2Fnm1295-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1295-1291%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DCapell%26aufirst%3DA.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Swedish%2520mutation%2520causes%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520%25CE%25B2-secretase%2520cleavage%2520within%2520the%2520secretory%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D1291%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">The γ-secretase inhibitor semagacestat was utilized for assay validation, providing 58% CSF Aβ reduction at 3 h with a 60 mg/kg oral dose in guinea pig.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv, E.</span><span> </span><span class="NLM_article-title">Cathepsins S, B and L with aminopeptidases display β-secretase activity associated with the pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=2011&pages=555-69&author=I.+Schechterauthor=E.+Ziv&title=Cathepsins+S%2C+B+and+L+with+aminopeptidases+display+%CE%B2-secretase+activity+associated+with+the+pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DZiv%26aufirst%3DE.%26atitle%3DCathepsins%2520S%252C%2520B%2520and%2520L%2520with%2520aminopeptidases%2520display%2520%25CE%25B2-secretase%2520activity%2520associated%2520with%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiol.%2520Chem.%26date%3D2011%26volume%3D392%26spage%3D555%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hook, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funkelstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hook, G.</span><span> </span><span class="NLM_article-title">Cysteine Cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer’s disease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1824</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=89-104&author=V.+Hookauthor=L.+Funkelsteinauthor=J.+Wegrzynauthor=S.+Barkauthor=M.+Kindyauthor=G.+Hook&title=Cysteine+Cathepsins+in+the+secretory+vesicle+produce+active+peptides%3A+cathepsin+L+generates+peptide+neurotransmitters+and+cathepsin+B+produces+beta-amyloid+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHook%26aufirst%3DV.%26aulast%3DFunkelstein%26aufirst%3DL.%26aulast%3DWegrzyn%26aufirst%3DJ.%26aulast%3DBark%26aufirst%3DS.%26aulast%3DKindy%26aufirst%3DM.%26aulast%3DHook%26aufirst%3DG.%26atitle%3DCysteine%2520Cathepsins%2520in%2520the%2520secretory%2520vesicle%2520produce%2520active%2520peptides%253A%2520cathepsin%2520L%2520generates%2520peptide%2520neurotransmitters%2520and%2520cathepsin%2520B%2520produces%2520beta-amyloid%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2012%26volume%3D1824%26spage%3D89%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+an+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0lhUrwVQRc_T4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520an%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D,A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+Debartoloauthor=D%2CA.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0lhUrwVQRc_T4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDebartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD%252CA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Sarasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedro, P.</span><span> </span><span class="NLM_article-title">Natural non-transgenic animal models for research in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.2174%2F156720509787602834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=19355852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Ois7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=171-178&author=M.+Sarasaauthor=P.+Pedro&title=Natural+non-transgenic+animal+models+for+research+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Non-transgenic animal models for research in Alzheimer's disease</span></div><div class="casAuthors">Sarasa, Manuel; Pesini, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The most common animal models currently used for Alzheimer disease (AD) research are transgenic mice that express a mutant form of human Aβ precursor protein (APP) and/or some of the enzymes implicated in their metabolic processing.  However, these transgenic mice carry their own APP and APP-processing enzymes, which may interfere in the prodn. of different amyloid-beta (Aβ) peptides encoded by the human transgenes.  Addnl., the genetic backgrounds of the different transgenic mice are a possible confounding factor with regard to crucial aspects of AD that they may (or may not) reproduce.  Thus, although the usefulness of transgenic mice is undisputed, we hypothesized that addnl. relevant information on the physiopathol. of AD could be obtained from other natural non-transgenic models.  We have analyzed the chick embryo and the dog, which may be better exptl. models because their enzymic machinery for processing APP is almost identical to that of humans.  The chick embryo is extremely easy to access and manipulate.  It could be an advantageous natural model in which to study the cell biol. and developmental function of APP and a potential assay system for drugs that regulate APP processing.  The dog suffers from an age-related syndrome of cognitive dysfunction that naturally reproduces key aspects of AD including Aβ cortical pathol., neuronal degeneration and learning and memory disabilities.  However, dense core neuritic plaques and neurofibrillary tangles have not been consistently demonstrated in the dog.  Thus, these species may be natural models with which to study the biol. of AD, and could also serve as assay systems for Aβ-targeted drugs or new therapeutic strategies against this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqisxU0H5w3y7Vg90H21EOLACvtfcHk0lhUrwVQRc_T4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Ois7o%253D&md5=85b170622b0ee4a7b6f387813fc9d021</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F156720509787602834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720509787602834%26sid%3Dliteratum%253Aachs%26aulast%3DSarasa%26aufirst%3DM.%26aulast%3DPedro%26aufirst%3DP.%26atitle%3DNatural%2520non-transgenic%2520animal%2520models%2520for%2520research%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2009%26volume%3D6%26spage%3D171%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The γ-secretase inhibitor semagacestat was utilized for assay validation, providing 40% CSF Aβ reduction at 3 h with a 60 mg/kg oral dose in rat.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span> </span><span class="NLM_article-title">Demystifying brain penetration in central nervous system drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301297f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2-12&author=L.+Diauthor=H.+Rongauthor=B.+Feng&title=Demystifying+brain+penetration+in+central+nervous+system+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Demystifying Brain Penetration in Central Nervous System Drug Discovery</span></div><div class="casAuthors">Di, Li; Rong, Haojing; Feng, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This Perspective provides important concepts about the blood-brain barrier (BBB) in drug discovery and how they should be applied effectively in designing successful CNS drugs.  Key parameters for brain penetration are discussed, including unbound brain concn., unbound brain-to-plasma ratio, BBB permeability, fraction unbound in brain and plasma, and transporters.  Results from a retrospective anal. of 32 Pfizer CNS clin. drug candidates are described.  Frequently encountered misconceptions about brain penetration in drug discovery programs are clarified.  Strategies and guidance are provided to enhance or minimize brain exposure for CNS or peripheral targets, resp.  Recommendations for screening methodologies and a cascade in assessing brain penetration potential are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmurs7cfju37Vg90H21EOLACvtfcHk0liANuqBUDoIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrJ&md5=8b88e2044bf41898ab40c45e18f2a20d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301297f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301297f%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DDemystifying%2520brain%2520penetration%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devanarayan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregro, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbeiser, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swestock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span> </span><span class="NLM_article-title">First demonstration of cerebrospinal fluid and plasma Aβ lowering with oral administration of a β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1124%2Fjpet.108.143628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18854490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFyltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=131-140&author=S.+Sankaranarayananauthor=M.+A.+Holahanauthor=D.+Colussiauthor=M.+C.+Crouthamelauthor=V.+Devanarayanauthor=J.+Ellisauthor=A.+Espesethauthor=A.+T.+Gatesauthor=S.+L.+Grahamauthor=A.+R.+Gregroauthor=D.+Hazudaauthor=J.+H.+Hochmanauthor=K.+Hollowayauthor=L.+Jinauthor=J.+Kahanaauthor=M.+T.+Laiauthor=J.+Linebergerauthor=G.+McGaugheyauthor=K.+P.+Mooreauthor=P.+Nantermetauthor=B.+Pietrakauthor=E.+A.+Priceauthor=H.+Rajapakseauthor=S.+Staufferauthor=M.+A.+Steinbeiserauthor=G.+Seabrookauthor=H.+G.+Selnickauthor=X.+P.+Shiauthor=M.+G.+Stantonauthor=J.+Swestockauthor=K.+Tugushevaauthor=K.+X.+Tylerauthor=J.+P.+Vaccaauthor=J.+Wongauthor=G.+Wuauthor=M.+Xuauthor=J.+J.+Cookauthor=A.+J.+Simon&title=First+demonstration+of+cerebrospinal+fluid+and+plasma+A%CE%B2+lowering+with+oral+administration+of+a+%CE%B2-site+amyloid+precursor+protein-cleaving+enzyme+1+inhibitor+in+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">First demonstration of cerebrospinal fluid and plasma Aβ lowering with oral administration of a β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates</span></div><div class="casAuthors">Sankaranarayanan, Sethu; Holahan, Marie A.; Colussi, Dennis; Crouthamel, Ming-Chih; Devanarayan, Viswanath; Ellis, Joan; Espeseth, Amy; Gates, Adam T.; Graham, Samuel L.; Gregro, Allison R.; Hazuda, Daria; Hochman, Jerome H.; Holloway, Katharine; Jin, Lixia; Kahana, Jason; Lai, Ming-tain; Lineberger, Janet; McGaughey, Georgia; Moore, Keith P.; Nantermet, Philippe; Pietrak, Beth; Price, Eric A.; Rajapakse, Hemaka; Stauffer, Shaun; Steinbeiser, Melissa A.; Seabrook, Guy; Selnick, Harold G.; Shi, Xiao-Ping; Stanton, Matthew G.; Swestock, John; Tugusheva, Katherine; Tyler, Keala X.; Vacca, Joseph P.; Wong, Jacky; Wu, Guoxin; Xu, Min; Cook, Jacquelynn J.; Simon, Adam J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-140</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein (APP)-cleaving enzyme (BACE) 1 cleavage of amyloid precursor protein is an essential step in the generation of the potentially neurotoxic and amyloidogenic Aβ42 peptides in Alzheimer's disease.  Although previous mouse studies have shown brain Aβ lowering after BACE1 inhibition, extension of such studies to nonhuman primates or man was precluded by poor potency, brain penetration, and pharmacokinetics of available inhibitors.  In this study, a novel tertiary carbinamine BACE1 inhibitor, tertiary carbinamine (TC)-1, was assessed in a unique cisterna magna ported rhesus monkey model, where the temporal dynamics of Aβ in cerebrospinal fluid (CSF) and plasma could be evaluated.  TC-1, a potent inhibitor (IC50 ∼ 0.4 nM), has excellent passive membrane permeability, low susceptibility to P-glycoprotein transport, and lowered brain Aβ levels in a mouse model.  I.v. infusion of TC-1 led to a significant but transient lowering of CSF and plasma Aβ levels in conscious rhesus monkeys because it underwent CYP3A4-mediated metab.  Oral codosing of TC-1 with ritonavir, a potent CYP3A4 inhibitor, twice daily over 3.5 days in rhesus monkeys led to sustained plasma TC-1 exposure and a significant and sustained redn. in CSF sAPPβ, Aβ40, Aβ42, and plasma Aβ40 levels.  CSF Aβ42 lowering showed an EC50 of ∼20 nM with respect to the CSF [TC-1] levels, demonstrating excellent concordance with its potency in a cell-based assay.  These results demonstrate the first in vivo proof of concept of CSF Aβ lowering after oral administration of a BACE1 inhibitor in a nonhuman primate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqnKtfwYLbwbVg90H21EOLACvtfcHk0liANuqBUDoIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFyltw%253D%253D&md5=bbbf7d925fabdae45d82fd01741c3eb6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143628%26sid%3Dliteratum%253Aachs%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DDevanarayan%26aufirst%3DV.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DGates%26aufirst%3DA.%2BT.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DGregro%26aufirst%3DA.%2BR.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DHolloway%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DKahana%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DMoore%26aufirst%3DK.%2BP.%26aulast%3DNantermet%26aufirst%3DP.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DRajapakse%26aufirst%3DH.%26aulast%3DStauffer%26aufirst%3DS.%26aulast%3DSteinbeiser%26aufirst%3DM.%2BA.%26aulast%3DSeabrook%26aufirst%3DG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DTyler%26aufirst%3DK.%2BX.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26atitle%3DFirst%2520demonstration%2520of%2520cerebrospinal%2520fluid%2520and%2520plasma%2520A%25CE%25B2%2520lowering%2520with%2520oral%2520administration%2520of%2520a%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein-cleaving%2520enzyme%25201%2520inhibitor%2520in%2520nonhuman%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D131%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High yield expression of human BACE constructs in <i>Eschericia coli</i> for refolding, purification, and high resolution diffracting crystal forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131-143&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+yield+expression+of+human+BACE+constructs+in+Eschericia+coli+for+refolding%2C+purification%2C+and+high+resolution+diffracting+crystal+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0liANuqBUDoIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520yield%2520expression%2520of%2520human%2520BACE%2520constructs%2520in%2520Eschericia%2520coli%2520for%2520refolding%252C%2520purification%252C%2520and%2520high%2520resolution%2520diffracting%2520crystal%2520forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosfim</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_contrib-group">Read, R. J.; Sussman, J. L.</span>, Eds.;  <span class="citation_source-book">NATO Science Series II: Mathematics, Physics, and Chemistry 245</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powellauthor=R.+J.+Read&author=J.+L.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosfim%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%2BJ.%26btitle%3DNATO%2520Science%2520Series%2520II%253A%2520Mathematics%252C%2520Physics%252C%2520and%2520Chemistry%2520245%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lgs1x9HNMsomg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4002154&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4002154&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4002154&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgs1x9HNMsomg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JOO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JOO','PDB','4JOO'); return false;">PDB: 4JOO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JP9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JP9','PDB','4JP9'); return false;">PDB: 4JP9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JPC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JPC','PDB','4JPC'); return false;">PDB: 4JPC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JPE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JPE','PDB','4JPE'); return false;">PDB: 4JPE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FNK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FNK','PDB','1FNK'); return false;">PDB: 1FNK</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4002154&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm4002154" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4002154" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990af74bf921e5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
